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Abstract 
There are two major protein translocases for protein export across the bacterial 
cytoplasmic membrane - the general secretory (Sec) system and the twin-arginine 
translocation (Tat) system. Both translocases can also insert membrane proteins. The 
Sec machinery inserts multiple transmembrane domains into the cytoplasmic membrane 
by a co-translational mechanism, whereas, the Tat machinery translocates fully folded 
proteins across the membrane and is only known to integrate proteins that carry a single 
transmembrane helix. 
The Rieske protein is a membrane-bound iron-sulphur protein found in electron transport 
chains. In most bacteria, assembly of Rieske is Tat-dependent, as iron-sulphur cofactor 
insertion occurs in the cytoplasm, and the protein usually contains a single 
transmembrane helix anchor. However, in Actinobacteria, this protein comprises three 
transmembrane domains prior to the cofactor-containing domain, causing a biosynthetic 
insertion problem. Previous work has shown that the Streptomyces coelicolor Rieske 
protein is dual-targeted to the cytoplasmic membrane since it requires both the Sec and 
Tat export pathways for correct insertion. 
The aim of this study was to investigate this dual-targeting mechanism and to understand 
the specific features of Rieske that facilitate its release by the Sec machinery and its 
subsequent recognition by the Tat machinery for complete insertion into the membrane. 
Development of reporter assays allowed assessment of the interaction of the 
transmembrane domains of Rieske with either the Sec or the Tat pathway. It was 
discovered that topological determinants, like hydrophobicity and the positive inside rule, 
are crucial to the Sec machinery releasing the third transmembrane domain. In 
comparison, the Tat machinery requires at least seven residues in the cytoplasmic loop 
preceding the Tat motif for efficient recognition of the membrane-tethered substrate. This 
work has elucidated the mechanism by which assembly of the Actinobacterial Rieske 
protein is co-ordinated.  
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1.1 Gram-negative bacteria 
Nearly all bacteria are classified into two types; Gram-positive and Gram-negative. This 
classification is from a staining procedure which was developed in 1884 where 
Gram-positive bacteria retain the staining and Gram-negative do not. This is because of 
the differences in their cell envelopes. 
Gram-negative bacteria, such as Escherichia coli, have three principle layers in their cell 
envelope; the outer membrane (OM), the peptidoglycan layer in the periplasm and the 
inner membrane (IM), as seen in Figure 1.1. The OM is a distinguishing feature of 
Gram-negative bacteria as it is not present in Gram-positive bacteria. The role of the OM 
is to protect the Gram-negative organisms from the environment, it does this by excluding 
toxins and providing a stabilising layer around the cell. The OM is asymmetric and 
composed of a phospholipid inner leaflet and a glycolipid outer leaflet, mostly composed 
of lipopolysaccharides (LPS) (Kamio & Nikaido, 1976). The base unit of the LPS is Lipid 
A, this is followed by inner and outer core polysaccharides and the O-specific 
polysaccharide (or O-antigen).  
Lipid A is also known as endotoxin and elicits a strong immune reaction in mammals. It 
anchors the LPS into the OM and serves as a scaffold for assembly of the LPS. The core 
of the LPS can be divided into two regions: the inner core which is covalently bound to 
Lipid A and the outer core which is the attachment site for the O-antigen. All inner cores 
possess an eight-carbon sugar deoxy-D-manno-octulosonic acid (Kdo) which is the link 
to Lipid A. Together the Kdo moieties and some of the phosphate groups on Lipid A are 
the binding sites for divalent cations that stabilise the OM. The outer cores have a less 
conserved chemical structure reflecting their exposure to selective pressure, for 
example, E. coli has five known core types, R1-4 and K-12 (Raetz & Whitfield, 2002). 
The outer core includes heptoses, hexoses and phosphate groups which can also modify 
Lipid A. The O-antigen is attached to the outer core and is comprised of repetitive units, 
mostly monosaccharides which vary between bacterial species and strains. O-antigen 
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protects the cell from antibiotics which makes it an important target of the complement 
pathway of the immune system (Raetz & Whitfield, 2002). 
 
 
Figure 1.1 Schematic representation of the Gram-negative cell envelope. 
The cell envelope of Gram-negative bacteria is composed of the cytoplasmic (inner) membrane, the 
periplasm and the OM. In the periplasm there is a layer of peptidoglycan and the OM of the LPS contains 
carbohydrate residues, coloured circles and squares. The membranes are composed of different lipids; 
phosphatidylethanolamine (red lipids), phosphatidylglycerol (yellow lipids), and cardiolipin (green lipids). Kdo 
(deoxy-D-manno-octulosonic acid); heptose (l-glycero-d-manno-heptose); n (variable number of O-antigen 
repeats); PPEtn (pyrophosphoethanolamine). Taken from Esko et al. (2009). 
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Proteins in the OM can generally be divided into two classes, lipoproteins and β-barrel 
proteins. Lipoproteins contain lipid moieties which are thought to embed the protein in 
the inner leaflet of the OM, therefore, lipoproteins are not believed to be transmembrane 
proteins. Most transmembrane OM proteins classically adopt β-barrel transmembrane 
structures to allow the passage of molecules. A large number of these are porins which 
are integral pore-forming proteins that function to mediate the transport of small nutrients 
and ions across the membrane with differing selectivity (Nikaido, 2003). 
In comparison to the OM, the IM, also known as the cytoplasmic membrane, consists of 
a symmetric bilayer of phospholipids. E. coli membranes contain approximately 75% 
phosphatidylethanolamine (PE), 20% phosphatidylglycerol (PG), and 5% cardiolipin (CL) 
(Cronan, 2003). This bilayer is semi-permeable and serves as an electrochemical barrier. 
Although some small molecules like O2, CO2 and H2O can freely diffuse through it, other 
molecules are transported by multiprotein complexes (Silhavy et al., 2010). Proteins 
present in the IM can be either peripherally associated with the surface or span the 
bilayer. Many proteins involved in energy production, such as cytochromes and ATP 
synthases, are localised in the IM, therefore, this is where all the energy production for 
the cell takes place during respiration. Translocation machineries are also present to 
enable proteins to be integrated into the membrane or transported into the periplasm. 
The periplasm is the aqueous space located between the IM and the OM and it contains 
the peptidoglycan cell wall. Peptidoglycan consists of parallel strands of 
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) connected by β-1,4 
glycosidic bonds (Vollmer et al., 2008). The rigidity of the peptidoglycan determines cell 
shape. The peptidoglycan wall is only a few layers thick in E. coli and is covalently linked 
to lipoproteins in the OM. The periplasm is more viscous than the cytoplasm and is 
densely packed with proteins (Mullineaux et al., 2006). Some of these proteins are 
involved in cell wall biogenesis and division, nutrient uptake, motor protein assembly and 
anaerobic respiration. 
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1.1.1 E. coli as a model organism 
E. coli is a Gram-negative, rod-shaped bacteria belonging to the family 
Enterobacteriaceae in the phylum of γ-proteobacteria. The E. coli bacterium is typically 
found in the mucus layer of the mammalian colon and it is the most abundant facultative 
anaerobe of the human intestinal microflora. Although most naturally occurring strains 
are harmless, there are some pathogenic strains which cause diarrheal diseases, urinary 
tract infections and meningitis, for example, enteropathogenic E. coli (EPEC) and 
enterhaemorrhagic E. coli (EHEC). Most virulent strains arise through the acquisition of 
virulence genes, such as those encoding the Shiga toxin, and can cause illness in even 
the healthiest host (Johnson & Nolan, 2009). 
The genetic tractability, fast reproduction time and simple growth requirements has 
enabled E. coli to be used as model organism and it has become one of the best 
characterised prokaryotes. The full sequencing of its entire genome has been reported, 
contributing to a better understanding of its genetic and phenotypic diversity. The size of 
the genome varies between strains; standard lab strains have genomes of ~4.5 million 
base pairs and 4000 genes compared to pathogenic strains with over 5.9 million base 
pairs and 5500 genes (Blattner et al., 1997, de Muinck et al., 2013, Lukjancenko et al., 
2010). E. coli K-12 has become a model bacterium used for biochemical and cellular 
studies.  
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1.2 Gram-positive bacteria 
The Gram-positive cell envelope differs from the Gram-negative in several key ways. 
Primarily there is no OM to protect the organism. Instead, the Gram-positive bacterial IM 
(cytoplasmic membrane) is surrounded by layers of peptidoglycan, much thicker than is 
found in Gram-negative bacteria to withstand the high intracellular pressure. Threading 
through the layers of peptidoglycan are long anionic polymers known as teichoic acids, 
which are composed of glycerol phosphate, glycol phosphate or ribitol phosphate 
repeats. A schematic representation of the Gram-positive cell envelope is shown in 
Figure 1.2. 
 
Figure 1.2 Schematic representation of the Gram-positive cell envelope. 
The cell envelope of Gram-positive bacteria is composed of the cytoplasmic (inner) membrane and a 
peptidoglycan layer. The membrane is composed of different lipids; phosphatidylethanolamine (red lipids), 
phosphatidylglycerol (yellow lipids) and LTA (lipoteichoic acids, in green). Taken from Esko et al. (2009). 
 
As in Gram-negative bacteria, the peptidoglycan is composed of disaccharide-peptide 
repeats coupled through glycosidic bonds to form linear glycan strands crosslinked into 
a mesh-like framework (Silhavy et al., 2010). However, unlike Gram-negative cells, the 
Gram-positive peptidoglycan contains many layers and is 30-100nm thick (10-20 layers). 
The specific crosslinks between the glycan strands can differ among organisms (Vollmer 
et al., 2008). 
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Teichoic acids are anionic cell surface polymers, there are two different types; wall 
teichoic acids (WTA) and lipoteichoic acids (LTA). WTAs are coupled to peptidoglycan 
and extend perpendicular to the peptidoglycan mesh, whereas LTAs are anchored to the 
cell membrane. Structural variations in WTAs are extensive but the most common types 
are composed of a disaccharide linkage unit joined to a polyribitol phosphate or 
polyglycerol phosphate chain. LTAs are similar to WTAs but contain polyglycerol 
phosphate repeats of opposite chirality. They are anchored to membrane-embedded 
glycolipids and so extend from the cell surface into the peptidoglycan layers. Both 
teichoic acids comprise a continuum of ionic charge which starts at the cell surface but 
extends beyond the peptidoglycan layer. Although neither WTAs nor LTAs are essential, 
deletion of both pathways is not possible as the genes involved are synthetic lethal (Oku 
et al., 2009, Morath et al., 2005). The functions of teichoic acids are varied and 
species-dependent. The anionic nature allows them to bind cations and play a role in 
cation homeostasis (Marquis et al., 1976). The networks of metal cations between WTAs 
can influence the rigidity of the cell wall and may be involved in scaffolding or activating 
hydrolytic enzymes. Collectively these polymers can contribute to over 60% of the mass 
of the Gram-positive cell wall, indicating their importance to structure and function. 
In addition to teichoic acids, there are a variety of surface proteins some of which are 
analogous to those within the Gram-negative periplasm (Dramsi et al., 2008). All of these 
proteins are retained in or near the membrane. This can be through membrane-spanning 
helices, lipid anchors in the membrane, covalently attached to the peptidoglycan or 
bound to teichoic acids (Scott & Barnett, 2006). These proteins are key to many functions 
of the cell, including; adhesion, invasion, evasion and virulence. 
Within the phylum of Actinobacteria, there is a suborder of Corynebacterineae which 
includes the genera Corynebacterium, Mycobacterium and Nocardia. These bacteria are 
generally classed as high G+C Gram-positive bacteria, however, their cell envelope also 
has characteristics of Gram-negative bacteria. A genome-based phylogeny places them 
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between Gram-positive and Gram-negative (Fu & Fu-Liu, 2002). The cell envelope of 
these bacteria is very complex and this contributes to their virulence.  
The peptidoglycan layer contains covalently attached arabinogalactan which is 
covalently attached to mycolic acids. Mycolic acids have long alkyl side chains giving a 
waxy appearance, which along with the high density of lipids present, interferes with the 
Gram staining test. Corynebacterineae have an OM which seems to be symmetrical, 
unlike the Gram-negative OM, containing the essential mycolic acids and potentially 
similar lipids in both leaflets (Hoffmann et al., 2008). This can be surrounded by a 
non-covalently linked outer capsule of proteins and polysaccharides. 
M. tuberculosis is the aetiological agent of tuberculosis and a member of the 
Corynabacterineae suborder. The unique bacterial cell envelope is key to its success as 
a pathogen. When in a host the envelope can be remodelled, this allows the generation 
of a population of cells which differ in composition of their cell envelopes, potentially 
increasing their survival in vivo (Seiler et al., 2003, Jain et al., 2007). The extractable 
lipids of the cell envelope can act as direct effectors of pathogenesis by modulating the 
host immune responses or altering intracellular trafficking. These differences to other 
bacteria could be useful as targets for inhibitors to treat human disease. 
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1.3 Actinobacteria 
The phylum Actinobacteria is comprised of bacteria with a relatively high Guanine and 
Cytosine content (>55 mol% in genomic DNA) and so are known as high G+C 
Gram-positive bacteria. They are one of the largest phyla within Bacteria and exhibit vast 
diversity in terms of their morphology, physiology and metabolic capabilities. 
Actinobacteria are ubiquitously distributed in both aquatic and terrestrial ecosystems, 
nonetheless, they are most abundant as saprophytic, soil-dwelling organisms that spend 
most of their life cycle as semidormant spores, especially if nutrients are limited. Soil 
populations are dominated by the genus Streptomyces accounting for over 95% of 
Actinomycetales strains isolated from soil. Actinobacteria prefer alkaline soil and soils 
rich in organic matter and are found both on the soil surface and at depths of more than 
2 m below ground (Goodfellow & Williams, 1983). A number of Actinobacteria live in 
close association with higher organisms as a component of different microbiomes, 
contributing to more than a third of healthy human microbiota. 
The life cycle of Actinobacteria is complex, most have a mycelial lifestyle and usually 
reproduce by forming asexual spores, as seen in Figure 1.3. Actinobacteria form a 
substrate mycelium but on solid surfaces may differentiate to aerial hyphae which 
produces reproductive spores. The morphologies of Actinobacteria differ with respect to 
the presence or absence of a substrate mycelium or aerial mycelium, the colour of the 
mycelium, the production of diffusible melanoid pigments, and the structure and 
appearance of their spores (Barka et al., 2016).  
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Figure 1.3 Schematic representation of the life cycle of sporulating Actinomycetes. 
The life cycle begins with spore germination and outgrowth of the substrate mycelium. Reproductive aerial 
hyphae are produced in response to nutritional and other stress signals. These then undergo cell division to 
form spores. Taken from Barka et al. (2016). 
Actinobacteria are of high importance in the field of biotechnology as they produce an 
abundance of bioactive secondary metabolites which have extensive industrial, medical 
and agricultural importance. In particular, Actinomycetes produce approximately 
two-thirds of all known antibiotics, the majority of which are produced by Streptomyces. 
There are also pathogenic strains which cause severe human and animal diseases as 
well as agricultural losses, for example; M. tuberculosis, Corynebacterium diphtheriae, 
and Streptomyces scabies. 
 
1.3.1 Streptomyces 
The genus Streptomyces includes over 150 known species, they are abundant and 
important in the soil and play major roles in the cycling of carbon trapped in insoluble 
organic debris by secreting a variety of hydrolytic exoenzymes. Streptomyces also 
produce a spectacular multitude and diversity of bioactive secondary metabolites which 
are used to compete with other microorganisms. Many of these metabolites have 
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beneficial properties and consequently are of great interest in medicine and industry, for 
example, antibiotic compounds. 
Streptomyces coelicolor is a model system for studying Actinobacteria and is known to 
produce a plethora of different antibiotic compounds, currently around 10000 bioactive 
products. When the genome sequence was published in 2002 for S. coelicolor A3(2) 
(Bentley et al., 2002) over 20 previously-undiscovered biosynthetic gene clusters for 
secondary metabolites were identified (Challis & Hopwood, 2003). This genome also 
contains an unprecedented proportion of regulatory genes, most likely to be involved in 
responses to external stimuli and stresses, possibly explaining why not all metabolites 
have been discovered previously. This indicates that there is potential for new antibiotics, 
anti-tumour drugs and other beneficial molecules from these organisms. 
Genome analysis has revealed a synteny between the central 'core' of the S. coelicolor 
chromosome and the whole chromosome of pathogens M. tuberculosis (Cole et al., 
1998) and C. diphtheriae (Cerdeno-Tarraga et al., 2003) indicating a potential for 
extrapolating data from S. coelicolor into other Actinobacteria. 
 
1.3.2 Mycobacterium 
The genus Mycobacterium harbours some of the most notorious human pathogens 
including M. tuberculosis and M. leprae, the agents responsible for tuberculosis (TB) and 
leprosy, respectively. Mycobacterial diseases are often associated with 
immunocompromised patients especially those with HIV. The pathogenic success of 
these bacteria is in their unusual cell envelope which is essential for intracellular survival 
and enables Mycobacteria to resist a number of antibiotics.  
TB is spread through the air, and M. tuberculosis can remain airborne in water droplets 
for hours. It only requires two or three bacteria to trigger the innate immune response 
where either the host will kill the bacterium, immediately develop an infection or the 
bacterium will remain latent within the body. M. tuberculosis can survive and multiply 
within macrophages which can lead to pulmonary disease or hematogenous 
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dissemination and potential seeding of multiple organs, which may eventually give rise 
to extrapulmonary disease (Getahun et al., 2015).  
The World Health Organisation (WHO) has predicted that nearly one third of the world 
has an asymptomatic or latent TB infection and TB now ranks alongside HIV as a leading 
cause of death worldwide. The Global tuberculosis report for 2015 
(http://www.who.int/tb/publications/global_report/en/) states that in 2014, TB killed 1.5 
million people (1.1 million HIV-negative and 0.4 million HIV-positive). Effective drug 
treatments for TB is a six-month regimen of four first-line drugs: isoniazid, rifampicin, 
ethambutol and pyrazinamide. M. tuberculosis bacteria are becoming resistant to some 
of these drugs, isoniazid and rifampicin, with 480000 cases of multidrug-resistant TB 
(MDR-TB) estimated to have occurred in 2014. New TB drugs are in development and 
TB vaccines are also being investigated. 
  
 
Chapter 1: Introduction 
13 
 
 
1.4 Protein Transport 
Different proteins are located to specific compartments of the bacterial cell. However, all 
of these proteins are synthesised by ribosomes in the cytoplasm and cannot cross 
through or insert into membranes by themselves. Therefore, there are specific protein 
transport machineries which translocate proteins into their designated compartment. 
Protein secretion is the movement of proteins from the cytoplasm through the IM and 
OM to the extracellular medium or into another target cell. This process is carried out by 
specialised Type I to Type VI secretion systems. In contrast, protein translocation is the 
movement of proteins across the IM by either the general secretory (Sec) pathway, the 
YidC-dependent integration pathway or the twin-arginine translocase (Tat) pathway. 
 
1.5 The general secretory (Sec) pathway 
In bacteria, many proteins undergo transport across the cytoplasmic membrane into the 
periplasm using the general secretory (Sec) pathway. This is the main route that proteins 
take to reach the periplasm and is conserved across all domains of life (Pohlschroder et 
al., 1997). The components of the E. coli Sec pathway were identified during the 1980s 
by genetic screening. A number of mutants were isolated exhibiting defective protein 
secretion (sec) and dominant suppressor mutant alleles of protein localisation (prl) genes 
which restored the export of substrates with altered signal peptides (Bieker et al., 1990, 
Trun et al., 1988, Danese & Silhavy, 1998). These mutants led to the discovery of two 
Sec protein complexes involved in the export of proteins (Bieker-Brady & Silhavy, 1992) 
which facilitated the reconstitution of the Sec translocase in vitro (Brundage et al., 1990, 
Akimaru et al., 1991, Bassilana & Wickner, 1993). 
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1.5.1 Sec signal peptides 
Proteins destined for export by the Sec pathway are synthesized as precursor proteins 
with an N-terminal signal peptide that targets them to the translocase. These signal 
peptides do not share sequence homology but have clearly definable features, as seen 
in Figure 1.4. They are usually 18-26 residues in length with a conserved tripartite 
structure. The n-region contains at least one positive charge and is followed by a core 
hydrophobic (h-) region and a polar c-region. These features are important for targeting 
to the Sec pathway; if the positive charges in the n-region are removed then Sec 
translocation is inhibited, in comparison, increasing the number of positive charges 
increases the efficiency of translocation (Sasaki et al., 1990). The c-region contains a 
signal peptidase cleavage site, usually an AxA motif, where A is alanine and x is any 
amino acid. Mutations to this site can inhibit cell growth and protein processing, due to 
the absence of mature Sec-dependent proteins (Barkocy-Gallagher & Bassford, 1992). 
The hydrophobicity of the h-region is crucial for efficient translocation and disruption of 
this hydrophobic core leads to defects in translocation (von Heijne, 1990). This region is 
also involved in targeting to the different Sec translocation routes; post-translationally 
exported proteins recognised by the molecular chaperone SecB or co-translationally 
exported proteins recognised at the ribosome by the signal recognition particle (SRP). 
Signal peptides with a more hydrophobic h-region target to the SRP-dependent pathway, 
whereas less hydrophobic h-regions will target to the SecA/SecB-dependent route for 
export through the Sec machinery (De Gier et al., 1997).  
 
Figure 1.4 General structure of Sec signal peptides. 
The N-terminal Sec signal peptide has a tripartite structure; a positive n-region (green), a hydrophobic 
h-region (grey) and a polar c-region (blue). The signal peptidase AxA cleavage site is located within the 
c-region. 
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1.5.2 Components of the Sec translocon 
The E. coli Sec translocon is heterotrimeric and consists of two universally conserved 
proteins SecY and SecE. A third protein SecG was identified by co-purification with the 
SecYE complex and is not essential for translocation or cell viability but has been seen 
to increase the efficiency of translocation, especially in low temperatures (Nishiyama et 
al., 1993, Nishiyama et al., 1994, Hanada et al., 1994). In eukaryotes the Sec machinery 
consists of Sec61αβγ and in archaea SecYEβ. The first high resolution insight into the 
Sec translocon came from the crystal structure of the archaeon Methanococcus 
jannaschii SecYEβ complex presenting the complex in a closed conformation, seen in 
Figure 1.5 (Van den Berg et al., 2004).  
 
 
Figure 1.5 Structure of the M. jannaschii Sec translocase. 
A) Side view and B) top view (cytosolic face) of the crystal structure obtained from SecYEβ of M. jannaschii 
(Van den Berg et al., 2004). The two halves of SecY are indicated in blue and orange with the plug domain 
in red. SecE is in green and SecG (Secβ) in purple. Figure taken from Du Plessis et al. (2010). 
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From the structure (Figure 1.5) it can been seen that SecY forms the translocation 
channel, consisting of 10 transmembrane domains (TMDs) which are divided into two 
halves (TMDs 1-5 and 6-10) that are pseudo-symmetrically aligned to generate a 
clamshell-like structure. An external loop acts as a hinge and connects TMD5 and TMD6 
at the back of the molecule. The TMDs form an hourglass shape which is constricted, 
approximately halfway across the membrane, by six hydrophobic residues. This is a seal 
that prevents the leakage of ions and may form a hydrophobic ring around the 
translocating polypeptide (Park & Rapoport, 2011, Gumbart & Schulten, 2008, Saparov 
et al., 2007). Structural data has shown that the protruding loops in the cytoplasmic face, 
between TMD6-7 and TMD8-9, are involved in the interactions of SecY with its partner 
protein SecA and the ribosome, indicated in Figure 1.5A (Frauenfeld et al., 2011, 
Menetret et al., 2007, Zimmer et al., 2008). 
A plug domain (Figure 1.5, in red), located on the periplasmic side, is formed by an 
extension of TMD2a and prevents the passage of ions. Deletion of this plug generates 
fluctuations in the channel between closed and open conformations indicating its 
importance in stability (Saparov et al., 2007). The plug is maintained in the closed state, 
however, during transport it undergoes a conformational change and is displaced. To 
allow the insertion of proteins into the IM, the SecY translocon opens laterally between 
TMD2-3 and TMD7-8. This conformational change occurs during protein translocation 
when the signal peptide interacts with TMD2b and TMD7 (Plath et al., 1998, du Plessis 
et al., 2011). 
In E. coli, SecE is an essential 3TMD protein that enwraps the SecY channel by 
contacting both sides of the lateral gate. TMD1 and TMD2 are not essential and are not 
present in most eubacterial SecE proteins, however, the conserved cytoplasmic region 
is found to be essential for function (Murphy & Beckwith, 1994). When SecE is 
underexpressed compared to SecY or when the latter is overexpressed, SecY is 
degraded by FtsH which can lead to an effect on membrane integrity, this indicates that 
SecE stabilises the SecY channel (Kihara et al., 1995). 
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1.5.3 Post-translational Sec translocation 
Proteins destined for the periplasm or the OM undergo post-translational targeting and 
translocation using the SecA/SecB pathway. This decision occurs at the ribosome exit 
tunnel where a cytosolic chaperone, Trigger Factor (TF), is recruited. TF interacts with 
the ribosome subunits L23 and L29 which are located at the ribosome exit tunnel and 
with the nascent chain maintaining it in an unfolded conformation (Kramer et al., 2002, 
Valent et al., 1995). The recognition of the signal peptide of the nascent polypeptide by 
TF recruits the SecB chaperone which binds the precursor protein in its mature region 
(Gannon et al., 1989). Studies of the precursor form of maltose binding protein (MBP) 
have found that in the absence of SecB, MBP will fold into a stable tertiary structure 
which is unable to translocate through the Sec translocon, consequently, the binding of 
SecB prevents the folding of the precursor protein before translocation (Bechtluft et al., 
2007, Collier et al., 1988). The dual functionality of SecB also involves a specific 
interaction with SecA which targets the precursor to the Sec translocon. SecB has been 
crystallised from Haemophilus influenzae and E. coli both structures showing that SecB 
is organised as a dimer of dimers, with two peptide binding grooves on each side (Xu et 
al., 2000, Dekker et al., 2003).  
The motor component of the Sec pathway is SecA, which recognises SecB via 22 
conserved residues in its extreme C-terminus (Fekkes et al., 1997) and also binds to the 
precursor through both its mature region and its signal peptide. SecA interacts with the 
SecYEG complex guiding both the precursor and SecB to the translocon (Hartl et al., 
1990). The precursor is then transferred from SecB to SecA in an energy-independent 
process and SecB is released upon the binding of ATP to SecA, it is this step which 
initiates translocation (Fekkes et al., 1997). 
SecA is a 204kDa ATPase which can be found in both soluble and membrane-bound 
forms. In addition to the C-terminal tail and zinc finger regions that are involved in the 
recognition of SecB, SecA has an N-terminal DEAD helicase motor domain which is 
essential for protein translocation (as the site of ATP binding and hydrolysis), and a 
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preprotein binding domain (Sianidis et al., 2001, Papanikou et al., 2005). The 
translocation of the precursor through the Sec translocon is driven by ATP hydrolysis 
and enhanced by the PMF. 
Translocation of a protein through the Sec pathway has three main steps; sorting and 
targeting (which is discussed above), translocase priming and activation, and the 
translocation of the precursor. Chatzi et al. suggested a model of SecA-mediated 
post-translational translocation through the Sec pathway (Chatzi et al., 2014). In this 
model, ADP-SecA is presented as a tight dimer in the cytoplasm and one subunit 
proceeds to dock onto the SecYEG complex. The preprotein, with or without the 
chaperone SecB, interacts with the SecA-SecYEG complex. Tight signal peptide binding 
to SecA promotes triggering where the activation energy state of the SecA-SecYEG 
complex is lowered, followed by an allosteric change of the conformation of the 
translocase (Gouridis et al., 2009). The preprotein is then trapped by the SecA dimer 
which monomerises and catalyses ATP hydrolysis. This step, with the PMF, initiates the 
translocation of the signal sequence into the SecYEG translocon. The interaction of the 
signal sequence with the lateral gate of SecY causes the flipping of the periplasmic plug 
domain to allow the full translocation of the polypeptide across the membrane (Tam et 
al., 2005). The PMF is involved in different stages of the translocation process, including 
the speeding up of the dissociation of SecA, either by conformational change in SecY or 
promoting ADP release from SecA. Cycles of ATP binding and hydrolysis alongside 
SecA dissociation and rebinding cause the translocation of the polypeptide across the 
membrane. Once the signal sequence reaches the periplasm it can be cleaved by the 
signal peptidase. A simplified model of this translocation process is presented in Figure 
1.6. 
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Figure 1.6 Simplified model of SecA/SecB-dependent post-translational translocation. 
1) Trigger factor (TF) binds the ribosome near the tunnel exit and interacts with the signal peptide (SP) of the nascent polypeptide. The chaperone SecB is recruited, binding the mature 
domain of the polypeptide to prevent premature folding. 2) The C-tail of the ATPase SecA binds SecB and the signal peptide of the polypeptide and recruits both to the SecYEG 
translocon.3) Following docking to the SecYEG complex, ATP binding to SecA elicits the release of SecB. 4) SecA hydrolyses ATP, initiating the insertion of the polypeptide into SecYEG. 
The proton motive force (PMF) and the interaction of the polypeptide with the lateral gate of SecY flips the plug domain causing the channel to open. 5) After translocation the signal 
peptide is cleaved and the mature protein is released into the periplasm and SecA dissociates from SecYEG translocon. ADP is indicated by a D in a red circle and ATP by a T in a 
green circle. 
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1.5.4 Co-translational Sec translocation 
The Sec pathway is also used to insert proteins into the IM independent of SecA/SecB. 
Instead the nascent polypeptide is recognised by the signal recognition particle (SRP) 
as it emerges from the ribosome, this complex is then targeted to the SecYEG complex 
for co-translational translocation to occur. A simplified scheme for the targeting of a 
protein with a single TMD, as a signal anchor, to the Sec complex is described in Figure 
1.7. 
The bacterial SRP is composed of the protein Ffh (fifty-four homologue) bound to 4.5S 
RNA generating a ribonucleoprotein which is essential in bacteria for translocation of 
proteins (Phillips & Silhavy, 1992). Ffh contains two functional domains connected by a 
linker. The C-terminal M-domain and an NG-domain which contains the N-terminal 
domain packed tightly against a central G-domain. The M-domain binds SRP RNA and 
the signal peptide (Hainzl et al., 2011, Keenan et al., 1998, Janda et al., 2010). The 
NG-domain binds the ribosomal subunit L23 at the tunnel exit site, contains the GTPase 
site and interacts with the SRP receptor (Freymann et al., 1997, Halic et al., 2006). 
SRP primarily docks to the L23 subunit of the ribosome close to the polypeptide exit 
tunnel where it scans the emerging nascent chains for hydrophobic sequences (Gu et 
al., 2003). The hydrophobic TMD segment or h-region of a signal peptide binds to a deep 
hydrophobic groove in the M-domain (Janda et al., 2010, Hainzl et al., 2011). This leads 
to the formation of the Ribosome Nascent chain (RNC) complex containing the SRP 
bound to the ribosome and the emerging polypeptide. This complex is targeted to the 
membrane and interacts with the SRP receptor, FtsY, a bacterial peripheral membrane 
protein. FtsY interacts with SecY through cytoplasmic loops C4 (between TMD6-7) and 
C5 (between TMD8-9) which targets the RNC complex to the SecYEG translocon 
(Angelini et al., 2005, Kuhn et al., 2011).  
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Figure 1.7 Simplified model of SRP-dependent co-translational translocation. 
1) During translation a hydrophobic signal anchor (SA) emerges from the ribosome exit tunnel forming a ribosome nascent chain complex (RNC). The signal recognition particle (SRP) 
is recruited. 2) The SRP binds to SA of the nascent polypeptide and the complex targets to the IM. 3) SRP interacts with its receptor (FtsY) and docks the complex onto the SecYEG 
translocon 4) GTP hydrolysis occurs for SRP and FtsY, stimulated by their interaction. SRP is released from the complex allowing the insertion of the polypeptide chain. The SA is 
inserted into the membrane through the lateral gate of SecYEG. 5) Following translocation the components are released. GTP is signified by T in a green circle. 
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The Ffh domain forms a dimer with FtsY with the interaction of their highly homologous 
NG-domains (Luirink et al., 1994, Egea et al., 2004). This dimerization causes 
conformational changes between open, early, closed and activated states which 
stimulates reciprocal GTPase activity of both NG-domains. The GTP hydrolysis allows 
the release of the RNC by weakening the SRP interactions and transfers the nascent 
chain to SecY (Angelini et al., 2005, Egea et al., 2004, Shan et al., 2007). The ribosome 
exit tunnel lines up with the SecY channel allowing translocation of the emerging 
polypeptide (Menetret et al., 2007). Nascent polypeptide insertion triggers lateral gate 
opening between TMD2b and TMD7 allowing TMDs to escape into the membrane (Egea 
& Stroud, 2010).  
Membrane proteins are targeted to the translocon as outlined in Figure 1.7. The 
insertional orientation of Sec-dependent proteins relies on topology determinants, Figure 
1.8 shows a schematic representation of the co-translational insertion of an Nin-Cout 
membrane protein promoted by the positive charges in the N-terminus which remain in 
the cytoplasm. When a hydrophobic segment is inserted into the SecYEG translocon it 
interacts with the lateral gate which opens by 12-14 Å (Egea & Stroud, 2010, Gogala et 
al., 2014). The interactions of the hydrophobic signal peptide with the mammalian Sec61 
channel have recently been unlocked using cryo-EM reconstructions. 
Previously it was found that in the quiescent state, the Sec channel is closed both 
laterally towards the lipid bilayer and axially across the membrane, as shown in Figure 
1.5 (Van den Berg et al., 2004). However, a structure containing the bound ribosome 
indicates that the interaction with the ribosome primes the channel, shown by a 
conformational change which causes a slight opening of the lateral gate and 
destabilisation of the channel (Voorhees et al., 2014). A functional translocation 
intermediate has been reconstructed through cryo-EM to show the RNC stalled at 
position 86 of the preprotein. This structure shows the location of the signal peptide 
between TMD2 and TMD7 of Sec61α, near the lateral gate, and the displacement of the 
plug domain (Voorhees & Hegde, 2016). 
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Figure 1.8 Schematic of co-translational Sec translocation. 
1) The hydrophobic nascent chain enters the Sec translocon directly from the ribosome. 2) Hydrophobic 
residues open the lateral gate within the translocon. 3) This allows the hydrophobic α-helix to contact the 
lipid bilayer and escape into the membrane as a transmembrane domain. 4) The plug is displaced by 
hydrophilic stretches of chain allowing it to cross the membrane into the periplasm. 5) The next hydrophobic 
stretch starts the process again by opening the lateral gate. 6) It then escapes into the membrane and the 
next hydrophilic stretch is released into the cytoplasm. 
 
From this it can be inferred that the hydrophobic segment, positioned in the region of the 
lateral gate, has energetically favourable interactions with the lipid bilayer, which is the 
driving force of intercalation into the lateral gate and the displacement of the plug domain, 
thus, producing a continuous translocation pore (Voorhees & Hegde, 2016). Therefore, 
the signal-engaged Sec61 is open both axially across the membrane and laterally 
towards the lipid bilayer. This open state can allow the hydrophobic segments to escape 
into membrane possibly through the hydrophobic effect, where the TMDs are partitioned 
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into the lipid bilayer using the thermodynamic partitioning model which is supported by 
hydrophobicity scales (Hessa et al., 2005, White & von Heijne, 2008).  
In comparison, hydrophilic segments are retained in the translocon and do not have such 
an effect on the conformation of the channel or lateral gate (Gogala et al., 2014). 
Non-cytoplasmic loops and domains are translocated into the bacterial periplasm or the 
ER lumen with long cytoplasmic regions probably translocated by a mode similar to 
post-translation translocation, continuing until the next hydrophobic segment interacts 
with the lateral gate. Cytosolic domains and loops are released through a gap of 10-20 Å 
on one side of the ribosome-translocon junction (Frauenfeld et al., 2011, Park et al., 
2014, Beckmann et al., 2001).  
 
1.5.5 SecDF-YajC accessory proteins 
SecD, SecF and YajC are membrane components which are encoded within the secD 
operon (Gardel et al., 1990). Together they from a membrane complex which associates 
transiently with the Sec translocon and is thought to stimulate translocation (Duong & 
Wickner, 1997a). Although SecD and SecF are not essential, in E. coli, their inactivation 
causes both a severe protein secretion defect and a severe growth inhibition, especially 
at low temperatures (Pogliano & Beckwith, 1994). Initially these proteins were implicated 
in the post-translational pathway and the cycling of SecA (Duong & Wickner, 1997b). 
They are also thought to be involved in PMF-dependent translocation, however, the 
absence of SecDF does not prevent this translocation (Nouwen et al., 2001).  
The Thermus thermophilus SecDF crystal structure suggests that SecDF is involved in 
the transfer of protons and uses the PMF to undergo conformational changes which 
helps to pull the translocating polypeptide from the SecYEG channel (Tsukazaki et al., 
2011). This is supported by analysis of the SecDF 3D structure by electron tomography 
and single particle reconstruction which showed the SecDF complex adopting two 
different conformations (Mio et al., 2014). 
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1.5.6 Determinants for topology of membrane proteins 
The correct orientation of a protein in the membrane is reliant on the interplay of a 
number of topology rules and determinants including; hydrophobicity, charge difference 
within a helix and the positive inside rule. These are illustrated in Figure 1.9 and 
described below. 
 
Figure 1.9 Topological determinants for the Sec machinery to correctly insert TMDs. 
1) Hydrophobicity is the driving force for TMD insertion into the membrane 2) The charge difference within 
a TMD is based on the location of charged residues within the helix 3) The positive inside rule specifies that 
positive charges are more likely to be located in the cytoplasmic loop regions. 
 
The insertion efficiency of TMDs critically depends on their hydrophobicity and length as 
this impacts the energetically favourable partitioning of the TMDs into the lipid bilayer 
(Hessa et al., 2007, Hessa et al., 2005). Typically this is additive, the more hydrophobic 
and longer the segment is then the higher the insertion propensity of the TMD (White & 
von Heijne, 2008). There have been a number of biological and computational 
hydrophobicity scales to assess the apparent free energy of insertion of a TMD into the 
membrane (MacCallum & Tieleman, 2011). Hessa et al. (2005 and 2007) investigated 
the insertion of engineered polypeptide segments into the endoplasmic reticulum (ER) 
Sec61 translocon, thereby determining the effect of residue position on TMD insertion 
experimentally. Together, this work has enabled the generation of a position-specific 
biological hydrophobicity scale for the ER membrane.  
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This scale shows that the energetic cost of insertion is increased if charged or polar 
residues are located in the central half of a TMD but this can be counterbalanced by the 
presence of flanking apolar residues. Also, that the interaction of the TMD with the lipid 
bilayer plays a role in the insertion of membrane proteins and their topology (Hessa et 
al., 2005, Hessa et al., 2007, White & von Heijne, 2008). 
A similar position-specific biological hydrophobicity scale was subsequently generated 
for the SecYEG-mediated insertion of TMDs into the bacterial IM (Ojemalm et al., 2013). 
The positional relevance of residues in a TMD within the bacterial IM correlates well with 
the values for the mammalian ER membrane (Hessa et al., 2005, Hessa et al., 2007). 
Although, there were differences such as the hydrophobicity threshold for TMD insertion 
is lower in the bacterial IM. 
Marginally hydrophobic helices lack sufficient hydrophobicity to overcome the 
hydrophobicity threshold of a membrane, instead they rely on sequence-extrinsic 
features for their Sec-mediated recognition and insertion. Cytosolic flanking loop regions 
containing positive charges increase the insertion efficiency at a distance and 
density-specific manner (Lerch-Bader et al., 2008). Other features that reduce the 
energetic cost of insertion include electrostatic interactions, hydrogen bond formation 
between neighbouring TMDs and hydrophobic packing (Zhang et al., 2007, Meindl-
Beinker et al., 2006, Ota et al., 2000). 
Positive charges are four times more prevalent in the cytoplasmic regions of a membrane 
protein compared to the periplasmic regions, this phenomenon is known as the positive 
inside rule (Heijne, 1986). This is highly preserved in bacteria and consequently it is rare 
that many positive charges are located in the periplasmic parts of membrane proteins. 
In most cases it is the net positively charged domain which has an impact on the 
orientation of the protein (Andersson et al., 1992). The explanations for the positive 
inside rule include that positive charges on nascent chains in the cytoplasm may interact 
with the negatively charged lipid head groups, therefore, remaining within the cytoplasm 
(Bogdanov et al., 2014). Alternatively, the Sec translocon could be less accommodating 
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for positive charges to be translocated due to the location of oppositely charged residues 
compared to the positive inside rule within the translocation channel (Goder et al., 2004, 
Monne et al., 2005). The PMF may also be involved as, in E. coli, if the membrane 
potential is dissipated, negative and positive charges are rendered topologically 
equivalent (Andersson & von Heijne, 1994). 
The positive charge bias between cytosolic and external domains correlates with the 
membrane topology of the protein (von Heijne, 1989, Nilsson & von Heijne, 1990). If 
positive charges are located in the cytosolic domains then co-translational insertion of 
the TMD is supported (Lerch-Bader et al., 2008, Enquist et al., 2009). Alternatively, 
charges located in non-cytosolic domains can prohibit insertion of the TMD leading to 
topologically frustrated helices (Gafvelin & von Heijne, 1994).  
The charge difference rule gives positive and negative charges equal topological 
strength if they are flanking the TMDs. Therefore, the alteration of the charge balance of 
these residues can affect the orientation of the TMD. This has been demonstrated in 
yeast (Harley et al., 1998) and E. coli (Kim et al., 1994) using single spanning hybrid 
chimeric constructs showing that a monotopic transmembrane protein can be 
engineered to adopt different orientations depending on the charge balance around the 
TMD. 
These topological determinants are especially important in the insertion of the first TMD 
as this topology can affect how all the other TMDs are oriented as most proteins adopt 
alternating orientations relative to the plane of the membrane as a sequential mode of 
topogenesis (Blobel, 1980). Signal sequences are inserted into the membrane in an 
Nin-Cout orientation this enables cleavage by signal peptidases trans of the membrane. 
In comparison, a signal anchor (which could also be TMD1) can be inserted into the 
membrane in two orientations Nout-Cin and Nin-Cout. There are two models for signal 
anchor insertion into the ER membrane; the N-terminal inserts first and then flips (Goder 
& Spiess, 2003, Devaraneni et al., 2011) or the insertion occurs as a hairpin-loop 
(Rapoport, 2007, Shaw et al., 1988). The orientation of the signal anchor is dependent 
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on its flanking charges, hydrophobicity and length of h-domain. The main driving force 
for the orientation is the positive inside rule, indicating that a positive dominance at one 
end favours a cytosolic location (Heijne, 1986, von Heijne, 1989). The other is 
hydrophobicity; increased hydrophobicity slows the rate of insertion, probably due to 
energetically favourable interactions with the lipid bilayer through the Sec lateral gate 
(Higy et al., 2004) and so the more hydrophobic the signal anchor the higher the 
probability for Nout-Cin orientation (Goder & Spiess, 2003, Wahlberg & Spiess, 1997). 
Devaraneni et al. (2011) predicted four mechanically distinct steps for the insertion of an 
Nin-Cout signal anchored protein into the ER membrane. The emerging polypeptide from 
the ribosome is inserted in an Nout-Cin orientation, this is followed by accumulation of the 
nascent chain within the ribosome-Sec61 complex. A topological inversion occurs to flip 
the signal anchor to an Nin-Cout orientation and the C-terminal domain is then translocated 
into the lumen. This inversion only occurs if the positive charges at the N-terminus are 
sufficient whereas high hydrophobicity of the anchor prevents this inversion (Goder & 
Spiess, 2003).   
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1.6 YidC-dependent protein insertion 
The YidC/Alb3/Oxa1 family of membrane proteins from the bacterial IM, the chloroplast 
thylakoid membrane and the mitochondrial membrane, respectively, are involved in the 
folding or insertion of substrates into membranes (Hennon et al., 2015). E. coli YidC is 
60 kDa with 6TMDs and a large periplasmic loop between TMD1 and TMD2 (Saaf et al., 
1998). YidC has 5 conserved TMD that are critical for function, however, the large 
periplasmic domain of E. coli YidC is not involved in the insertase function (Jiang et al., 
2003). YidC is essential in E. coli and a depletion of YidC results in an inhibition of 
membrane protein insertion (Samuelson et al., 2000). 
YidC has been found to crosslink to the Sec substrate (FtsQ) during its membrane 
insertion and is co-purified with SecYEG and SecDF-YajC (Scotti et al., 2000). This 
indicates a role for YidC as a protein insertase cooperating with the Sec machinery. 
When involved in Sec-dependent protein insertion, YidC forms a supercomplex with the 
Sec machinery and functions as a holoenzyme (Scotti et al., 2000, Schulze et al., 2014). 
This positions YidC in close proximity to the SecY channel allowing access to proteins 
escaping into the lipid bilayer by the lateral gate (Sachelaru et al., 2013). Therefore, YidC 
promotes the removal of TMD segments from the SecY channel, facilitates their 
integration into the lipid bilayer and acts as an assembly site for multi-spanning TMD 
proteins (Zhu et al., 2012, Urbanus et al., 2001, Beck et al., 2001). 
In bacteria and mitochondria, YidC and Oxa1, primarily insert and assemble protein 
complexes that are functionally involved in respiration (van der Laan et al., 2005). In 
bacteria, this can occur by YidC alone or with the Sec machinery (Dalbey et al., 2014). 
Important determinants for YidC substrates are moderately hydrophobic TMDs and 
charged residues in the periplasmic domains (Zhu et al., 2013). 
  
 
Chapter 1: Introduction 
30 
 
 
YidC has been crystallised from Bacillus halodurans (Kumazaki et al., 2014c) and E. coli 
(Kumazaki et al., 2014b). These two structures are similar and the transmembrane 
segments of E. coli YidC are shown in Figure 1.10. The conserved 5TMDs of YidC create 
a hydrophilic cavity which is closed from the extracellular side of the membrane but open 
to the cytoplasm and the lipid bilayer. At the entrance to the cavity there is a helical 
hairpin and within the cavity a strictly conserved positively charged residue. The 
C-terminal half of the helical hairpin is conserved and essential for activity in E. coli but 
the positive charge is not important in the Gram-negative YidC (Chen et al., 2014). Most 
substrate interactions occur in the hydrophilic grove between TMD3 and TMD5 
(Kumazaki et al., 2014a, Yu et al., 2008, Klenner & Kuhn, 2012). It is thought that the 
residues facing the hydrophilic cavity bind to the hydrophilic region of the substrate 
whereas the residues that face the membrane help to insert the hydrophobic segment 
into the lipid bilayer. 
 
 
Figure 1.10 Crystal structure of the membrane portion of E. coli YidC. 
Ribbon representations of E. coli YidC with the P1 domain removed and the conserved Arginine-366 shown 
in pink within the hydrophilic cavity. Taken from Hennon et al. (2015). 
  
 
Chapter 1: Introduction 
31 
 
 
From the recent structures of YidC a mechanism for insertion of membrane proteins can 
be deduced (Kumazaki et al., 2014a), the schematic is shown in Figure 1.11. Firstly the 
YidC substrate binds to the membrane, then the N-tail is recruited to the YidC hydrophilic 
groove where it potentially interacts with the conserved positive charge. The N-tail 
crosses the membrane which could be catalysed by the action of the PMF on the 
negative charges present in the translocated region and the hydrophobic interaction 
between the TMD and YidC. Following this, the hydrophobic region probably moves as 
a greasy slide between TMD3 and TMD5 to generate a TMD which is then released from 
YidC into the lipid bilayer. 
 
 
Figure 1.11 Model of membrane protein insertion by YidC. 
A) The substrate is bound to the membrane through its hydrophobicity and YidC is in its resting state. B) 
The hydrophilic segment on the protein contacts the hydrophilic groove of YidC. C) The PMF, hydrophobic 
interactions between the substrate and YidC, and thinning of the membrane facilitate the translocation of the 
substrate. D) The substrate is released into the lipid bilayer and YidC returns to resting state. Taken from 
Hennon et al. (2015). 
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1.7 The twin-arginine (Tat) pathway 
The first insight into a Sec-independent translocation pathway which transports folded 
proteins was from study of plant thylakoid membranes. It was found that a proton 
gradient (ΔpH) was required for translocation of two lumenal proteins across the 
thylakoid membrane (Mould & Robinson, 1991). This ΔpH-dependent pathway was 
recognised to have the ability to translocate fully-folded globular proteins, this is in 
contrast to the Sec pathway which translocates unfolded proteins (Clark & Theg, 1997, 
Hynds et al., 1998). The targeting of these folded proteins is dependent on a signal 
peptide that contains a targeting motif which comprises twin-arginine residues that are 
essential for translocation and when mutated the transport of known substrates is 
prevented (Chaddock et al., 1995). A mutation, hcf106, disrupting the translocation of 
proteins through the ΔpH-dependent pathway was identified in maize (Settles et al., 
1997). This hcf106 gene shows homology to bacterial genes indicating a conservation 
of this pathway between bacteria and plants. 
Similar twin-arginine motifs were located in the signal sequences of a number of bacterial 
proteins which contain oxygen sensitive complex cofactors (Berks, 1996). It was 
hypothesised that these proteins would fold in the cytoplasm as this was the 
compartment in which the cofactors would interact with their proteins. Therefore, a 
different translocating pathway was required as the SecYEG translocon would be unable 
to transport these folded proteins across the IM. An operon mttABC was identified, which 
was required for Sec-independent translocation of proteins presenting the twin-arginine 
motif in their signal peptide and harbouring a cofactor-containing globular domain 
(Weiner et al., 1998). The mutation mttA had no effect on the translocation of Sec 
substrates, however, it prevented the periplasmic location of NapA (nitrate reductase), 
TorA (trimethylamine N-oxide reductase) and DmsA (subunit of the dimethylsulfoxide 
reductase). Subsequently, two E. coli genes were identified which were homologous to 
the maize hcf106 genes and were required for the export of cofactor-containing proteins 
with a twin-arginine motif in their signal peptide (Sargent et al., 1998). This novel pathway 
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which exports folded proteins was named after the targeting motif; the twin-arginine 
translocase (Tat) pathway. 
 
1.7.1 The Tat signal peptide 
Similar to Sec-dependent proteins, substrates of the Tat pathway contain an N-terminal 
cleavable signal peptide used for targeting to the translocation machinery (Berks, 1996). 
They have a related tripartite structure consisting of a polar n-region, a hydrophobic 
h-region and a basic c-region (Figure 1.12), but there are some critical differences 
compared to the Sec signal peptides. The most distinguishable is the Tat motif which is 
essential for targeting and it is located in the junction of the n- and h-regions of the signal 
peptide.  
 
 
Figure 1.12 The tripartite structure of the Tat signal peptide. 
The N-terminal Tat signal peptide has a tripartite structure; a basic n-region (green), a hydrophobic h-region 
(grey) and a polar c-region (blue). The essential Tat motif is found within the n-region, whereas the signal 
peptidase cleavage site is located within the c-region. 
 
This motif, in bacteria, is well conserved with a consensus sequence; SRRxLFK, where 
the twin-arginines are usually invariant (Berks, 1996). There have been many studies 
investigating the requirement of these residues for transport. Site-directed mutagenesis 
of the signal peptide of the E. coli Tat substrates SufI and YacK/CueO found that 
substitutions of one arginine to a positively charged lysine maintained slow transport 
through Tat but substitutions to twin-lysine inhibited Tat translocation (Stanley et al., 
2000). The second arginine is predicted to be more critical for Tat transport (Buchanan 
et al., 2001). Indeed, there are several natural Tat substrates that have variant signal 
peptides where the first arginine is replaced (Hinsley et al., 2001, Ignatova et al., 2002). 
Although the twin-arginine motif is the hallmark for targeting to the Tat machinery alone, 
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they do not prevent translocation by the Sec machinery as there are several Sec 
targeting substrates that also contain twin-arginines in their signal sequences. 
The residue preceding the twin-arginine motif, located position -1 relative to the 
conserved arginines, is frequently a serine and this residue is predicted to act as a helix 
capping residue and stabilises a potential α-helix that is formed by the signal peptide. 
However, when this serine residue in the signal peptide of SufI was substituted to an 
alanine no significant effect was found (Stanley et al., 2000), this is in contrast to similar 
substitutions in the signal peptides of TorA and DmsD which showed either a severe 
slowing or inhibition of export (Mendel et al., 2008). 
The residue at position +3, directly following the twin-arginines, is not conserved, 
therefore, is not predicted to have a role in Tat transport. However, this residue is 
predicted to be required as a spacer between the twin-arginine motif and the following 
hydrophobic residues (Buchanan et al., 2001, Stanley et al., 2000). 
The highly conserved phenylalanine, located at position +4, was found to be important 
for transport. Substitution of this residue for a less hydrophobic residue (tyrosine) or 
charged residues (arginine or aspartate) severely decreased or entirely abolished Tat 
translocation (Stanley et al., 2000, Mendel et al., 2008). Hydrophobicity also seems 
important for the consensus leucine (position +5). In contrast, the positively charged 
lysine residue in position +6 that separates the hydrophobic residues from the h-region 
is thought to slow down the translocation of substrates, potentially to allow time for 
cofactor insertion (Stanley et al., 2000).  
The h-regions of Tat signal peptides (Figure 1.12) are usually less hydrophobic than Sec 
signal peptides. It has been found that increasing the hydrophobicity of the h-region of 
the signal peptide of TorA which was fused to the P2 loop of the Sec-dependent IM 
protein Leader peptidase (Lep) rerouted translocation to the Sec machinery (Cristobal et 
al., 1999). This indicates that the hydrophobicity of the h-region plays a role in Sec 
avoidance. The positive charges located in the c-region have also been found to be a 
Sec avoidance motif critical in preventing targeting to the Sec machinery (Cristobal et 
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al., 1999, Bogsch et al., 1997, Blaudeck et al., 2003). The c-region also contains the 
signal peptidase recognition site, this is usually an AxA motif which allows cleavage of 
the signal peptide by LepB (Luke et al., 2009). This presumably occurs in the later stages 
of translocation when the c-region of the signal peptide reaches the periplasm. 
 
1.7.2 Tat substrates 
The number of Tat substrates which have been predicted and experimentally confirmed 
varies between organisms. E. coli currently has 27 experimentally confirmed substrates 
which are exported into the periplasm using a twin-arginine signal peptide (Tullman-
Ercek et al., 2007, Palmer & Berks, 2012, Berks et al., 2005). A list of current substrates 
is shown in Table 1.1, this reveals that the substrates which utilise the Tat pathway 
usually contain a number of different metal cofactors. Although the Tat pathway is not 
essential in E. coli many of these substrates are involved in important bacterial processes 
which are affected in tat mutant strains; for example, cell growth, motility and iron 
acquisition.  
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Table 1.1 List of known and predicted Tat substrates of E. coli K-12. 
In some cases a Tat substrate lacks its own signal peptide and so is exported in a complex with a signal peptide-binding partner. These substrates listed have the name of the partner 
and the sequence of the signal peptide used for export. Assembly chaperones, which are often involved in the insertion of bound cofactors, are also indicated. ? indicates unknown 
cofactors (Palmer et al., 2010, Berks et al., 2005). 
Protein Physiological role Cofactors Potential Tat chaperone(s) 
Signal 
peptide  Sequence of signal peptide 
Proteins with complex multiatom cofactors 
DmsA DMSO reductase α-subunit MGD, [4Fe-4S] DmsD DmsA MKTKIPDAVLAAEVSRRGLVKTTAIGGLAMASSALTLPFSRIA
HA  
DmsB DMSO reductase β-subunit 4 x [4Fe-4S] DmsD DmsA MKTKIPDAVLAAEVSRRGLVKTTAIGGLAMASSALTLPFSRIA
HA 
FdnG Nitrate-inducible formate dehydrogenase 
α-subunit 
MGD, [4Fe-4S] FdhE FdnG MDVSRRQFFKICAGGMAGTTVAALGFAPKQALAQA  
FdnH Nitrate-inducible formate dehydrogenase 
β-subunit 
4 x [4Fe-4S] FdhE FdnG MDVSRRQFFKICAGGMAGTTVAALGFAPKQALAQA 
FdoG Formate dehydrogenase-O α-subunit MGD, [4Fe-4S] FdhE FdoG MQVSRRQFFKICAGGMAGTTAAALGFAPSVALA 
FdoH Formate dehydrogenase-O β-subunit 4 x [4Fe-4S] FdhE FdoG MQVSRRQFFKICAGGMAGTTAAALGFAPSVALA 
HyaA Hydrogenase-1 small subunit 2 x 4Fe-4S] HyaE, HyaF HyaA MNNEETFYQAMRRQGVTRRSFLKYCSLAATSLGLGAGMAP
KIAWA[ 
HyaB Hydrogenase-1 large subunit [Ni-Fe(CN)2CO] HyaE, HyaF HyaA MNNEETFYQAMRRQGVTRRSFLKYCSLAATSLGLGAGMAP
KIAWA[ 
HybA Electron transfer to hydrogenase 2 4 x [4Fe-4S] - HybA MNRRNFIKAASCGALLTGALPSVSHA 
HybC Hydrogenase-2 large subunit [Ni-Fe(CN)2CO] HybE HybO MTGDNTLIHSHGINRRDFMKLCAALAATMGLSSKAAA 
HybO Hydrogenase-2 small subunit 2 x [4Fe-4S] HybE HybO MTGDNTLIHSHGINRRDFMKLCAALAATMGLSSKAAA 
NapA Periplasmic nitrate reductase MGD, [4Fe-4S] NapD NapA MKLSRRSFMKANAVAAAAAAAGLSVPGVA 
NapG Electron transfer to periplasmic nitrate 
reductase 
4 x [4Fe-4S] - NapG MSRSAKPQNGRRRFLRDVVRTAGGLAAVGVALGLQQQTAR
A 
NrfC Electron transfer to periplasmic nitrate 
reductase 
4 x [4Fe-4S] - NrfC MTWSRRQFLTGVGVLAAVSGTAGRVVA 
TorA TMAO reductase MGD TorD TorA MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQ
A 
TorZ TorA homologue MGD ? TorZ MTLTRREFIKHSGIAAGALVVTSAAPLPAWA 
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YagR Xanthine dehydrogenase family domain 
homologue 
MCD? YagQ YagT MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAVVYPH
STLAASVPA 
YagS Xanthine dehydrogenase family domain 
homologue 
FAD YagQ YagT MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAVVYPH
STLAASVPA 
YagT Xanthine dehydrogenase family domain 
homologue 
2 x [4Fe-4S] YagQ YagT MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAVVYPH
STLAASVPA 
YdhX Iron-sulfur protein 4 x [4Fe-4S] - YdhX MSWIGWTVAATALGDNQMSFTRRKFVLGMGTVIFFTGSASS
LLA 
YedY Sulfite oxidase superfamily homologue Molybdopterin - YedY MKRRQVLKALGISATALSLPHAAHA 
YnfE DmsA homologue MGD, [4Fe-4S] DmsD YnfE MSKNERMVGISRRTLVKSTAIGSLALAAGGFSLPFTLRNAAA 
YnfF DmsA homologue MGD, [4Fe-4S] DmsD YnfF MMKIHTTEALMKAEISRRSLMKTSALGSLALASSAFTLPFSQ
MVRA 
YnfG DmsB homologue 4 x [4Fe-4S] DmsD YnfE/YnfF MSKNERMVGISRRTLVKSTAIGSLALAAGGFSLPFTLRNAAA 
Proteins that lack complex multiatom cofactors 
AmiA N-acetylmuramoyl-L-alanine amidase Metal ions? - AmiA MSTFKPLKTLTSRRQVLKAGLAALTLSGMSQAIA 
AmiC N-acetylmuramoyl-L-alanine amidase Metal ions? - AmiC MSGSNTAISRRRLLQGAGAMWLLSVSQVSLA 
CueO Multicopper oxidase linked to copper 
resistance 
Cu ions - CueO MQRRDFLKYSVALGVASALPLWSRAVFA 
FhuD Ferrichrome-binding protein Fe(III) - FhuD MSGLPLISRRRLLTAMALSPLLWQMNTAHA 
MdoD Involved in osmoregulated periplasmic 
glucan biosynthesis 
? - MdoO MDRRRFIKGSMAMAAVCGTSGIASLFSQAAFA 
SufI Multicopy suppressor of an ftsl mutation None - SufI MSLSRRQFIQASGIALCAGAVPLKASA 
Yael Probable metallo-phosphoesterase Metal ions? - Yael MISRRRFLQATAATIATSSGFGYMHYC 
YahJ Probable metallo-hydrolase Metal ions? - YahJ MKESNSRREFLSQSGKMVTAAALFGTSVPLAHA 
YcbK Unknown ? - YcbK MDKFDANRRKLLALGGVALGAAILPTPAFA 
YcdB Unknown; structural gene overlaps that of 
YcdO 
? - YcdB MQYKDENGVNEPSRRRLLKVIGALALAGSCPVAHA 
YcdO Unknown; structural gene overlaps that of 
YcdB 
? - YcdO MTINFRRNALQLSVAALFSSAFMANA 
WcaM Coded in colonic acid biosynthetic gene 
cluster; possible lyase 
? - WcaM MPFKKLSRRTFLTASSALAFLHTPFARA 
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Streptomyces species are predicted to have a lot more Tat substrates than E. coli, 
indicating that this translocation pathway is more important in these bacteria. For 
example, bioinformatic analysis of the genome sequence of S. coelicolor suggested that 
189 proteins may be substrates of the Tat pathway (Dilks et al., 2003, Bendtsen et al., 
2005). Proteomic studies of S. coelicolor strains with and without the Tat system along 
with testing of candidate Tat signal peptides in Tat-dependent reporter assays has 
confirmed 33 Tat substrates (Widdick et al., 2006, Li et al., 2005). More than 100 
substrates of S. scabies have also been predicted to be exported using the Tat pathway 
and 47 substrates have been verified using an agarose reporter assay with candidate 
Tat signal peptides (Joshi et al., 2010). 
In comparison to most bacteria, M. tuberculosis has an essential functional Tat system 
(Palmer & Berks, 2012, Saint-Joanis et al., 2006). 18 Tat substrates have been 
confirmed using a Bla reporter fused to the candidate Tat signal sequence (Ligon et al., 
2012, McDonough et al., 2005). A number of these substrates are known to contribute 
directly to virulence and drug resistance, for example, the β-lactamase BlaC and 
phospholipase C enzymes (McDonough et al., 2005, Raynaud et al., 2002). As the Tat 
system is absent in humans and essential in M. tuberculosis, it has been investigated as 
a potential drug target for future treatment of TB (Vasil et al., 2012). 
Tat substrates vary in folded size from 20 to 70 Å in diameter, therefore, the Tat 
translocase machinery must be able to accommodate this range of substrates while 
maintaining an ionic seal (Berks et al., 2000). This begs the question as to the need for 
the existence of the Tat pathway and there are several reasons why Tat substrates are 
required to be folded in the cytoplasm before export. 
Primarily, insertion of non-covalently bound complex metal cofactors must take place in 
the cytoplasm. Some of these cofactors are highly oxygen sensitive, therefore, they 
require insertion into the protein in a reducing environment like the cytoplasm (Berks, 
1996). Insertion of other cofactors (for example, nickel into hydrogenase) requires the 
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hydrolysis of nucleotide triphosphates, like GTP, which are only available in the 
cytoplasm (Maier et al., 1995). 
Folding in the cytoplasm could avoid competition between different metal ions for the 
active site of the proteins which could result in the incorporation of an inappropriate metal 
ion. The cell controls this by compartmentalisation, for example, in the cyanobacterium 
Synechocystis PCC 6803 the Mn2+-binding protein, MncA, will only bind the appropriate 
metal ion if it is in molar excess over other ions, as Mn2+ is a weak-binding metal (Tottey 
et al., 2008). Therefore, this ligand binding occurs in the cytoplasm, where other 
competing metal ions, like Cu2+ and Zn2+ are already tightly bound to other proteins, 
before export into the periplasm by the Tat pathway. In comparison, CucA, which binds 
Cu2+, is exported by the Sec pathway and folds in the periplasm where there is an 
abundance of unbound Cu2+. This highlights the importance of the different targeting 
pathways to ensure the appropriate metal is bound to the protein.  
There are also a number of Tat substrates that do not contain cofactors, such as, the cell 
wall amidases AmiA and AmiC (Ize et al., 2003). Other Tat substrates include SoxY and 
SoxZ neither of which contain cofactors, however, they do form a heterodimer, SoxYZ, 
which is involved in thiosulfate oxidation in Paracoccus pantrophus. Only SoxY maintains 
a Tat signal peptide, consequently, these two proteins fold and form a complex before 
co-translocation through the Tat machinery with SoxY carrying SoxZ in a ‘piggy-back’ 
manner (Sauve et al., 2007). Another example of this hitchhiking is E. coli 
hydrogenase 2. The small subunit (HybO) contains a Tat signal peptide whereas the 
large subunit (HybC) does not. However, when either of these proteins are expressed 
without the other they accumulate in the cytoplasm, indicating that the signal sequence 
on HybO is not sufficient to translocate this subunit without the folding and dimerization 
of HybC (Rodrigue et al., 1999). This leads to an alternative justification of the presence 
of the Tat pathway, for the co-translocation of heterodimeric complexes. 
The Tat pathway is versatile and has also been found to translocate lipoproteins and 
some membrane-bound substrates. Several small subunits of bacterial respiratory 
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formate dehydrogenases and uptake hydrogenases are membrane anchored by a single 
carboxy-terminal helix (C-tail). These include; hydrogenase-2 subunits HybO and HybA, 
hydrogenase-1 subunit HyaA, nitrate inducible formate dehydrogenase subunit FdnH 
and formate dehydrogenase-O β-subunit FdoH (Hatzixanthis et al., 2003). The E. coli 
FdnH, a Tat substrate and a major component of nitrate respiration, has been shown to 
contain a TMD by crystallography (Jormakka et al., 2002). This C-tail is potentially a 
‘stop-transfer’ sequence although it could also be laterally translocated into the 
membrane. The use of a YidC depletion strain showed that YidC is not involved with the 
translocation or insertion of these membrane bound Tat substrates (Hatzixanthis et al., 
2003). Another known membrane-bound substrate is the Rieske Iron-sulfur (FeS) 
protein. In contrast, this Tat substrate is anchored to the membrane via an N-terminal 
helix composed of its Tat signal peptide (Molik et al., 2001, Aldridge et al., 2008, 
Bachmann et al., 2006, De Buck et al., 2007). 
Although non-essential in most organisms, the Tat pathway is present in many bacterial 
pathogens, for example, the opportunistic pathogen Pseudomonas aeruginosa 
(Voulhoux et al., 2001), the enterohaemorrhagic E. coli serotype O157:H7 (Pradel et al., 
2003) and Legionella pneumophila (Rossier & Cianciotto, 2005). Conversely, the Tat 
machinery is essential for viability in several organisms; M. tuberculosis (Saint-Joanis et 
al., 2006), haloarchaea (Dilks et al., 2005), Sinorhizobium melitoti (Pickering & Oresnik, 
2010) and Bdellovibrio bacteiovorus (Chang et al., 2011). This indicates important roles 
for Tat substrates and the Tat pathway in virulence. 
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1.7.3 Substrate proofreading and Quality control 
The Tat system has been found to some extent to distinguish between folded and 
unfolded substrates. A fusion of a Tat signal peptide to the Sec-dependent PhoA showed 
no transport into the periplasm as PhoA remains unfolded in the cytoplasm due to the 
reducing environment which prevents the formation of two intra-molecular disulphide 
bonds that are essential for activity and stability (Stanley et al., 2002). However, the 
same fusion expressed in cells engineered to have an oxidising cytoplasm allowed the 
folding of the protein and therefore subsequent translocation through the Tat pathway 
(DeLisa et al., 2003). This led to the hypothesis of a folding quality control mechanism. 
Nevertheless, the E. coli Tat machinery has also been found to translocate small 
unstructured hydrophilic proteins into the periplasm. Unfolded high potential iron-sulfur 
protein (HiPIP) was found to be compatible with translocation through the Tat system as 
it is sufficiently hydrophilic in an unfolded state, however, the addition of a stretch of 
hydrophobic residues abolished translocation (Richter et al., 2007). This is likely due to 
the interactions of the exposed hydrophobic residues with the membrane at a late stage 
in translocation, whereas, in folded proteins these residues are usually hidden. 
Therefore, it is unlikely that the Tat machinery has a specific quality control mechanism, 
but exposed hydrophobic segments in unfolded proteins are prevented from 
translocating by interacting with the lipids in the membrane. 
Proof reading chaperones are not essential for all Tat substrates, as an in vitro assay 
found that SufI was able to be translocated in the absence of any cytosolic chaperones 
(Holzapfel et al., 2009). Nevertheless, chaperone proteins have been found to interact 
with certain Tat substrates before translocation, as depicted in Figure 1.13. 
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Figure 1.13 Quality control and proofreading in the Tat system. 
The correct insertion of cofactors and folding of the Tat substrate protein is ensured by Tat proofreading and 
quality control.1) Chaperones (green) are able to tightly bind to the signal peptide (RR) or domains within 
the apoprotein (blue). 2) Cofactor (red) insertion into the substrate and binding of any partner subunits to 
form a complex (not shown). 3) Chaperones are released and Tat substrates either 4a) interact directly with 
the Tat system or 4b) bind to the lipid bilayer before lateral diffusion toward the Tat system (Bageshwar et 
al., 2009, Shanmugham et al., 2006). The Tat system has been proposed to reject unfolded Tat substrates 
in a process called quality control (DeLisa et al., 2003). Figure adapted from Palmer et al. (2010). 
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DmsD is essential for the biogenesis of the molybdopterin guanine dinucleotide 
(MGD)-containing E. coli enzyme dimethyl sulfoxide (DMSO) reductase (DmsA) and in 
dmsD mutant strains there is no DMSO reductase activity. DmsA binds MGD as a 
catalytic cofactor and DmsD interacts with this preprotein through its signal peptide 
(Oresnik et al., 2001).  
Another chaperone, TorD, which is closely related to DmsD (Sargent et al., 2002), is 
involved in the biogenesis of trimethylamine N-oxide (TMAO) reductase (TorA). TorD 
binds to both the signal peptide and the unfolded mature domain of TorA before the 
molybdenum cofactor has been inserted (Jack et al., 2004, Hatzixanthis et al., 2005, 
Pommier et al., 1998). Recently, a pre-export cofactor-free TorAD complex was 
characterised using small-angle X-ray scattering (SAXS) finding a 1:1 stoichiometry 
which identified two high-affinity binding sites for TorD. When the Tat signal sequence of 
TorA was removed, a stable TorAD complex was still able to be isolated suggesting that 
the correct folding of TorA when the cofactor is inserted, triggers its release from TorD 
prior to translocation through the Tat machinery (Dow et al., 2013).  
NapD, is another Tat chaperone unrelated to TorD and DmsD, and is a small monomeric 
cytoplasmic protein which is essential for the biogenesis of the periplasmic nitrate 
reductase (NapA). NapD interacts with primarily with the NapA signal peptide (Maillard 
et al., 2007). The signal peptide of NapA has been found to undergo conformational 
change upon binding NapD. Analytical centrifugation and SAXS have found the NapAD 
complex in a 1:1 stoichiometry, however, unlike TorAD, this complex cannot form when 
the Tat signal peptide is removed indicating that the NapD chaperone binds solely to the 
NapA signal peptide (Dow et al., 2014). These chaperone-substrate contacts have been 
proposed to delay the interaction of the substrate with the Tat machinery to allow time 
for the passenger domain to fold around the inserted cofactor. 
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1.7.4 Components of the Tat translocon 
The E. coli Tat machinery is a 600 kDa complex consisting of four related membrane 
proteins; TatA, TatB, TatC and TatE (Bogsch et al., 1998, Sargent et al., 1998, Weiner 
et al., 1998). Three of these are encoded on one operon (Figure 1.14A), tatA, tatB and 
tatC, along with a fourth gene, tatD. TatD is a cytoplasmic protein with DNase activity 
but has no function in protein export by the Tat system (Wexler et al., 2000, Sargent et 
al., 1998). The tatE gene is monocistronic (Figure 1.14B), thought to be a cryptic gene 
duplication encoding a functional homologue of TatA (Sargent et al., 1998, Bolhuis et al., 
2001).  
 
Figure 1.14 Organisation of E. coli tat genes. 
Genes encoding components of the Tat system are specified in grey. Nearby genes are shown in white. 
Above the genes the base numbers on the E. coli MG1655 genome are indicated. A) The essential genes 
of the Tat system are located in a single operon alongside tatD, a gene that is co-transcribed but not involved 
with protein translocation (Wexler et al., 2000). B) tatE gene, located as a monocistronic operon found in a 
different region of the genome (Sargent et al., 1998). 
 
Expression studies have shown that tatABC and tatE are constitutively expressed, 
indicating the importance of the translocase system for both aerobic and anaerobic 
growth conditions (Jack et al., 2001). Nevertheless, it has been found that tatE is 
expressed at significantly lower levels than tatA. TatE has over 50% identity with TatA 
and they have overlapping functions so that one protein can partially substitute 
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functionally for the other, although it has been found that TatA is more important for Tat 
translocation (Sargent et al., 1998). A cellular molar ratio has been determined for the 
main Tat components of TatA:B:C as 40:2:1 (Jack et al., 2001, Sargent et al., 1998). 
However, a recent in vivo study has found that TatE potentially interacts with active Tat 
translocases and thus, might be a constituent component of TatABC-based translocases 
under certain conditions (Eimer et al., 2015). 
The TatA family encompasses proteins TatA, TatB and TatE. All of these proteins are 
membrane spanning with one TMD at the N-terminus followed by a short hinge region 
and an amphipathic helix at the C-terminal lying at the membrane-water interface (Hu et 
al., 2010). In E. coli, both TatA and TatB are essential for Tat transport indicating that 
they have distinct roles, conversely, some Gram-positive bacteria have minimal Tat 
systems comprising of just TatA and TatC (Freudl, 2013, Robinson et al., 2011). These 
TatA proteins appear to be bifunctional as the Bacillus subtilis TatA can complement 
both tatA and tatB deletions in E. coli (Barnett et al., 2008). It seems that early gene 
duplication has led to TatB diverging in sequence and function from TatA giving them 
distinct roles in Tat translocation (Yen et al., 2002).  
Solution NMR structures have been obtained for E. coli TatA and TatB proteins, seen in 
Figure 1.15 (Rodriguez et al., 2013, Zhang et al., 2014), and B. subtilis TatAd which is 
representative of the TatA from a minimal Tat system (Hu et al., 2010). All these proteins 
have a similar core structure with a short hydrophobic N-terminal helix suggested to span 
the membrane, positioned at a right angle to an amphipathic helix (APH) which lies 
approximately along the membrane surface. Protease sensitivity experiments and 
cysteine accessibility have found that the C-terminus of these proteins is located in the 
cytoplasm (Porcelli et al., 2002, Koch et al., 2012).  
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Figure 1.15 Solution NMR structures of E. coli TatA and TatB. 
The transmembrane helices (TMHs) and amphipathic helices (APHs) are indicated and the natively 
unstructured C-terminal tails are represented by dashed lines. The essential residue F39 is depicted for 
TatA. Structures were obtained by Zhang et al. (2014) and Rodriguez et al. (2013). Adapted from Berks 
(2015). 
 
TatA proteins oligomerise and increase their association with TatC in response to 
substrate binding and are believed to make up the translocation channel. The TMD is 
essential for oligomerisation (De Leeuw et al., 2001, Porcelli et al., 2002) and the APH 
is vital for function indicated by its intolerance to mutations (Hicks et al., 2005, Barrett et 
al., 2003, Barrett & Robinson, 2005). Crosslinking and single molecule florescence 
discovered that TatA exists in an unstimulated membrane as a homotetramer (Dabney-
Smith & Cline, 2009, Leake et al., 2008), whereas the formation of larger oligomers 
generates a ring structure which can be seen with single particle electron microscopy 
and is thought to be the translocation channel (Gohlke et al., 2005). 
TatB proteins exist in an equimolar complex with TatC and are part of the substrate 
recognition complex. They have a similar structure to TatA but with an additional two 
APH before the disordered C-terminal tail. This longer C-tail can be deleted without 
eliminating TatB function (Lee et al., 2002). Many studies have found that the TMD of 
TatB associates with TatC TMD5, this is known through suppressor analysis (Kneuper 
et al., 2012), site-directed photocrosslinking (Blummel et al., 2015) and disulphide 
scanning crosslinking (Kneuper et al., 2012, Rollauer et al., 2012). 
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Recently structures of the TatC protein of the thermophilic bacterium Aquifex aeolicus 
have been determined by X-ray crystallography in three distinct crystal environments 
(Ramasamy et al., 2013, Rollauer et al., 2012). The similarity between these structures 
indicates that TatC has limited conformational flexibility. The A. aeolicus TatC has 40% 
sequence identity to the E. coli TatC which has allowed functional data to be mapped 
onto the structure giving a greater understanding of the interactions of the TatC protein. 
The structure, shown in Figure 1.16, indicates that the TatC TMDs create a folded shape 
of a cupped hand where the ‘palm’ is a strikingly broad concave cavity and the loops 1 
and 2 act to stabilise the structure with an overhanging cap. TMD5 and TMD6 are too 
short to span the membrane generating a gap between the helix ends and the capping 
structure, thought to be a route between the cavity and the periplasm. The membrane is 
distorted around these two helices which thins the bilayer, potentially as part of the 
translocation process.  
Mutagenesis studies have discovered several key residues in TatC involved in Tat 
translocation. A phenylalanine (F94 in E. coli) residue located in the first cytoplasmic loop 
has been found to inactivate Tat and prevent substrate binding, possibly due to the 
hindrance of substrate recognition (Buchanan et al., 2002, Strauch & Georgiou, 2007, 
Holzapfel et al., 2007). TatC also contains a strictly conserved glutamate/glutamine 
which is located in the centre of the TatC cavity thought to generate a polar environment 
and replacement of this residue compromises E. coli Tat translocation (Holzapfel et al., 
2007, Buchanan et al., 2002). 
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Figure 1.16 X-ray crystal structure of A. aeolicus TatC. 
A) Cartoon representation of the TatC structure coloured from blue (N-terminus) to red (C-terminus) with the 
helix number in the corresponding colour. The position of the membrane bilayer is predicted by molecular 
dynamic simulations. A semi-ordered lauryl maltose neopentyl glycol (LMNG) detergent molecule is shown 
in purple. B) Surface representation of the TatC model. Left and right hand views in A and B are the same 
orientation. Taken from Rollauer et al. (2012). 
 
The TatBC complex is involved in the recognition of the substrate which is the initiating 
step for Tat translocation. There are 6-8 copies of TatB and TatC proteins in this complex 
with equal stoichiometry of each protein (Bolhuis et al., 2001, Tarry et al., 2009). 
Crosslinking experiments have shown that the signal peptide of substrates interacts with 
TatC whereas the passenger domain and the h-region of the signal peptide interacts with 
TatB (Alami et al., 2003, Gerard & Cline, 2006, Maurer et al., 2010). The binding of the 
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twin-arginine motif to TatC mediates specificity of substrate recognition (Rollauer et al., 
2012, Zoufaly et al., 2012, Ma & Cline, 2010, Kreutzenbeck et al., 2007, Strauch & 
Georgiou, 2007). It has been found that the n-region of the signal peptide interacts with 
a surface patch on the cytoplasmic face of TatC, comprising the N-terminal tail and the 
loop region between TMD2 and TMD3. The twin-arginines interact with two conserved 
glutamic acid residues, whereas the consensus phenylalanine in the signal peptide is 
proposed to stack with a conserved phenylalanine (F94 in E. coli) on TatC (Berks et al., 
2014). 
Gerard et al. (2007) studied Thylakoid Tat translocation and discovered that the signal 
peptide can interact with the TatBC complex in two different modes; peripheral-binding 
and deep-interaction. The peripheral-binding mode permitted weak electrostatic 
interactions between the signal peptide and the TatBC complex allowing proteolysis of 
the signal peptide to occur. The deep-interaction mode enabled the signal peptide to be 
buried within the TatBC complex, therefore, inaccessible for proteolysis. Substrates 
could convert to deep-interaction mode when the PMF was present (Gerard & Cline, 
2007). Similarly, two binding modes have been recognised for an E. coli Tat substrate, 
weak-binding to the TatBC complex where the substrate can be exchanged and 
strong-binding where the substrate and TatBC can be co-purified (Bageshwar et al., 
2009, Tarry et al., 2009). Other studies have found the signal peptide and the early 
mature domain binding to the TatBC complex in an inverted hairpin conformation where 
the h-domain is the same height as the TatB TMD, potentially similar to deep-insertion 
mode (Frobel et al., 2012, Hou et al., 2006). 
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1.7.5 Tat translocation 
Four steps have been defined in Tat translocation, shown schematically in Figure 1.17. 
Firstly, the signal peptide is recognised by the TatBC complex. This is followed by the 
assembly of the final translocase with the polymerisation of TatA. Subsequently the 
passenger domain is translocated into the periplasm where the signal peptide is cleaved 
and the translocase dissociates. 
 
Figure 1.17 Schematic model for the Tat translocation cycle in E. coli. 
The Tat translocase is made up of three main proteins; TatA (purple), TatB (orange) and TatC (green). Under 
resting conditions these proteins are found in two distinct complexes, TatBC with 1:1 stoichiometry and TatA 
in tetrameric form (Palmer & Berks, 2012, Leake et al., 2008). 1) The translocation cycle is initiated by the 
interaction of the TatBC complex and the signal peptide of a folded Tat substrate. 2) Upon substrate binding 
to TatBC, TatA polymerisation occurs forming a pore across the cytoplasmic membrane. 3) The substrate 
then crosses the membrane through the TatA channel. 4) Following translocation the signal peptide is 
cleaved by a signal peptidase. TatA subunits dissociate from TatBC and depolymerise back to tetramers.  
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Initially the signal peptide of the Tat substrate binds to the TatBC complex (Cline & Mori, 
2001, Gerard & Cline, 2007). This binding is independent of TatA and does not require 
the PMF (Gerard & Cline, 2007). The substrate might be targeted to the translocation 
machinery by chaperones or through 2D diffusion along the membrane surface (Papish 
et al., 2003, Shanmugham et al., 2006, Bageshwar et al., 2009). 
The formation of a TatBC-substrate complex triggers association of TatA with the TatBC 
complex, leading to the formation of an active translocon (Cline & McCaffery, 2007, Mori 
& Cline, 2002, Maurer et al., 2010). This is a transient interaction of TatA with TatBC 
which is dependent upon the PMF. Chemical crosslinking has shown that thylakoid TatA 
undergoes polymerisation which is induced by the TatBC-substrate complex and the 
PMF (Dabney-Smith & Cline, 2009, Dabney-Smith et al., 2006). In vivo studies with 
E. coli TatA labelled with YFP, have seen that low order oligomers were formed without 
TatBC but when TatBC was present TatA-YFP formed larger complexes (Leake et al., 
2008). However, crosslinking and co-purification experiments have found monomeric 
TatA associated with TatBC before substrate binding, potentially as a nucleation site for 
further TatA polymerisation (Frobel et al., 2011, Taubert et al., 2015, de Leeuw et al., 
2002). The folding state of the substrate appears to be monitored by polymerised TatA 
which is indicated by an in vitro transport reporter protein (PhoA) fused to the signal 
peptide of TorA that stalls with the PhoA passenger domain as a protease resistant 
fragment interacting with TatA (Panahandeh et al., 2008).  
There are two potential models for the translocation system, the first proposes a 
form-fitting channel lined by TatA, occurring in varying diameters to enable translocation 
of differently sized substrates (Sargent et al., 2006, Gohlke et al., 2005). Alternatively, a 
second model proposes that the bilayer is weakened and thinned by oligomerisation of 
TatA and this instability is harnessed to generate transient pores for translocation 
(Dabney-Smith & Cline, 2009, Bruser & Sanders, 2003), this model is supported by 
modelling analysis (Rodriguez et al., 2013). 
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Following translocation the mature substrate is released trans side of the membrane and 
the signal peptide can be cleaved in the c-region at the AxA site by signal peptidase 
(Luke et al., 2009, Yahr & Wickner, 2001). The translocation machinery dissociates upon 
substrate release which is shown by a loss of crosslinking between TatA and TatBC 
(Mori & Cline, 2002).  
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1.8 Respiratory chain 
The aerobic electron transport chain (respiratory chain) of mitochondria and many 
bacteria has four complexes which shuttle electrons to generate a transmembrane 
electrochemical proton gradient (Crofts, 2004). The transfer of electrons is coupled to 
the movement of protons from a region of low proton concentration and negative 
electrical potential (N phase) to a region of high proton concentration and positive 
electrical potential (P phase). This generates an electrochemical proton gradient across 
the membrane which can be used in the cell as an energy source, particularly for the 
synthesis of ATP.  
In mitochondria the components of the respiratory chain are known as Complex I to IV. 
Complex I is a NADH-ubiquinone reductase (NADH dehydrogenase) which catalyses the 
transfer of electrons from the electron donor, NADH, to ubiquinone (UQ). Complex II, 
succinate dehydrogenase, also catalyses the transfer of electrons to UQ but from the 
electron donor reduced FAD. Complex III, ubiquinol-cytochrome c oxidoreductase, 
oxidises UQH2, transferring two electrons to cytochrome c, in a reaction known as the Q 
cycle. Following this, a mobile cytochrome c (known as cytochrome c2 in bacteria) 
shuttles the electrons to Complex IV (cytochrome c oxidase) which transfers them to a 
final acceptor, O2.  
 
1.8.1 Cytochrome bc1 complex and the Rieske protein 
The central component of this system is Complex III, the ubiquinol-cytochrome c 
oxidoreductase which in bacteria and mitochondria is known as the cytochrome bc1 
complex. It has a homologue in plant and algal chloroplasts and in cyanobacteria is 
known as the cytochrome b6f complex (Darrouzet et al., 2004, Berry et al., 2000). This 
complex has three conserved redox active components: cytochrome b, cytochrome c1 or 
f and an FeS cluster containing protein (Berry et al., 2000). It functions to catalyse an 
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electron transfer reaction from a lipophilic substrate ubiquinol (UQH2) to cytochrome c 
coupled with proton translocation across the membrane. 
Cytochrome b consists of 8TMDs and co-ordinates two b-type hemes; bL which is located 
on the periplasmic side (P phase) and is a low potential heme and bH which is located 
on the cytoplasmic side (N phase) and is a high potential heme. There are also two 
possible binding sites for the quinone moieties adjacent to either heme: Qo and Qi. 
Cytochrome c1 is membrane-bound by a C-terminal anchor and has a periplasmic 
domain containing a c type heme. In comparison, the FeS protein (known as Rieske) has 
an N-terminal membrane anchor connected to a globular periplasmic domain containing 
an FeS cluster, [2Fe-2S]. The flexible linker of these domains has the ability to rotate 
allowing the catalytic domain to rearrange its position. The functional form of this complex 
is as a dimer where the Rieske protein interacts with both monomers, its catalytic domain 
interacting with one and the TMD with the other (Xia et al., 1997, Kurisu et al., 2003). 
The mobile cytochrome c2 binds cytochrome c1 substoichiometrically as it only binds to 
one monomer in the dimer. 
The Q cycle involves a two electron carrier, ubiquinol (UQH2), to bind to cytochrome b 
where it can interact with a one electron carrier, Rieske, permitting the transfer of 
electrons to the soluble cytochrome c, as modelled in Figure 1.18 (Cooley, 2013). UQH2 
binds to the Qo site of cytochrome b, one electron is transferred to the FeS domain of 
Rieske and follows a high potential electron transfer chain. There is a 14 Å limit for 
transfer of electrons, therefore, it is vital that the catalytic domain FeS is repositioned to 
dock onto cytochrome c1 for electron transfer, this involves movement of 20 Å (Iwata et 
al., 1998, Zhang et al., 1998, Crofts, 2004). Following the transfer of this electron to the 
membrane bound c-type heme of cytochrome c1, which passes it on to a mobile electron 
carrier protein cytochrome c2, this protein is able to shuttle the electron to the cytochrome 
c oxidase complex. This high potential reaction is coupled to the transfer of two protons 
across the membrane. The second electron is passed to the bL heme of cytochrome b 
where it is transferred to the bH heme and onto the quinone in the Qi site. This is a low 
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potential chain of electron transfer. This entire process is repeated resulting in a net 
transfer of two electrons to cytochrome c and four protons across the membrane.  
 
Figure 1.18 Cartoon model of the turnover of the cytochrome bc1 complex.  
QH2 binds to the Qo site on Cytochrome b and its two electrons are transferred through either a high (blue) 
or low (red) potential electron transport chains. The high potential chain involves transfer through the Rieske 
FeS protein to cytochrome c1 and onto the mobile electron carrier cytochrome c2. The low potential chain 
involves electron cycling through the b-type hemes on cytochrome b. N side is cytoplasmic whereas P side 
is periplasmic. Taken from Cooley (2013). 
 
The biogenesis of cytochrome bc1 involves both the Sec and the Tat translocation 
pathways. Apo-cytochrome c1 and apo-cytochrome b are both inserted into the 
membrane by the Sec pathway (Thony-Meyer & Kunzler, 1997). The c-type heme is 
covalently inserted into cytochrome c1 by the system I cytochrome c biogenesis 
machinery, whereas, the b-type heme is spontaneously inserted into cytochrome b. The 
cofactor insertion into Rieske is coordinated by Cys residues which form a disulphide 
bond for stability (Iwata et al., 1998, Hunte et al., 2000). The domain is folded as a 
globular structure which incorporates the FeS cluster close to the surface and is 
connected to the N-terminal membrane anchor through a flexible tether linker. Failure to 
insert the FeS cluster into Rieske impairs the assembly of this protein into the 
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cytochrome bc1 complex (Gutierrez-Cirlos et al., 2002). In the B. subtilis Rieske protein 
there is a sequential and hierarchical quality control for cofactor binding and disulphide 
bond formation to prevent membrane insertion of unfolded, cofactor-less proteins 
(Goosens et al., 2014).  
In contrast to the cytochromes, the Rieske protein has been found to be a Tat substrate 
in bacteria and plants, for example in Legionella pneumophila, Paracoccus dentrificans 
and in plant thylakoids (De Buck et al., 2007, Molik et al., 2001, Bachmann et al., 2006). 
There are two classes of Tat-dependent substrates that are inserted into the membrane; 
C-terminal anchored and N-terminal anchored (Berks, 1996). The Rieske protein is in 
the latter class, the N-terminal anchor is composed of the Tat targeting signal sequence 
which is uncleaved and remains in the membrane (Aldridge et al., 2008, Bachmann et 
al., 2006, De Buck et al., 2007, Molik et al., 2001, Meloni et al., 2003). 
 
1.8.2 Actinobacterial cytochrome bc1 complex 
In Actinobacteria, the major route for aerobic quinol oxidation is through the cytochrome 
bc1 and cytochrome aa3 complexes. Studies in Corynebacterium glutamicum have 
identified the genes coding for cytochrome bc1 and cytochrome aa3 complexes (Niebisch 
& Bott, 2001, Sone et al., 2001). Cytochrome bc1 genes are qcrA, qcrB and qcrC and 
these are located in a cluster, downstream of subunit III of cytochrome aa3, ctaE. The 
other cytochrome aa3 subunit genes are located elsewhere, ctaD and ctaC. These genes 
are homologous in Mycobacteria and Streptomyces (Sone et al., 2001). 
There are distinct differences between the cytochrome bc1 complex in Actinobacteria, 
compared to other bacteria (Niebisch & Bott, 2001, Sone et al., 2001). The cytochrome 
b (QcrB) has 9 TMD instead of 8 and a small globular domain is present at the trans side 
of the membrane. The cytochrome c1 (QcrC) has been found to have two CxxCH motifs 
which are important for covalent heme attachment. This implies that it is a di-heme c-type 
cytochrome. As there are no soluble c-type cytochromes present in these bacteria it is 
predicted that this additional c-type heme functions as the cytochrome c2 and shuttles 
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the electrons from cytochrome c1 to cytochrome aa3 complex. This functionality would 
only be possible if the two complexes were interacting. Both complexes can be 
co-purified together indicating the potential for a supercomplex of cytochrome bc1-aa3 
(Niebisch & Bott, 2003). The Rieske protein (QcrA) is also different in these cytochrome 
bc1 complexes as it has increased hydrophobicity with 3 TMDs N-terminal to the globular 
domain instead of 1 TMD. Despite these differences in the complexes involved in proton 
transfer and the importance of these bacteria as agents of disease, not much is known 
about the essential respiratory chain in these organisms. 
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1.9 Co-operation between Sec and Tat translocation 
The protein sequence alignment seen in Figure 1.19 shows that Actinobacterial Rieske 
proteins (from S. coelicolor, C. glutamicum and M. tuberculosis) have three TMDs 
directly before the catalytic FeS globular domain, this is in comparison to other bacterial 
Rieske proteins. The increased TMDs causes a biosynthetic problem for insertion of 
Rieske proteins as they are usually Tat-dependent and it is not known whether the Tat 
machinery is able to insert more than one TMD. From the alignment of amino acid 
sequences of Rieske proteins, the essential Tat motif is located N-terminal of TMD3, 
suggesting that the Tat machinery is involved in the insertion of TMD3 and the 
translocation of the cofactor domain. Keller et al. (2012) investigated the insertion of 
S. coelicolor Rieske within the heterologous host E. coli. Using reporters fused to the 
transmembrane component of Rieske they discovered that the Tat motif is recognised 
and TMD3 and the FeS domain are translocated by the Tat machinery. In comparison, 
the first two TMD interact with the Sec machinery for insertion, probably through the 
co-translational SRP pathway and has been shown to be YidC-dependent.  
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Figure 1.19 Protein sequence alignment of the Rieske iron-sulfur proteins from different bacteria.  
Proteins were aligned using Clustal WS and Jalview (Waterhouse et al., 2009). The longer Rieske FeS 
proteins of actinobacterial representatives (Streptomyces coelicolor, Corynebacterium glutamicum and M. 
tuberculosis) are aligned alongside the well-characterised Rieske proteins of Rhodobacter sphaeroides and 
Paracoccus dentrificans. Transmembrane domains (TMD) were predicted using TMHMM Server v. 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) and are marked in red above the alignment. The consensus 
twin-arginine (Tat) motif is highlighted in purple. Conserved boxes I and II that coordinate the 2Fe-2S cluster 
are highlighted in green. The arrow indicates the position after which the reporter proteins were fused. The 
differences in shading (from light blue to dark) refer to the level of amino acid conservation between the 
different species. 
 
From this data, a model of insertion was suggested (Figure 1.20), where TMD1 and 
TMD2 are inserted into the cytoplasmic membrane by the Sec machinery with the 
assistance of YidC. Following the release of the polypeptide by the Sec machinery, the 
FeS cluster is assembled into the globular domain in the cytoplasm before the Tat 
machinery takes over and inserts the final TMD and translocates the cofactor containing 
domain into the periplasm. 
These results were confirmed in S. coelicolor, the native organism, where the Tat system 
was demonstrated to be essential for the activity of the cytochrome bc1 complex. This is 
due to the requirement for the Tat machinery to translocate the FeS domain of Rieske. 
However, the Rieske protein is stably inserted into the membrane in the absence of the 
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Tat system implying that the Rieske protein is dual targeted to the membrane within 
S. coelicolor (Hopkins et al., 2014). This is the first protein known to require co-operation 
of the Sec and Tat pathways for its insertion. 
 
 
Figure 1.20 Model for the biogenesis of the S. coelicolor Rieske protein. 
1) SRP binds to the first hydrophobic segment of Rieske emerging from the ribosome and guiding the 
complex to the Sec machinery. 2) The first two TMDs of Rieske are inserted into the membrane 
co-translationally. 3) The FeS cluster is inserted into Rieske, leading to the folding of the globular domain. 
4) The Tat system inserts TMD3 and translocates the FeS cluster-containing domain into the periplasm. 5) 
Fully assembled Rieske is released into the membrane, where it interacts with partner proteins in the 
cytochrome bc1 complex. Adapted from Keller et al. (2012). 
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1.10  Aims 
The overall aim of this study is to define key regions of the S. coelicolor Rieske protein 
that are important for the interaction with the Sec and Tat machineries during its dual 
targeted insertion. Specifically, to identify which features of the Rieske protein promote 
the protein’s release from the Sec pathway and which facilitate recognition of an internal 
signal sequence by the Tat machinery. This work used reporter proteins fused to the 
TMDs of S. coelicolor Rieske and expressed in the heterologous host E. coli.  
First, it was essential to investigate potential fusion reporters to ensure robust and 
reliable assays that indicated clear positive and negative results (Chapter 3). Following 
this, a full programme of mutagenesis was undertaken to elucidate any important 
features for interactions with the Sec or Tat machinery, which was then followed by 
biochemical approaches to confirm these results (Chapters 4 and 5). 
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2 Materials and Methods 
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2.1 Bacterial strains 
All strains used in this study are derived from Escherichia coli K-12 and are listed in 
Table 2.1. Strain DH5α was used for general transformation of plasmid vectors and 
cloning. Strains MC4100 and DADE were used for all work with β-lactamase-encoding 
constructs and MCDSSAC and MCDSSAC∆tat were used for all work with 
AmiA-encoding constructs, as appropriate tat+ and tat- strains, respectively. 
 
Table 2.1 Bacterial strains used in this study. 
Strains Genotype Resistance Reference 
MC4100 F-∆lacU169 araD139 rpsL150 relA1 ptsF 
rbs flbB5301 
None (Casadaban & 
Cohen, 1979) 
DADE MC4100 ∆tatABCD ∆tatE None (Wexler et al., 
2000) 
MCDSSAC MC4100 amiA∆2-33, amiC∆2-32  None (Ize et al., 2003) 
MCDSSAC∆tat  MCDSSAC, ∆tatABC::Apra  Apra (Keller et al., 
2012) 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 
gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK- mK+), 
λ– 
None (Grant et al., 
1990) 
 
2.2 Materials 
2.2.1 Growth media and growth conditions 
Growth media and additives used in this study are outlined in Table 2.2, Table 2.3 and 
Table 2.4. Strains were commonly grown aerobically overnight at 37°C in Luria-Bertani 
(LB) liquid broth with vigorous shaking at 200 rpm. Growth on solid media was also 
performed at 37°C. 
Long term storage of strains was carried out at -80°C by the addition of a final 
concentration of 25% glycerol to a stationary phase culture, with this being flash frozen 
in liquid nitrogen before storage. 
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Table 2.2 Growth media used in this study. 
Media name Component Concentration 
Luria-Bertani (LB) medium Tryptone 
Yeast extract 
NaCl 
1.0 % (w/v)  
0.5 % (w/v) 
1.0 % (w/v) 
LB agar Agar 
Tryptone 
Yeast extract 
NaCl 
1.5 % (w/v) 
1.0 % (w/v)  
0.5 % (w/v) 
1.0 % (w/v) 
Low salt LB agar Agar 
Tryptone 
Yeast extract 
NaCl 
1.5 % (w/v) 
1.0 % (w/v)  
0.5 % (w/v) 
0.5 % (w/v) 
TSB/DMSO medium 
(transformation buffer) 
Tryptone 
Yeast extract 
NaCl 
DMSO 
MgSO4 
Polyethylene glycol (MW 6000) 
1.0 % (w/v)  
0.5 % (w/v) 
1.0 % (w/v) 
5.0 % (v/v) 
50 mM 
10.0 % (w/v) 
 
Table 2.3 Additives used throughout this study. 
Supplement Stock solution Final concentration 
Sodium dodecyl sulphate (SDS) 20 % (w/v) 1-2 % 
 
Table 2.4 Antibiotics used in this study with their stock and working conditions. 
Stock solutions of amp, Kan and apra were prepared in distilled water. Cm was prepared in 80 % (v/v) 
ethanol. All stock solutions were filter sterilised prior to use.  
Antibiotic Stock concentration Final concentration 
Ampicillin (amp) 125 mg/ml 125 µg/ml 
Kanamycin (Kan) 50 mg/ml 50 µg/ml 
Apramycin (apra) 25 mg/ml 25 µg/ml 
Chloramphenicol (Cm) 25 mg/ml 25 µg/ml 
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2.3 Buffers and solutions 
Table 2.5 General buffers and solutions used in this study 
Buffer/solution Composition Concentration 
APS Ammonium persulphate 10 % (w/v) 
DNA loading dye Bromophenol blue  
Xylene cyanol blue  
Sucrose  
0.25 % (w/v) 
0.25 % (w/v)  
40 % (w/v) 
6x sample buffer Tris‐HCl (pH 6.8) 
SDS 
β‐mercaptoethanol 
Glycerol 
Bromophenol blue 
62.5 mM 
2 % (w/v) 
15 % (v/v) 
25 % (v/v) 
0.01 % (w/v) 
Laemmli sample buffer (2x) Tris‐HCl (pH 6.8) 
SDS 
β‐mercaptoethanol 
Glycerol 
Bromophenol blue 
65.8 mM 
2.1 % (w/v) 
355 mM 
26.3 % (w/v) 
0.01 % (w/v) 
HEPES/MgCl2 (pH 6.8) HEPES 
MgCl2 
50 mM 
5 mM 
SDS running buffer (10x) Tris-HCl (pH 8.3) 
Glycine 
SDS 
250 mM 
1.92 M 
1.0 % (w/v) 
TAE buffer Tris-HCl (pH 8.0) 
Glacial acetic acid 
EDTA 
40 mM 
1.142 % (v/v) 
1 mM 
Tris Buffered Saline (TBS)  
 
Tris‐HCl (pH 7.5) 
NaCl 
20 mM 
137 mM 
TBS/Tween (TBST) Tris-HCl (pH7.5) 
NaCl 
Tween®20 
20 mM 
137 mM 
0.1 % (v/v) 
Tris-glycine transfer buffer Tris/HCl (pH8.8) 
Glycine 
Methanol 
25 mM 
192 mM 
10 % (v/v) 
Buffer 1 (membrane buffer) Tris-HCl (pH 7.5) 
NaCl 
20 mM 
200 mM 
Buffer 2 (membrane 
resuspension buffer) 
Tris-HCl (pH7.5) 
MgCl2 
Glycerol 
50 mM 
5 mM 
10 % (v/v) 
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2.4 Molecular biology techniques 
2.4.1 Preparation of competent cells and transformation with plasmid 
DNA 
50 ml of LB broth (with required antibiotics) was inoculated at 1:100 dilution from a 
stationary phase culture and grown aerobically at 37°C with shaking at 200 rpm until an 
OD600 of 0.4 was achieved. After incubation for 20 min on ice, cells were harvested by 
centrifugation at 3000 x g for 10 min. Cell pellets were resuspended in ice cold 
TSB/DMSO medium and kept on ice for a minimum of 10 min before use or frozen in 
liquid nitrogen and stored at -80°C. Transformation was performed by incubating 100 µl 
of competent cells with 1 µl of plasmid (or 10 µl of ligation mix) for 15 min on ice. Cells 
were subjected to heat-shock at 42°C for 90 s followed by an additional 2 min incubation 
on ice. 1 ml of LB was added and cells were grown, with shaking, at 37°C for 1 h. Cells 
were then pelleted by centrifugation at 16000 x g for 1 min. This was followed by plating 
of cells onto LB agar plates containing required antibiotics and incubation overnight at 
37°C. 
 
2.4.2 Plasmid DNA preparation 
Plasmid extraction from E. coli strains was undertaken using the QIAprep® Spin Miniprep 
kit (Qiagen), as per the manufacturer’s instructions, this procedure uses an alkaline lysis 
method developed by Birnboim and Doly (Birnboim & Doly, 1979). A single colony was 
used to inoculate a 5 ml culture which was grown until stationary phase before 
centrifugation for 10 min at 3000 x g. Cells were subsequently resuspended in lysis buffer 
and then treated with neutralisation buffer before isolation of the plasmid DNA through 
adsorption onto a silica membrane under high salt conditions. After washing, the DNA 
was eluted from the membrane in 30 µl of either a low-salt elution buffer or ultra-pure 
water. 
The plasmids used in this study are shown in Table 2.6. 
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Table 2.6 Bacterial plasmids used in this study. 
Plasmid name Vector Characteristics Antibiotic 
resistance 
Reference  
pSUPROM pSU40 Expression vector with constitutive E. coli tatA promoter  Kan (Jack et al., 
2004) 
pSU18 pSU18 Expression vector with constitutive E. coli lac promoter Cm (Bartolome et 
al., 1991) 
pSUPROM Rieske-Bla pSUPROM pSUPROM producing aa 1-185 of Sco2149 fused to aa 24-286 of 
β-lactamase obtained by PCR amplification from pBR322 (source 
of Bla from transposon Tn3) 
Kan This study 
pSUPROM Rieske-AmiA pSUPROM pSUPROM producing aa 1-185 of Sco2149 fused to aa 32-289 of 
E. coli AmiA 
Kan This study 
pSU18 AmiA pSU18 pSU18 producing aa 1-289 of E. coli AmiA Cm (Ize et al., 
2003) 
pSUPROM AmiA pSUPROM pSUPROM producing aa 1-289 of E. coli AmiA  Kan This study 
pSUPROM Bla pSUPROM pSUPROM producing aa 24-286 of β-lactamase obtained by PCR 
amplification from pBR322 
Kan This study 
pSU18 Rieske-AmiA pSU18 pSU18 producing aa 1-185 of Sco2149 fused to aa 32-289 of 
E. coli AmiA 
Cm (Keller et al., 
2012) 
pSU18 RRKK-Rieske-AmiA pSU18 pSU-TM123-AmiA with substitution of aa 161-162 of Sco2149 
from RR to KK 
Cm (Keller et al., 
2012) 
pHASoxYZ pSU20 pFLUOR2A_YFP_C producing P. panthotrophus soxYZ under the 
control of E. coli tatA promoter with the signal peptide of SoxY 
replaced by an N-terminal haemagglutinin tag  
Cm (Bauer et al., 
2011) 
pSUPROM MTB Rieske-AmiA pSUPROM pSUPROM producing aa 1-227 of M. tuberculosis H37Rv QcrA 
codon optimised for E. coli fused to aa 32-289 of E. coli AmiA 
Kan This study 
pSUPROM MTB Rieske-Bla pSUPROM pSUPROM producing aa 1-227 of M. tuberculosis H37Rv QcrA 
codon optimised for E. coli fused to aa 24-286 of β-lactamase 
obtained by PCR amplification from pBR322 
Kan This study 
pSUPROM Rieske-Bla RHHR pSUPROM pSUPROM Rieske-Bla with substitution of aa 133-134 of Rieske 
from RH to HR 
Kan This study 
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pSUPROM Rieske-Bla RHKK pSUPROM pSUPROM Rieske-Bla with substitution of aa 133-134 of Rieske 
from RH to KK 
Kan This study 
pSUPROM Rieske-Bla A138P pSUPROM pSUPROM Rieske-Bla with substitution of aa 138 of Rieske from 
A to P 
Kan This study 
pSUPROM Rieske-Bla A144P pSUPROM pSUPROM Rieske-Bla with substitution of aa 144 of Rieske from 
A to P 
Kan This study 
pSUPROM Rieske-Bla A148P pSUPROM pSUPROM Rieske-Bla with substitution of aa 148 of Rieske from 
A to P 
Kan This study 
pSUPROM Rieske-Bla A154P pSUPROM pSUPROM Rieske-Bla with substitution of aa 154 of Rieske from 
A to P 
Kan This study 
pSUPROM Rieske-Bla M124A pSUPROM pSUPROM Rieske-Bla with substitution of aa 124 of Rieske from 
M to A 
Kan This study 
pSUPROM Rieske-Bla S125A pSUPROM pSUPROM Rieske-Bla with substitution of aa 125 of Rieske from 
S to A 
Kan This study 
pSUPROM Rieske-Bla D126A pSUPROM pSUPROM Rieske-Bla with substitution of aa 126 of Rieske from 
D to A 
Kan This study 
pSUPROM Rieske-Bla E127A pSUPROM pSUPROM Rieske-Bla with substitution of aa 127 of Rieske from 
E to A 
Kan This study 
pSUPROM Rieske-Bla M124L pSUPROM pSUPROM Rieske-Bla with substitution of aa 124 of Rieske from 
M to L 
Kan This study 
pSUPROM Rieske-Bla S125L pSUPROM pSUPROM Rieske-Bla with substitution of aa 125 of Rieske from 
S to L 
Kan This study 
pSUPROM Rieske-Bla D126L pSUPROM pSUPROM Rieske-Bla with substitution of aa 126 of Rieske from 
D to L 
Kan This study 
pSUPROM Rieske-Bla E127L pSUPROM pSUPROM Rieske-Bla with substitution of aa 127 of Rieske from 
E to L 
Kan This study 
pSUPROM Rieske-Bla RRKK pSUPROM pSUPROM Rieske-Bla with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to KK 
Kan This study 
pSUPROM Rieske-Bla RRKQ pSUPROM pSUPROM Rieske-Bla with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to KQ 
Kan This study 
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pSUPROM Rieske-Bla RRAA pSUPROM pSUPROM Rieske-Bla with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to AA 
Kan This study 
pSUPROM Rieske-Bla RRAD pSUPROM pSUPROM Rieske-Bla with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to AD 
Kan This study 
pSUPROM Rieske-Bla ∆RR pSUPROM pSUPROM Rieske-Bla with deletion of aa (RR Tat motif) 161-162 
of Rieske  
Kan This study 
pSUPROM Rieske-Bla ∆118-122 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-122 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆123-127 pSUPROM pSUPROM Rieske-Bla with deletion of aa 123-127 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆128-132 pSUPROM pSUPROM Rieske-Bla with deletion of aa 128-132 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆133-137 pSUPROM pSUPROM Rieske-Bla with deletion of aa 133-137 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆138-142 pSUPROM pSUPROM Rieske-Bla with deletion of aa 138-142 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆143-147 pSUPROM pSUPROM Rieske-Bla with deletion of aa 143-147 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆148-152 pSUPROM pSUPROM Rieske-Bla with deletion of aa 148-152 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆153-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 153-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-127 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-127 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆128-137 pSUPROM pSUPROM Rieske-Bla with deletion of aa 128-137 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆138-147 pSUPROM pSUPROM Rieske-Bla with deletion of aa 138-147 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆148-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 148-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆138-152 pSUPROM pSUPROM Rieske-Bla with deletion of aa 138-152 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆123-137 pSUPROM pSUPROM Rieske-Bla with deletion of aa 123-137 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆128-142 pSUPROM pSUPROM Rieske-Bla with deletion of aa 128-142 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆133-147 pSUPROM pSUPROM Rieske-Bla with deletion of aa 133-147 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-132 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-132 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆143-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 143-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-137 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-137 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆138-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 138-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-142 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-142 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆123-147 pSUPROM pSUPROM Rieske-Bla with deletion of aa 123-147 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆128-152 pSUPROM pSUPROM Rieske-Bla with deletion of aa 128-152 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆133-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 133-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-147 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-147 of Rieske Kan This study 
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pSUPROM Rieske-Bla ∆123-152 pSUPROM pSUPROM Rieske-Bla with deletion of aa 123-152 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆128-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 128-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆123-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 123-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-152 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-152 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-153 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-153 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-154 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-154 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-155 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-155 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-156 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-156 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆118-157 pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-157 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆126-127 pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-127of Rieske Kan This study 
pSUPROM Rieske-Bla ∆127-128 pSUPROM pSUPROM Rieske-Bla with deletion of aa 127-128 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆126-128 pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-128 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆131-132 pSUPROM pSUPROM Rieske-Bla with deletion of aa 131-132 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆137Δ141 pSUPROM pSUPROM Rieske-Bla with deletion of aa 137 & 141of Rieske Kan This study 
pSUPROM Rieske-Bla ∆149Δ156 pSUPROM pSUPROM Rieske-Bla with deletion of aa 149 & 156 of Rieske Kan This study 
pSUPROM Rieske-Bla ∆131-132 
Δ141 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 131 & 132 & 141 of 
Rieske 
Kan This study 
pSUPROM Rieske-Bla ∆126-128 
Δ131-132 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-128 &131-132 of 
Rieske 
Kan This study 
pSUPROM Rieske-Bla ∆126-128 
Δ137 Δ141 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-128 &137 &141 of 
Rieske 
Kan This study 
pSUPROM Rieske-Bla ∆131-132 
Δ137 Δ141 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 131-132 & 137 &141 of 
Rieske 
Kan This study 
pSUPROM Rieske-Bla ∆126-128 
Δ131-132 Δ137 Δ141 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-128 &131-132 
&137 & 141 of Rieske 
Kan This study 
pSUPROM Rieske-Bla ∆126-128 
Δ131-132 Δ137 Δ141 Δ149 Δ156 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 126-128 &131-132 
&137 & 141 &149 & 156 of Rieske 
Kan This study 
pSUPROM Rieske-Bla D131A E132A pSUPROM pSUPROM Rieske-Bla with substitution of aa 131 & 132 of Rieske 
to A 
Kan This study 
pSUPROM Rieske-Bla E137A E141A pSUPROM pSUPROM Rieske-Bla with substitution of aa 137 & 141 of Rieske 
to A 
Kan This study 
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pSUPROM Rieske-Bla D126A E127A 
E128A 
pSUPROM pSUPROM Rieske-Bla with substitution of aa 126 & 127 & 128 of 
Rieske to A 
Kan This study 
pSUPROM Rieske-Bla D131K E132K pSUPROM pSUPROM Rieske-Bla with substitution of aa 131 & 132 of Rieske 
to K 
Kan This study 
pSUPROM Rieske-Bla E137K E141K pSUPROM pSUPROM Rieske-Bla with substitution of aa 137 & 141 of Rieske 
to K 
Kan This study 
pSUPROM Rieske-Bla D126K E127K 
E128K 
pSUPROM pSUPROM Rieske-Bla with substitution of aa 126 & 127 & 128 of 
Rieske to K 
Kan This study 
pSUPROM Rieske-Bla INS D129 
E130 E131 
pSUPROM pSUPROM Rieske-Bla with insertion of DEE at positions aa 129-
131 of Rieske 
Kan This study 
pSUPROM Rieske-Bla D126K E127K 
E128K E137K E141K 
pSUPROM pSUPROM Rieske-Bla with substitution of aa 126-128 & 137 & 
141 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla D126K E127K 
E128K D131K E132K E137K E141K 
pSUPROM pSUPROM Rieske-Bla with substitution of aa 126-128 & 131-132 
& 137 & 141 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla R185C pSUPROM pSUPROM Rieske-Bla with substitution of aa 185 of Rieske to C Kan This study 
pSUPROM Rieske-Bla R185A pSUPROM pSUPROM Rieske-Bla with substitution of aa 185 of Rieske to A Kan This study 
pSUPROM Rieske-Bla P177L S179L 
G180L 
pSUPROM pSUPROM Rieske-Bla with substitution of aa 177 &179 & 180 of 
Rieske to L 
Kan This study 
pSUPROM Rieske-Bla S179L G180L pSUPROM pSUPROM Rieske-Bla with substitution of aa 179 & 180 of Rieske 
to L 
Kan This study 
pSUPROM Rieske-Bla S179L  pSUPROM Rieske-Bla with substitution of aa 179 of Rieske to L Kan This study 
pSUPROM Rieske-Bla G180L pSUPROM pSUPROM Rieske-Bla with substitution of aa 180 of Rieske to L Kan This study 
pSUPROM Rieske-Bla V158K pSUPROM pSUPROM Rieske-Bla with substitution of aa 158 of Rieske to K Kan This study 
pSUPROM Rieske-Bla ∆118-153 
V158K 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-153 of Rieske & 
substitution of aa 158 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla ∆118-154 
V158K 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-154 of Rieske & 
substitution of aa 158 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla ∆118-155 
V158K 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-155 of Rieske & 
substitution of aa 158 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla ∆118-156 
V158K 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-156 of Rieske & 
substitution of aa 158 of Rieske to K 
Kan This study 
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pSUPROM Rieske-Bla ∆118-157 
V158K 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-157 of Rieske & 
substitution of aa 158 of Rieske to K 
Kan This study 
pSUPROM Rieske-Bla V158C pSUPROM pSUPROM Rieske-Bla with substitution of aa 158 of Rieske to C Kan This study 
pSUPROM Rieske-Bla ∆118-153 
V158C 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-153 of Rieske & 
substitution of aa 158 of Rieske to C 
Kan This study 
pSUPROM Rieske-Bla ∆118-154 
V158C 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-154 of Rieske & 
substitution of aa 158 of Rieske to C 
Kan This study 
pSUPROM Rieske-Bla ∆118-155 
V158C 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-155 of Rieske & 
substitution of aa 158 of Rieske to C 
Kan This study 
pSUPROM Rieske-Bla ∆118-156 
V158C 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-156 of Rieske & 
substitution of aa 158 of Rieske to C 
Kan This study 
pSUPROM Rieske-Bla ∆118-157 
V158C 
pSUPROM pSUPROM Rieske-Bla with deletion of aa 118-157 of Rieske & 
substitution of aa 158 of Rieske to C 
Kan This study 
pSUPROM Rieske-Bla V82C pSUPROM pSUPROM Rieske-Bla with substitution of aa 82 of Rieske to C Kan This study 
pSUPROM Rieske-AmiA RHHR pSUPROM pSUPROM Rieske-AmiA with substitution of aa 133-134 of Rieske 
from RH to HR 
Kan This study 
pSUPROM Rieske-AmiA RHKK pSUPROM pSUPROM Rieske-AmiA with substitution of aa 133-134 of Rieske 
from RH to KK 
Kan This study 
pSUPROM Rieske-AmiA A138P pSUPROM pSUPROM Rieske-AmiA with substitution of aa 138 of Rieske 
from A to P 
Kan This study 
pSUPROM Rieske-AmiA A144P pSUPROM pSUPROM Rieske-AmiA with substitution of aa 144 of Rieske 
from A to P 
Kan This study 
pSUPROM Rieske-AmiA A148P pSUPROM pSUPROM Rieske-AmiA with substitution of aa 148 of Rieske 
from A to P 
Kan This study 
pSUPROM Rieske-AmiA A154P pSUPROM pSUPROM Rieske-AmiA with substitution of aa 154 of Rieske 
from A to P 
Kan This study 
pSUPROM Rieske-AmiA M124A pSUPROM pSUPROM Rieske-AmiA with substitution of aa 124 of Rieske 
from M to A 
Kan This study 
pSUPROM Rieske-AmiA S125A pSUPROM pSUPROM Rieske-AmiA with substitution of aa 125 of Rieske 
from S to A 
Kan This study 
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pSUPROM Rieske-AmiA D126A pSUPROM pSUPROM Rieske-AmiA with substitution of aa 126 of Rieske 
from D to A 
Kan This study 
pSUPROM Rieske-AmiA E127A pSUPROM pSUPROM Rieske-AmiA with substitution of aa 127 of Rieske 
from E to A 
Kan This study 
pSUPROM Rieske-AmiA M124L pSUPROM pSUPROM Rieske-AmiA with substitution of aa 124 of Rieske 
from M to L 
Kan This study 
pSUPROM Rieske-AmiA S125L pSUPROM pSUPROM Rieske-AmiA with substitution of aa 125 of Rieske 
from S to L 
Kan This study 
pSUPROM Rieske-AmiA D126L pSUPROM pSUPROM Rieske-AmiA with substitution of aa 126 of Rieske 
from D to L 
Kan This study 
pSUPROM Rieske-AmiA E127L pSUPROM pSUPROM Rieske-AmiA with substitution of aa 127 of Rieske 
from E to L 
Kan This study 
pSUPROM Rieske-AmiA RRKK pSUPROM pSUPROM Rieske-AmiA with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to KK 
Kan This study 
pSUPROM Rieske-AmiA RRKQ pSUPROM pSUPROM Rieske-AmiA with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to KQ 
Kan This study 
pSUPROM Rieske-AmiA RRAA pSUPROM pSUPROM Rieske-AmiA with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to AA 
Kan This study 
pSUPROM Rieske-AmiA RRAD pSUPROM pSUPROM Rieske-AmiA with substitution of aa 161-162 of Rieske 
from RR (Tat motif) to AD 
Kan This study 
pSUPROM Rieske-AmiA ∆RR pSUPROM pSUPROM Rieske-AmiA with deletion of aa (RR Tat motif) 161-
162 of Rieske  
Kan This study 
pSUPROM Rieske-AmiA ∆118-122 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-122 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆123-127 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 123-127 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆128-132 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 128-132 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆133-137 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 133-137 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆138-142 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 138-142 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆143-147 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 143-147 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆148-152 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 148-152 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆153-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 153-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆158-162 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 158-162 of Rieske Kan This study 
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pSUPROM Rieske-AmiA ∆118-127 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-127 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆128-137 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 128-137 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆138-147 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 138-147 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆148-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 148-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-132 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-132 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆123-137 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 123-137 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆128-142 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 128-142 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆133-147 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 133-147 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆138-152 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 138-152 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆143-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 143-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-137 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-137 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆138-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 138-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-142 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-142 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆123-147 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 123-147 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆128-152 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 128-152 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆133-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 133-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-147 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-147 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆123-152 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 123-152 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆128-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 128-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆123-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 123-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-152 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-152 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-153 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-153 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-154 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-154 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-155 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-155 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-156 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-156 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆118-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 118-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆124-157  pSUPROM pSUPROM Rieske-AmiA with deletion of aa 124-157 of Rieske Kan This study 
pSUPROM Rieske-AmiA ∆125-157  pSUPROM pSUPROM Rieske-AmiA with deletion of aa 125-157 of Rieske  Kan This study 
pSUPROM Rieske-AmiA ∆126-157  pSUPROM pSUPROM Rieske-AmiA with deletion of aa 126-157 of Rieske  Kan This study 
pSUPROM Rieske-AmiA ∆127-157 pSUPROM pSUPROM Rieske-AmiA with deletion of aa 127-153 of Rieske Kan This study 
pSUPROM Rieske-AmiA HWAKES  pSUPROM pSUPROM Rieske-AmiA with deletion of aa 121-154 of Rieske  Kan This study 
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pSUPROM Rieske-AmiA HWKES  pSUPROM pSUPROM Rieske-AmiA with deletion of aa 120-154 of Rieske Kan This study 
pSUPROM Rieske-AmiA HWES pSUPROM pSUPROM Rieske-AmiA with deletion of aa 120-155 of Rieske Kan This study 
pSUPROM MTB Rieske-Bla RRAD pSUPROM pSUPROM MTB Rieske-Bla substitution of aa 199 & 200 of 
Rieske to AD 
Kan This study 
pSUPROM MTB 243ext-Rieske-Bla pSUPROM pSUPROM MTB Rieske-Bla extension of sequence from aa 227 
to 243 
Kan This study 
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2.4.3 Amplification of DNA by Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) is a biochemical technique that allows the 
amplification of specific regions of DNA by several orders of magnitude. This procedure 
utilises thermostable DNA polymerase enzymes and oligonucleotide primers, which are 
designed to be complementary to the 5’ and 3’ ends of a thermally denatured single 
stranded DNA template. DNA elongation occurs in a 5’ to 3’ direction, enabling the 
strands to extend towards one another.  
A typical PCR reaction mixture was composed of optional DMSO, less than 50 ng 
template DNA (or as required), 1 µl of forward/reverse primer (from a 100 µM stock), 
0.5 µl dNTPs (from a 20 mM stock), 0.5 µl DNA Polymerase and appropriate enzyme 
buffer. This was made up to 50 µl using ultra-pure water. The PCR programme consists 
of three essential steps; a denaturing step at 96°C, an annealing step at 50-60°C and an 
elongation step at 72°C. These steps were repeated for 15-30 cycles and followed by a 
final elongation at 72°C. PCR products were assessed by agarose gel electrophoresis 
and were cleaned using a QIAquick® Gel extraction kit or a QIAquick® PCR Purification 
kit (Qiagen) before use in subsequent cloning applications. 
 
2.4.4 Site-directed mutagenesis by QuikchangeTM PCR 
Site-specific mutations were introduced based on the QuikchangeTM manual from 
Stratagene. Complementary primers were designed (Sigma) to introduce specific amino 
acid substitutions into a template sequence. The codon of interest was positioned in the 
middle of the 30 base pair sequence. Truncation and deletion mutations were generated 
using Liu and Naismith’s modified QuikchangeTM method of partial overlapping primer 
design (Liu & Naismith, 2008). DNA was amplified by PCR before the methylated 
template DNA present in the sample was digested with DpnI (Roche). DNA was 
subsequently transformed into chemically competent cells of E. coli strain DH5α and 
extracted by use of QIAPrep® Spin Miniprep Kit (Qiagen) according to the 
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manufacturer’s instructions (Section 2.4.2). All oligonucleotides used in this study are 
found in the Appendix. 
2.4.5 Agarose gel electrophoresis 
DNA samples were analysed by agarose gel electrophoresis using 1% (w/v) agarose 
gels prepared with TAE buffer and containing 0.001% (v/v) Gel Red dye (Biotium). 
Loading dye was added to samples to create a visible running front and DNA size 
markers (1 kb Plus DNA Ladder, Invitrogen) were run on gels to allow identification of 
target bands. 
 
2.4.6 DNA digestion and preparation for cloning 
DNA was digested using 10 units of the appropriate restriction enzymes with the 
coordinated restriction enzyme buffer. This was in a final volume of 40 or 50 µl depending 
on whether the digestion was 1 µg of plasmid or 50 µl of PCR product. Samples were 
incubated for at least 2 h at 37°C. Digested vectors were then treated with alkaline 
phosphatase to dephosphorylate the vector thereby preventing self-religation. This 
involved incubation with 5 µl of 10x alkaline phosphatase buffer and 5 µl alkaline 
phosphatase at 37°C for 30 min. Samples were then assessed using agarose gel 
electrophoresis and visualised under UV light. Bands of interest were excised and 
purified using a QIAquick® Gel extraction kit (Qiagen) according to the manufacturer’s 
instructions. 
 
2.4.7 DNA ligation 
DNA fragments of interest were ligated to a linearized vector using T4 DNA ligase 
(Roche). A molar excess ratio of vector:insert of 1:3 was used. The following equation 
(1) was used to calculate the appropriate amounts of DNA. 
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣[𝑛𝑛𝑛𝑛] =
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣[𝑛𝑛𝑛𝑛]×𝑚𝑚𝑠𝑠𝑠𝑠𝑣𝑣𝑖𝑖𝑖𝑖𝑖𝑖𝑣𝑣𝑣𝑣𝑣𝑣[𝑏𝑏𝑏𝑏]
𝑚𝑚𝑠𝑠𝑠𝑠𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣[𝑏𝑏𝑏𝑏]
𝑥𝑥3    (1) 
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DNA fragments were ligated in a final volume of 10 µl containing ligation buffer and 1 µl 
of ligase. Ligations were performed at 18°C for 1 h or overnight before the entire reaction 
volume was used in transformation with chemically competent cells of E. coli strain 
DH5α. 
2.4.8 DNA sequencing 
Subsequent to cloning, DNA sequencing was used to confirm sequences of plasmids. 
Sequencing of DNA was performed by the MRC PPU DNA Sequencing & Services at 
the School of Life Sciences, University of Dundee. Chromatogram files obtained from 
sequencing reactions were analysed using BioEdit Sequence Alignment Editor 
(Copyright © 1997-2011 Tom Hall). 
 
2.5 Protein methods 
2.5.1 SDS-PAGE 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) is used to separate proteins under 
denaturing conditions according to molecular weight (Laemmli, 1970). Tris-glycine 
SDS-PAGE gels of 0.75mm thickness were prepared for use with the Mini-PROTEAN II 
system (Bio-Rad) at varying polyacrylamide concentrations (7.5%, 12% or 15%) 
depending on the experimental requirements. The compositions of resolving and 
stacking gels can be found in Table 2.7. 
Table 2.7 Composition of SDS-PAGE resolving and stacking gel. 
Resolving gel Stacking gel 
Acrylamide/bis-acrylamide 
(37.5:1) 
7.5% or 12% or 
15% (v/v) 
Acrylamide/bis-acrylamide 
(37.5:1) 
4% (v/v) 
Tris-HCl pH 8.8 0.375 M Tris-HCl pH 6.8 0.125 M 
SDS 0.1% (w/v) SDS 0.1% (w/v) 
APS 0.1% (w/v) APS 0.1% (w/v) 
TEMED 0.1% (v/v) TEMED 0.1% (v/v) 
 
Tris-glycine gels were submerged in a gel electrophoresis tank (Bio-Rad) filled with SDS 
running buffer. Samples were prepared by mixing 1:5 with 6x sample buffer or 1:1 with 
2x Laemmli sample buffer both containing β-mercaptoethanol and loaded along with the 
marker, Precision Plus ProteinTM All Blue standards (Bio-Rad). The gel was run at 100 V 
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until the dye passed beyond the stacking gel, before the voltage was increased to 
150-200 V until the appropriate marker reached the bottom of the gel. Gels were then 
used further in semi-dry or dry western immunoblotting. 
2.5.2 Semi-dry and dry Western Blotting  
Samples to be analysed were first separated using SDS-PAGE as described above, 
subsequently they were transferred to nitrocellulose membrane using either the semi-dry 
or dry transfer systems.  
For semi-dry transfer, gels were soaked in Tris-glycine transfer buffer before being 
placed on pre-soaked nitrocellulose membrane (Amersham Hybond-ECL, GE 
Healthcare). These were sandwiched between 4 pieces of pre-soaked 3MM Whatmann 
paper before being placed inside a TransBlot SD SemiDry Transfer Cell (Bio-Rad) for 
protein transfer. Transfer was performed at 10 V for 30 min.  
The iBlot2 device (Life technologies) was used for dry transfer along with 
pre-manufactured iBlot transfer stacks, a top cathode stack and a bottom anode stack, 
the transfer was performed according to the manufacturer’s instructions. The Top 
cathode stack is made of a gel matrix containing cathode buffer and a copper cathode 
layer and the bottom anode stack is made of a copper anode layer, a gel matrix 
containing anode buffer and a nitrocellulose blotting membrane. The bottom stack was 
placed on the machine topped with the pre-run SDS-PAGE gel, a deionised water 
soaked filter paper, the top stack and a sponge. Transfer programme p0 (20 V for 1 min, 
23 V for 4 min and 35 V for 2 min) was used to transfer proteins onto nitrocellulose 
membrane. 
After transfer the membrane was blocked in TBS-Tween with 5% skimmed milk for 1 h 
at room temperature or overnight at 4°C, with shaking. This was followed by washing in 
TBS-Tween, before a 1 h incubation with primary antibody suitably diluted in 
TBS-Tween. This was followed by 3 washes in TBS-Tween before the incubation for 1 h 
with the secondary antibody, also suitably diluted in TBS-Tween. The working solutions 
for antibodies are provided in Table 2.8. Enhanced chemiluminescent detection was 
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used to visualise the bands. The secondary antibodies (and some primary antibodies) 
were conjugated to horseradish peroxidase (HRP) this oxidises luminol in the presence 
of peroxide, resulting in the emission of light proportional to protein quantities as the 
luminol decays. This reaction allows for the detection of HRP-coupled antibodies bound 
directly or indirectly to the target protein on the membrane. These immunoreactive 
protein bands were detected using ClarityTM Western ECL substrate kit (Bio-Rad) and 
exposure to medical film (Konica Minolta) developed in the medical film processor 
SRX-101A (Konica Minolta) or visualised with a CCCD camera (GeneGNOME XRQ 
Syngene). 
 
Table 2.8 Antibodies used in this study. 
Primary Antibody Working 
concentration 
Raised in Reference 
Monoclonal Rieske peptide antibody 1:10000 Rabbit Generated by GenScript *  
Monoclonal Anti-HA peroxidase 1:3000 Mouse Sigma-aldrich (Cat. #H6533) 
Polyclonal Rieske antiserum 1:10000 Rabbit (Keller et al., 2012) 
Monoclonal Βla antibody 1:5000 Mouse Abcam® (Cat. #ab12251) 
Monoclonal BamA antibody 1:10000 Rabbit (Lehr et al., 2010) 
Secondary Antibody    
anti-mouse IgG HRP conjugate 1:10000 Goat Bio-rad 
anti-rabbit IgG HRP conjugate 1:10000 Goat Bio-rad 
* N-terminal epitope (sequence: CLPPHEPRVQDVDER) 
 
2.5.3 Determination of protein concentration 
Protein concentrations in protein samples were determined by the Lowry method (Lowry 
et al., 1951) using the DCTM Protein Assay kit (Bio-Rad). A standard curve was generated 
using Bovine serum albumin (BSA) for sample comparison. 
 
2.5.4 Protein precipitation 
Acetone precipitation was used in this work as it is a good method for precipitating 
soluble proteins by removing salts and lipid-soluble contaminants. Ice cold acetone was 
added to samples at a volume four times the amount of sample, this mixture was then 
vortexed and incubated for 1 h at -20°C. The samples were then centrifuged for 10 min 
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at 16000 x g and the supernatant was discarded. The protein pellet was air dried for 20 
min at room temperature to remove the remaining acetone before the pellet was 
resuspended in the appropriate buffer. 
2.6 Preparation of membrane fractions 
50 µl of a stationary phase culture was subcultured into 50 ml LB and grown at 37°C with 
shaking until OD600 of 0.2 was reached. The cells were harvested by centrifugation at 
3000 x g for 10 min at 4°C and the supernatant was discarded. The cell pellet was 
resuspended in 1 ml of Buffer 1. The cells were lysed by sonication at 20% amplitude for 
1 min (Branson Digital Sonifier). The lysates were then centrifuged to remove cell debris 
at 17000 x g for 5 min followed by ultracentrifugation to pellet the membrane at 227000 
x g for 30 min at 4°C. The pellets were resuspended in Buffer 2. An appropriate amount 
of 6x sample buffer with 5% β-mercaptoethanol was added before the samples were 
analysed by SDS-PAGE and Western blotting. 
 
2.7 Densitometry analysis of protein production 
Image Processing and Analysis in Java (ImageJ, NIH, (Schneider et al., 2012)) was used 
to analyse the protein level of Rieske fused variants. Membrane fractions were prepared 
as Section 2.6 and analysed by SDS-PAGE and Western Blotting with anti-Rieske-
peptide to detect the Rieske protein, and anti-BamA as a loading control. The density of 
the band was calculated by densitometry analysis and Rieske-associated signals were 
normalised with BamA-associated signals. The results were expressed as percentage of 
the normalised signal obtained for ‘wild type’ Rieske-AmiA or Rieske-Bla. 
 
2.8 Sulphydryl labelling of cysteine residues 
Labelling of cysteine residues was performed with methoxypolyethylene glycol 
maleimide (mal-PEG). Mal-PEG has a molecular mass of 5 kDa and forms a covalent 
3-thiosuccinimidyl ether linkage with thiols via the maleimide group, this reaction is 
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specific for pH 6.5-7.5. This coupling of cysteine residues with mal-PEG can be detected 
by a band shift after SDS-PAGE and Western blotting. Mal-PEG is 
membrane-impermeable, therefore, after treatment only accessible cysteines are 
labelled. Single cysteine substituted cysteine variants of Rieske were expressed in 
appropriate E. coli strains and labelling was undertaken. Sulphydryl labelling was 
performed on crude membrane fractions where all cysteines should be accessible and 
whole cells where only those cysteines in the periplasm should be labelled. 
 
2.8.1 Sulphydryl labelling in membrane fractions 
Membrane fractions were prepared as described in Section 2.6. Sulphydryl labelling of 
membrane fractions was carried out using membrane fractions resuspended in 
HEPES/MgCl2 buffer (pH 6.8). 30 µl of membrane fraction was incubated with 5 mM 
mal-PEG in a final volume of 50 µl for 1 h at room temperature, the reaction composition 
is described in Table 2.9. 
Table 2.9 Composition of sulphydryl labelling reaction with crude membrane fractions. 
 Unlabelled labelled [C]f 
HEPES buffer 20 µl 15 µl  
Membrane fraction 30 µl 30 µl  
mal-PEG 50mM  5 µl 5 mM 
Final volume 50 µl 50 µl  
 
The labelling reaction was stopped by the addition of 0.5 M dithiothreitol (DTT, 100 mM 
final concentration). The samples were mixed with 50 µl 2x Laemmli sample buffer 
containing 5% β-mercaptoethanol and analysed by SDS-PAGE and Western blotting. 
 
2.8.2 Sulphydryl labelling in intact cells and membrane preparation 
1500 µl of a stationary phase culture was subcultured into 50 ml LB with appropriate 
antibiotics and grown at 37°C with shaking until OD600 of 0.6-0.7 was reached. The cells 
were harvested by centrifugation at 3000 x g for 15 min and the supernatant was 
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discarded. The cell pellet was resuspended and washed in 20 ml HEPES/MgCl2 buffer. 
The cells were spun down at 3000 x g for 15 min and the supernatant was discarded. 
The cell pellet was resuspended in 1ml HEPES/MgCl2 buffer (pH 6.8). per 0.3 units of 
OD600 measured before harvesting. The resuspended cells were split into two 800 µl 
aliquots supplemented with either buffer or mal-PEG in a final volume of 1 ml. EDTA was 
included in all of the samples to increase the permeability of mal-PEG through the OM 
(Leive, 1968). The reaction composition is described in Table 2.10. 
Table 2.10 Composition of sulphydryl labelling reactions with whole cells. 
 unlabelled labelled [C]f 
HEPES buffer 180 µl 80 µl  
EDTA 250mM 20 µl 20 µl 5mM 
Cells 800 µl 800 µl  
PEG-Mal 50mM  100 µl 5mM 
Final volume 1 ml 1 ml  
 
After incubation for 1 h at room temperature the reactions were stopped with 1M DTT 
(100 mM final concentration). 100 µl of each sample was precipitated as described in 
Section 2.5.4 and resuspended in 30 µl of Buffer 2. The remaining 900 µl of each sample 
was used for membrane preparation. 300 µl of HEPES/MgCl2 buffer was added to each 
sample to decrease the viscosity. The samples were then lysed by sonication at 20% 
amplitude in 5 s bursts for a total of 1 min (Branson Digital Sonifier). The lysates were 
centrifuged to remove cell debris at 17000 x g for 5 min followed by ultracentrifugation to 
pellet the membranes at 227000 x g for 30 min at 4°C. The resulting membrane pellets 
were then resuspended in Buffer 2. An appropriate volume of 6x sample buffer with 5% 
β-mercaptoehanol was added before the samples were analysed by SDS-PAGE and 
Western blotting. 
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2.9 Growth assays 
Two fusion reporters were used throughout this study; AmiA and Bla. Growth assays 
were developed for each fusion reporter to test for Tat- or Sec-dependent transport using 
a tat+ or tat- strain accordingly. 
2.9.1 Growth assays for fusion reporter AmiA 
Growth assays to test Tat-dependent survival in the presence of the detergent SDS were 
performed in two ways. Stationary phase cultures were subcultured and grown at 37°C 
until an OD600 of 0.5 was reached, after which 5 µl of culture was spotted on LB solid 
medium supplemented with 2% SDS and appropriate antibiotics. Alternatively 5 µl 
aliquots of a stationary phase culture was spotted on LB solid medium supplemented 
with 1% SDS as a serial dilution of 104 cells to 10 cells per 5 µl. Plates were incubated 
at 37°C for 16 h. 
 
2.9.2 Growth assays for fusion reporter Bla 
Growth assays to test Sec/Tat-dependent survival in the presence of ampicillin were 
performed in two ways. A 5 µl aliquot of a stationary phase culture was spotted on LB 
solid medium supplemented with increasing concentrations of ampicillin from 0-50 µg/ml, 
these were incubated at 37°C for 16 h. Alternatively a growth curve was performed where 
stationary phase cultures were diluted to OD600 of 0.03 in LB with increasing 
concentrations of ampicillin from 0-50 µg/ml, then 100 µl culture was added to a 96 well 
plate. This was placed into Synergy 2 platereader (Biotek) and incubated at 37°C with 
continuous shaking. OD600 readings were taken every 20 min for 10 h. 
Bla fusion variants were tested for Sec-dependent transport using the tat- strain (DADE) 
and a quantitative assay that determines the antimicrobial susceptibility of the bacteria 
to ampicillin via the Minimum Inhibitory Concentration (M.I.C.). To do this Oxoid 
M.I.C.EvaluatorTM (Thermo Fisher Scientific) test strips were used, these contain a 
continuous antibiotic concentration gradient, in this case ampicillin with a gradient from 
0-256 µg/ml. The strip is placed on an LB agar plate containing a lawn of bacteria and 
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after incubation, a symmetrical inhibition ellipse centred along the strip is seen. The 
M.I.C. value (in µg/ml) is read from the scale where the pointed end of the ellipse 
intersects the strip.  
Stationary phase cultures were diluted to OD600 of 0.1 and an LB agar plate was 
inoculated by swabbing with the diluted culture to generate a lawn of bacteria. The 
M.I.C.EvaluatorTM test strip was placed onto the lawn of bacteria and the plates were 
incubated at 37°C for 18 h after which the M.I.C. was read off the strip. A minimum of 3 
biological replicates per variant was tested.
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3.1 Introduction 
3.1.1 The use of fusion reporters in protein analysis 
Keller et al. (2012) used reporter fusions to determine the topology of the transmembrane 
region of the Streptomyces coelicolor Rieske FeS protein when it was expressed in 
E. coli. Gene fusions have been used extensively as tools to probe transport pathways 
and determine transmembrane protein topologies. The basis of this approach is to 
choose a reporter protein with a specific subcellular compartmental activity which is then 
fused to protein fragments containing prospective targeting sequences. A good fusion 
reporter requires a distinct well-defined phenotype, these generally involve plate screens 
which specify a growth output or a colour change. Consequently, when this fusion 
undergoes testing, the targeted compartment is indicated by the activity of the reporter 
protein (Stanley et al., 2002). The following proteins will be discussed further in this 
section. 
 
3.1.1.1 Amidase A 
E. coli contains three N-acetylmuramyl-L-alanine amidases; AmiA, B and C. These are 
periplasmic enzymes that cleave the peptide moiety from N-acetylmuramic acid thereby 
removing murein crosslinks. This is particularly important during cell division as splitting 
the murein septum is vital to separation of the daughter cells (Bernhardt & de Boer, 2003, 
Heidrich et al., 2001, Uehara et al., 2010). Deletion of these amidases results in cells 
forming long chains, and similar cell chains along with a pleiotropic OM defect are also 
observed when essential Tat system components are absent (Stanley et al., 2001). It 
was subsequently shown that AmiA and AmiC are exported to the periplasm by the Tat 
pathway and the failure to export these proteins accounts for the cell-chaining and OM 
defect of tat mutant strains (Heidrich et al., 2001, Ize et al., 2003). 
Due to the cell envelope defects, deleting these Tat-dependent enzymes in E. coli strains 
causes the cells to be sensitive to killing by the detergent SDS (Ize et al., 2003). This 
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makes for a good phenotypic screening system, as strains with an inactive Tat system 
or tat+ strains lacking AmiA and AmiC in the periplasm will fail to grow on SDS-containing 
growth media (Keller et al., 2012). 
 
3.1.1.2 β-Lactamase 
β-lactam antibiotics, like ampicillin, kill cells by inactivating the enzymes involved in cell 
wall biosynthesis, and β-lactamases (Bla) cleave the amide bond in the β-lactam ring of 
the inbound antibiotics, thereby protecting cells against lysis (Broome-Smith & Spratt, 
1986). Bla is required to be in the periplasm for function and although it is usually a 
substrate of the Sec pathway, it is also compatible with export by the Tat pathway if it is 
supplied with a twin-arginine signal peptide (Pradel et al., 2009, McCann et al., 2007). 
As this protein specifies ampicillin resistance, it has frequently been used as a reporter, 
with phenotypic screening of growth on ampicillin-containing medium when Bla has been 
translocated into the periplasm (Stanley et al., 2002, McCann et al., 2007, Broome-Smith 
et al., 1990, Mansell et al., 2010). 
 
3.1.1.3 Maltose binding protein 
E. coli maltose binding protein (MalE or MBP) is an essential periplasmic component of 
a membrane bound transporter ATPase binding cassette superfamily which catalyses 
the uptake of maltose. Its export to the periplasm is via the Sec pathway, with a strong 
dependence on the chaperone, SecB (Fekkes & Driessen, 1999). However, replacement 
of its signal peptide with a Tat-targeting sequence can specifically redirect MBP to the 
Tat pathway, although some residual Sec translocation of MBP may still be observed 
depending on the Tat targeting sequence used (Blaudeck et al., 2003, DeLisa et al., 
2002). malE- cells expressing a plasmid that produces a low proportion of MBP, which is 
exported to the periplasm, can grow on minimal media if provided with a maltose carbon 
source, this provides a straightforward qualitative method for detecting MBP export. 
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The leaky cell envelope phenotype of tat- strains also effects the utility of MBP as an 
export reporter, as even in the absence of malE, some maltose can be transported by 
tat mutants (but not by malE- tat+ strains). This impacts on the utility of this reporter when 
testing for growth on maltose-containing minimal medium as false positives may be 
found. High concentrations of calcium or magnesium have been found to act as a 
chemical repair to this pleiotropic OM defect of tat- cells (Caldelari et al., 2008). 
 
3.1.2 Co-ordinating crosstalk between the Sec and Tat machineries during 
assembly of Rieske 
An alignment of amino acid sequences of Rieske FeS proteins from different bacteria 
shows the highly conserved regions between the different Rieske proteins (Figure 1.19). 
This includes the essential twin-arginine motif required for translocation by the Tat 
machinery, which is found N-terminal to TMD3 in actinobacterial Rieske proteins 
(S. coelicolor, C. glutamicum and M. tuberculosis) (Figure 1.19, highlighted in purple). 
This highly conserved motif strongly suggested that despite the unusual topology of 
these Rieske proteins they still use the Tat system for translocating the globular FeS 
domain across the membrane. 
Keller et al. (2012) investigated the Tat-dependence of the membrane portion of 
S. coelicolor Rieske using fusion reporter proteins where the TMDs of Rieske were fused 
to MBP or AmiA in order to assess the translocation of TMD3 of Rieske (as indicated by 
the arrow in Figure 1.19). The reporter assays used were able to identify translocation of 
the fused reporter into the periplasm leading to the conclusion that S. coelicolor Rieske 
was inserted into the membrane using a co-operation of the Sec and Tat translocation 
pathways.  
The overall aim of this thesis was to define key regions of S. coelicolor Rieske that are 
important for the interaction of the protein with the Sec and Tat machineries. To this end 
it is essential that the TMDs of Rieske are fused to reporter proteins that provide robust 
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and reliable assays, and that can indicate clear positive and negative results. Therefore, 
the aim of the work in this chapter was to test and validate reporters to assess Sec and 
Tat translocation of Rieske and to develop quantitative methods to determine the degree 
of Sec and Tat integration. This would ultimately support a full programme of 
mutagenesis aimed at dissecting features of Rieske that dictate interaction with the Sec 
and Tat pathways. 
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3.2 Results 
3.2.1 Selection of reporter fusions to reliably test Sec- and 
Tat-dependence of Rieske variants 
In previous work (Keller et al., 2012) two reporter proteins were fused after TMD3 of 
S. coelicolor Rieske; MBP and AmiA. These constructs were expressed in E. coli tat+ 
and tat- (ΔtatABC/ΔtatE) strains and different assays were undertaken to test for Tat 
dependence. The MBP assay relies on the translocation of MBP to the periplasmic side 
of the membrane where it promotes transport and fermentation of the maltose causing 
an acidification reaction, which is detected in liquid medium by a pH indicator dye and a 
colour change from purple to yellow. In comparison, the AmiA assay relies on the 
translocation of AmiA into the periplasm allowing the growth of cells lacking native AmiA 
and AmiC on solid media containing SDS. 
The E. coli tat- mutant strain is known to have a pleiotropic cell envelope phenotype 
which leads to a leaky OM (Ize et al., 2003, Stanley et al., 2001). This phenotype can be 
partly compensated by the addition of CaCl2 but the envelope phenotype cannot be 
completely repaired and confers a partial mal+ phenotype even in the absence of 
periplasmic MBP (Caldelari et al., 2008). The combination of the leaky membrane 
phenotype of the E.coli tat- strain and the indirect readout of a colour change makes it 
very difficult to score for mal+/mal- phenotypes in the tat- strain. To undertake a 
mechanistic dissection of S. coelicolor Rieske membrane insertion, a robust reporter 
system is required where the results are to be reliable and small changes can be scored, 
ruling out the utility of MBP as a reporter fusion protein. 
Unlike MBP, AmiA is a more reliable fusion reporter in this context. When expressed in 
a tat+ strain lacking chromosomally-encoded AmiA/C, AmiA will be translocated to the 
periplasm allowing cells to grow on media containing SDS. If AmiA is not translocated, 
for example when expressed in the tat- strain, there will be no growth on media containing 
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SDS. As AmiA has a direct and reliable readout it was selected as one of the fusion 
reporters in this project. 
A different reporter that has previously been used in fusion reporter studies is Bla (Lee 
& Hughes, 2006, Stanley et al., 2002). As Bla specifies ampicillin resistance, 
translocation into the periplasm will allow growth of cells on medium containing ampicillin, 
therefore, a direct and reliable readout can be assessed. This would potentially make 
Bla a robust fusion reporter for evaluating Rieske insertion. 
Keller et al. (2012) used the pBAD24 vector to generate MBP fusion constructs, which 
expresses genes that are under the control of the arabinose promoter (Guzman et al., 
1995). This plasmid specifies ampicillin resistance and thus cannot be used in 
conjunction with the Bla fusion reporter which also specifies ampicillin resistance. 
Therefore a different vector system, pSUPROM, was chosen for cloning of DNA 
encoding the fusion reporter proteins, which specifies kanamycin resistance and 
expresses genes under the control of the tat promoter (Jack et al., 2004). To maintain 
consistency between reporter fusion proteins the same expression vector was used to 
express both AmiA and Bla fusions with the S. coelicolor Rieske protein. 
The generation of the fusion reporters is described in detail in Chapter 2 and followed 
the approach of Keller et al. (2012), whereby the globular FeS domain was genetically 
removed from S. coelicolor Rieske and either the mature region of the E. coli Tat 
substrate AmiA (to generate Rieske-AmiA) or the mature region of Bla obtained by PCR 
amplification from pBR322 (to generate Rieske-Bla) were fused to the C-terminal end of 
the TMD3 of Rieske, as outlined in Figure 3.1. As in Keller et al. (2012), the signal 
peptidase I cleavage site of AmiA (Ala-Xaa-Ala) was included in the construct, thus 
allowing release of the amidase from the membrane. 
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Figure 3.1 Generation of S. coelicolor Rieske TMD fusion proteins with reporters AmiA and Bla. 
(A) Schematic representation of S. coelicolor Rieske comprising of three TMD followed by the globular FeS 
(FeS) cofactor-containing domain. (B) Fusion protein Rieske-AmiA where the FeS domain has been 
replaced with mature E. coli AmiA domain (i.e. with the native N-terminal twin-arginine signal sequence 
removed). A cleavage site has also been included between the C-terminal end of TMD3 and the AmiA 
sequence to allow release AmiA of to the periplasm to better access the peptidoglycan substrate (indicated 
by scissors). (C) Fusion protein Rieske-Bla where the FeS domain has been replaced by mature β-lactamase 
(Bla) domain with the native N-terminal Sec signal sequence removed. The position of the twin-arginine motif 
is indicated by RR at the N-terminal end of TMD3.  
 
3.2.2 Assessing Tat-dependence of the Rieske-AmiA Reporter Fusion 
3.2.2.1 SDS spot testing shows Tat-dependent membrane insertion of 
Rieske-AmiA 
The fusion construct Rieske-AmiA was tested for Tat-dependence using E. coli tat+ and 
tat- strains, MCDSSAC (Ize et al., 2003) and MCDSSACΔtat (Keller et al., 2012), 
respectively. These strains have chromosomal deletions in the AmiA and AmiC signal 
peptide coding regions (ΔssAmiAC), thereby trapping the expressed proteins in the 
cytoplasm where they are unable to function, and the tat- strain lacks the tatABC genes. 
The tat+ and tat- strains harbouring plasmid-encoded Rieske-AmiA, a positive control of 
plasmid-encoded full length AmiA (with its native Tat signal sequence) and a negative 
control of pSUPROM (Empty vector) were grown in liquid culture lacking SDS and were 
subsequently spotted onto LB medium containing 2% SDS. As Figure 3.2A indicates, 
translocation of Rieske-AmiA into the periplasm is Tat-dependent, as growth occurred in 
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the presence of SDS when the construct was expressed in the tat+ strain, but there was 
no growth when the Rieske-AmiA construct was expressed in the tat- strain. As expected, 
the positive control, full length AmiA, showed typical Tat-dependent translocation 
behaviour. This result confirms the previous work of Keller et al. (2012) showing that 
AmiA is a useful reporter to study Tat-dependence of Rieske membrane insertion (Figure 
3.2B).  
 
Figure 3.2 Tat-dependent translocation of the Rieske-AmiA fusion protein.  
(A) Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector 
(pSUPROM), or the pSUPROM vector encoding either full length AmiA (with its native Tat signal peptide) or 
Rieske-AmiA. Strains were grown overnight in LB medium, subcultured to give a final OD600 of 0.5 and 5 µl 
aliquots were spotted onto LB medium containing 2% (w/v) SDS. LB agar plates were incubated at 37°C for 
16h. (B) Predicted topology of the Rieske-AmiA fusion protein when expressed in tat+ and tat- strains. 
 
3.2.2.2 A Rieske-AmiA twin-lysine variant is still recognised by the Tat machinery 
The next step was to generate a substitution in the twin-arginine motif of the Rieske-AmiA 
variant to abolish Tat-translocation. The twin-arginine motif in Rieske-AmiA is located at 
the N-terminal end of TMD3 (Figure 1.19), and substitutions of the consensus 
twin-arginines are the most effective way to prevent translocation of proteins through the 
Tat machinery. In most cases translocation through the Tat pathway can be fully 
abolished by a double arginine to lysine substitution (Bachmann et al., 2006, Buchanan 
et al., 2001, Widdick et al., 2008, Stanley et al., 2000), and indeed this was shown 
previously to block recognition of Rieske-AmiA by the Tat machinery (Keller et al., 2012). 
The double mutation of twin-arginine to twin-lysine (RRKK) in the Tat motif of 
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Rieske-AmiA was generated in the pSUPROM construct and introduced into the tat+ and 
tat- strains before undertaking the spot assay on media containing SDS. Surprisingly, 
and in contrast to Keller et al. (2012), the tat+ strain producing the RRKK substituted 
Rieske-AmiA was able to grow in the presence of SDS (Figure 3.5). 
In most soluble native Tat substrate proteins the RRKK substitution almost universally 
blocks Tat translocation, even if the substrate is highly overexpressed (e.g. (Sargent et 
al., 2001)). However, mechanistically, the twin-lysine substitution must have some 
compatibility with the Tat pathway because export of very sensitive Tat reporters such 
as colicin V and MBP can still be detected when twin-lysines are introduced into the 
signal peptide (Kreutzenbeck et al., 2007, Ize et al., 2002a, Ize et al., 2002b). AmiA is, 
however, not as sensitive a reporter as colicin V and MBP, and indeed a twin-lysine 
substitution of the twin-arginines of the native AmiA signal peptide completely blocked 
detectable transport by the Tat pathway, even when the protein was overproduced (Ize 
et al., 2003). It should be noted, however, that the Rieske-AmiA fusion protein is already 
anchored at the membrane due to insertion of the first two TMD by the Sec pathway. 
This effectively constrains diffusion of the protein to two dimensions instead of three, 
greatly increasing the concentration of this protein close to the Tat machinery, potentially 
facilitating recognition of the variant twin-lysine signal sequence. 
 
3.2.2.3 The Rieske-AmiA fusion protein is produced at a higher level from 
pSUPROM than from pSU18 
As described above, the variant RRKK-Rieske-AmiA was able to support growth of the 
MCDSSAC strain on media containing SDS. This is in contradiction to the work by Keller 
et al. (2012) where export of RRKK-Rieske-AmiA was not observed in the same strain 
background. To examine this further, the growth tests were repeated using the 
RRKK-Rieske-AmiA construct made by Keller et al. (2012) in the pSU18 vector and the 
RRKK-Rieske-AmiA generated here in the pSUPROM vector. As shown in Figure 3.3, 
no growth on SDS was observed when the variant fusion protein was produced from 
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pSU18, in agreement with the published findings, whereas clear growth was again 
observed when it was produced from pSUPROM. 
 
Figure 3.3 Growth in the presence of SDS depends upon the vector from RRKK-Rieske-AmiA is 
produced. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector 
(pSUPROM), or the pSUPROM vector encoding full length AmiA, ‘wild type’ Rieske-AmiA and twin-lysine 
substituted Rieske-AmiA (RRKK-Rieske-AmiA), or the pSU18 vector encoding the twin-lysine substituted 
Rieske-AmiA (RRKK-Rieske-AmiA). Strains were grown overnight in liquid media, subcultured to give a final 
OD600 of 0.5 and 5 µl aliquots were spotted onto LB medium containing 2% (w/v) SDS. LB agar plates were 
incubated at 37°C for 16 h. 
 
The major difference between the two constructs is the nature of the plasmid vector, with 
Keller et al. (2012) using plasmid pSU18 as an expression vector whereas the work in 
this thesis uses the pSUPROM expression vector. pSUPROM is a standard expression 
vector, based on the kanamycin resistance plasmid pSU40 (Bartolome et al., 1991). This 
plasmid, which contains the lac promoter, has been modified to also contain the E. coli 
constitutive tatA promoter followed by a strong ribosome binding site (RBS) – this 
enables a relatively high level of gene expression (Jack et al., 2004). In comparison 
pSU18 contains the lac promoter followed by a weak RBS (Bartolome et al., 1991). It 
should be noted that all of the strains used in this thesis and in the study of Keller et al. 
(2012) are MC4100 derivatives which are lacI-, and therefore the lac promoter is 
constitutively active in these strain backgrounds.  
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To determine if the growth difference seen in Figure 3.3 results from in a difference in 
the level of protein production between the two vectors, cells from the tat+ strain 
harbouring both pSU18 RRKK-Rieske-AmiA and pSUPROM RRKK-Rieske-AmiA were 
analysed by Western blotting with an anti-Rieske antiserum. As shown in Figure 3.4, the 
level of Rieske-AmiA fusion protein produced from pSU18 RRKK-Rieske-AmiA is much 
lower than from pSUPROM RRKK-Rieske-AmiA. This may be a reflection of the double 
promoter present on pSUPROM and the fact that pSU18 has a weaker RBS. Thus it can 
be concluded that the ability of the pSUPROM expressed variant of RRKK-Rieske-AmiA 
to support growth of the MCDSSAC strain on media containing SDS is a result of the 
elevated level of protein production relative to that produced from pSU18 
RRKK-Rieske-AmiA. 
 
Figure 3.4 RRKK-Rieske-AmiA is produced at different levels from pSU18 and pSUPROM.  
Equivalent amounts of whole cells of the tat+ strain MCDSSAC harbouring pSUPROM Rieske-AmiA, 
pSUPROM RRKK-Rieske-AmiA or pSU18 RRKK-Rieske-AmiA were separated by SDS-PAGE (12% 
acrylamide), electroblotted and immunoreactive bands were detected with anti-Rieske (top) and anti-BamA 
(bottom) antisera. BamA was used as a loading control and bands corresponding to Rieske-AmiA are 
indicated by an arrow.  
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3.2.2.4 Identifying inactive twin-arginine variants of Rieske-AmiA  
Since a variant of Rieske-AmiA that was unable to engage with the Tat pathway was 
required, further substitutions of the twin-arginine motif were generated to find a mutation 
that completely abolished Tat translocation of Rieske-AmiA. Therefore, substitutions of 
the twin-arginines to lysine-glutamine (RRKD), twin-alanine (RRAA), alanine-aspartate 
(RRAD) and deletion of both arginines (ΔRR) were generated and the variants were 
expressed in the tat+ and tat- strains and tested for growth on media containing SDS.  
Figure 3.5 shows that mutation of the twin-arginine to lysine-glutamine still retained some 
recognition by the Tat pathway. This contrasts with the findings of Kreutzenbeck et al. 
(2007) who showed that a similar substitution to the twin-arginines of a TorA signal 
sequence-MalE reporter fusion abolished Tat-translocation. However, mutations of the 
twin-arginine motif to di-alanine, alanine-glutamine or deletion of both arginines 
successfully abolished Tat translocation. It is believed that the Tat machinery to some 
extent relies on electrostatic interactions to recognise the twin-arginine in the Tat motif. 
This is supported by the results presented in Figure 3.5 as the abolition of 
positively-charged residues at the twin-arginine positions of Rieske-AmiA (by substitution 
for the electro-neutral twin alanine, or negatively charged alanine-aspartate pairing) is 
sufficient to prevent any translocation through the Tat machinery.  
Without a confirming the expression of these variants I cannot be certain whether these 
results are a result of a lack of expression or a genuine defect. 
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Figure 3.5 Assessing Tat-dependent translocation of Rieske-AmiA twin-arginine substitutions or 
deletions. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector 
(pSUPROM), or the pSUPROM vector encoding full length AmiA, Rieske-AmiA or the twin-arginine variants 
RRKK-Rieske-AmiA, RRKQ-Rieske-AmiA, RRAD-Rieske-AmiA, RRAA-Rieske-AmiA and 
ΔRR-Rieske-AmiA. Strains were grown overnight in liquid media, subcultured to give an OD600 of 0.5 and 
5 µl aliquots were spotted onto LB medium containing 2% (w/v) SDS. LB agar plates were incubated at 37°C 
for 16h. 
 
3.2.2.5 Finding a reliable quantification assay for Tat-dependence using the 
Rieske-AmiA fusion 
The SDS spot testing method used above can clearly indicate Tat-dependence of 
Rieske-AmiA fusion variants. However, ideally, a more quantitative assay is required 
where small growth differences between variants can be easily observed. To this end a 
serial dilution assay was optimised - the tat+ and tat- strains expressing the twin-arginine 
variants of the Rieske-AmiA fusion were grown until they reached stationary phase in 
liquid media, diluted to give approximately 10, 100, 1,000 or 10,000 cells per 5µl aliquot 
and spotted onto standard (10g NaCl/l) or low salt (5g NaCl/l)-containing LB (as it was 
noted previously by Rebecca Keller that the level of salt in the LB may alter the behaviour 
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of the Rieske-AmiA fusion protein; personal communication). The plates also contained 
differing concentrations of SDS (1 or 2%). 
As shown in Figure 3.6A, in the absence of SDS, all of the strains and plasmid 
combinations were able to grow equally well, indicating that none of the constructs were 
toxic to the cells. Figure 3.6 panels B & C indicate that when grown on low salt LB 
medium containing either 1 or 2% SDS variants of Rieske-AmiA that were previously 
shown in Figure 3.5 to be Tat-inactive (RRAD-Rieske-AmiA and RRAA-Rieske-AmiA) 
now allowed some growth of the tat+ strain. In comparison, when the same strain and 
plasmid combinations were spotted onto standard LB medium containing 1 or 2% SDS 
the same variants were again unable to support any growth on SDS (Figure 3.6D & E). 
It is not clear why changing the level of salt should result in these differences, but it may 
relate to osmotic balance and cell wall stress.  
Interestingly, it can be seen that although the RRKK-Rieske-AmiA still supports some 
growth of the tat+ strain in standard LB medium containing 1% SDS, it was clearly much 
less than the ‘wild type’ twin-arginine-containing construct, and no growth at all was 
observed in the presence of 2% SDS in this experiment. Since the presence of 1% SDS 
allows a better differentiation between the severity of twin-arginine substitutions, it was 
decided that in all future experiments the assay for Tat-dependence of Rieske-AmiA will 
involve serial dilutions of stationary phase cultures and spotting onto standard LB 
medium containing 1% SDS, followed by growth at 37°C for 16 h. 
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Figure 3.6 Tat-dependence of twin-arginine fusion variants on different compositions of LB agar 
plates containing 1-2% SDS. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector 
(pSUPROM), or the pSUPROM vector encoding full length AmiA, Rieske-AmiA or the twin-arginine variants 
RRKK-Rieske-AmiA, RRAD-Rieske-AmiA and RRAA-Rieske-AmiA. Strains were grown overnight in liquid 
media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 5 µl aliquots which were spotted onto 
standard LB agar (panel A) or standard or low salt LB solid agar containing either 1% or 2% (w/v) SDS. LB 
agar plates were incubated at 37°C for 16 h. (A) standard LB medium (B) Low salt LB with 1% (w/v) SDS 
(C) Low salt LB with 2% (w/v) SDS (D) standard LB with 1% (w/v) SDS (E) standard LB with 2% (w/v) SDS. 
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3.2.3 Assessing Tat-dependence of the Rieske-Bla Reporter Fusion 
3.2.3.1 Spot testing indicates partially Tat-dependent membrane insertion of 
Rieske-Bla 
The fusion construct Rieske-Bla was tested for Tat-dependence using tat+ and tat- E. coli 
strains, MC4100 and DADE, respectively. The tat- strain (DADE) lacks all known tat 
genes (ΔtatABC/ΔtatE) (Wexler et al., 2000). The tat+ and tat- strains harbouring 
Rieske-Bla, and a negative control of pSUPROM (empty vector) were plated and 
colonies were picked for dilution and spotting onto LB containing different concentrations 
of ampicillin.  
If the Rieske-Bla fusion protein is fully Tat-dependent for the integration of TMD3, there 
should be no growth on ampicillin-containing media of the tat- strain producing this 
construct. It should be noted that unlike AmiA, Bla is a periplasmic protein that is normally 
exported co-translationally by the Sec pathway, therefore, it is a reporter that can use 
either Sec or Tat machinery for translocation depending on the signal sequence to which 
it is fused (Pradel et al., 2009). Figure 3.7 shows that the Rieske-Bla fusion construct 
appears to be recognised by both of these pathways. The tat+ strain has a higher level 
of ampicillin resistance than the tat- strain so there must clearly be some recognition and 
integration of the fusion protein by the Tat pathway (assuming that the level of the fusion 
protein is similar in the tat+ and tat- strains). However the tat- strain, DADE, expressing 
the Rieske-Bla construct showed some growth on solid medium containing up to 
37.5 µg/ml ampicillin. This result clearly shows that TMD3 of the Rieske protein is at least 
partly compatible with the Sec machinery. This is a new finding, as partial Sec recognition 
of TMD3 was not noted by Keller et al. (2012). 
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Figure 3.7 Translocation of the Rieske-Bla fusion protein is partially Tat-dependent. 
Spot tests of strains MC4100 (tat+ strain) and DADE (tat- strain) harbouring an empty vector (pSUPROM), 
or the same vector encoding Rieske-Bla. An approximately equivalent number of colonies were resuspended 
in 100 µl of LB medium and 5 µl of the suspension was spotted onto LB medium containing ampicillin at 
concentrations of 12.5, 25, 37.5 and 50 µg/ml. The plates were incubated at 37°C for 16 h. 
 
3.2.3.1.1 Testing Rieske-Bla twin-arginine variants for Tat-dependence 
It was previously shown for the Rieske-AmiA reporter that introduction of the RRKK 
substitution unexpectedly still allowed some Tat-dependent transport, therefore, a similar 
twin-lysine substitution was also introduced into the Bla reporter to determine whether it 
would also still permit some Tat recognition. Unfortunately, it soon became clear that the 
spot test assay used in Figure 3.7 was rather variable, making it unreliable. To this end, 
a liquid growth assay in the presence of varying ampicillin concentrations was developed.  
Figure 3.8 shows growth of tat+ and tat- strains harbouring Rieske-Bla and the RRKK, 
RRKQ and RRAD variants in liquid medium supplemented with varying concentrations 
of ampicillin. The behaviour of tat+ cells producing the Rieske-Bla and the RRKK variant 
of Rieske-Bla appeared comparable, both showed similar growth kinetics in the presence 
of 12.5 and 25 µg/ml ampicillin, and showed some growth in the presence of 50 µg/ml 
ampicillin, as seen in the spot test (Figure 3.7). The RRKQ and RRAD variants of 
Rieske-Bla also supported some growth of the tat+ strain in the presence of ampicillin, 
but not as well as the wild type or the RRKK variant. This indicates that in this assay 
these variants are to some extent Tat-dependent. 
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Figure 3.8 Tat- and Sec-dependent translocation of Rieske-Bla twin-arginine variants.  
Representative growth curves of MC4100 (tat+) and DADE (tat-) strains harbouring pSUPROM vector 
encoding Rieske-Bla and twin-arginine variants RRKK-Rieske-Bla, RRKQ-Rieske-Bla and 
RRAD-Rieske-Bla. Stationary phase cultures were diluted to an OD600 of 0.03 with LB only or LB containing 
ampicillin at a final concentration of 12.5, 25 & 50 µg/ml ampicillin. Cultures were incubated for 10 h at 37°C 
with shaking and OD600 readings were taken every 20 min. 
 
Comparison of growth seen for the tat- strain harbouring these fusion proteins yielded 
some interesting findings. It can be seen that the RRKQ and RRAD variants of 
Rieske-Bla produced in the tat- strain supported no significant growth when the medium 
contained ampicillin. This would suggest that these two substitutions result in TMD3 no 
longer being recognised by the Sec pathway (but must still allow some recognition by 
the Tat pathway to account for the growth seen in the tat+ strain). By contrast, the 
Rieske-Bla and RRKK-Rieske-Bla constructs supported some growth at 25 µg/ml 
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ampicillin, and so TMD3 must still be partially recognised by the Sec pathway in these 
cases. 
To confirm that the lack of growth in ampicillin-containing media for the tat- strain 
producing the RRKQ-Rieske-Bla and RRAD-Rieske-Bla fusions is due to an effect of the 
amino acid substitutions and not to lack of protein production or protein stability, whole 
cells of the tat+ and tat- strains producing these fusion constructs were analysed by 
Western blotting using a polyclonal anti-Bla antibody. Figure 3.9 shows that the 
Rieske-Bla variant proteins are produced in both tat+ and tat- strains, although the levels 
of protein detected are quite variable. Nonetheless, since RRKQ-Rieske-Bla and RRAD-
Rieske-Bla can be detected in the tat- strain, the absence of growth must be due to effects 
of the substitutions on recognition by the Sec pathway. 
 
Figure 3.9 The Rieske-Bla twin-arginine variants are stably produced. 
Whole cells of MC4100 (tat+) and DADE (tat-) strains harbouring an empty vector (pSUPROM) or the 
pSUPROM vector encoding Rieske-Bla or variants RRKK-Rieske-Bla, RRKQ-Rieske-Bla and 
RRAD-Rieske-Bla were separated on SDS-PAGE (12% acrylamide), electroblotted and immunoreactive 
bands were detected with anti-Bla antibody. As a loading control the levels of the OM protein BamA were 
detected using an anti-BamA antiserum. 
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Analysis of the effect of twin-arginine mutations on the membrane integration of the 
Rieske-Bla construct is complicated by the fact that the translocation of Bla is mediated 
by both Sec and Tat. Some of the substitutions (for example RRAD) clearly abolished 
recognition of TMD3 by the Sec pathway as the tat- strain harbouring this variant was 
unable to grow even at the lowest level of ampicillin used. This is not surprising as 
negative charges present in the n-regions of Sec signal peptides are known to retard 
translocation by the Sec pathway (Vlasuk et al., 1983, Inouye et al., 1982).  
The fact that the Rieske-Bla fusion shows dual recognition of TMD3 means that it will not 
be a particularly useful tool to examine the exact requirements for recognition by the Tat 
pathway, as observations will be complicated by underlying Sec recognition (which will 
also vary when site-directed substitutions are introduced). However, Rieske-Bla is a 
useful construct in the selection of mutations that enhance interaction with the Sec 
pathway, since this should lead to growth on high concentrations of ampicillin in tat 
mutant strains. For the rest of this project Rieske-Bla will be used to analyse the insertion 
of Rieske by the Sec machinery and all tests for Sec-dependence will be undertaken 
using only the tat- strain (DADE; ΔtatABC/ΔtatE) as this shows only Sec-translocation of 
Rieske-Bla. 
 
3.2.3.2 Finding an assay to reliably show Sec translocation of the Rieske-Bla 
fusion  
A reliable, robust and quantitative assay needed to be found to analyse the extent of Sec 
translocation of each of the Rieske-Bla fusion variants. To develop this, Oxoid 
M.I.C.EvaluatorTM (Thermo Fisher Scientific) test strips were used. These contain a 
continuous antibiotic concentration gradient, in this case ampicillin, with a gradient from 
0-256 µg/ml. The strip is placed on an LB agar plate containing a lawn of bacteria and 
after incubation, a symmetrical inhibition ellipse centred along the strip is seen. The 
minimum inhibitory concentration (M.I.C.) value (in µg/ml) is read from the scale where 
the pointed end of the ellipse intersects the strip. 
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3.2.3.2.1 Minimum Inhibitory Concentration Evaluator test strips confirms Sec 
and Tat translocation of the Rieske-Bla fusion  
Firstly the M.I.C.EvaluatorTM test strip was tested against the necessary controls; cells 
only of both the tat+ and tat- strains and the same strains harbouring the empty vector 
(pSUPROM) or the pSUPROM vector containing Rieske-Bla. As Figure 3.10 indicates, 
the M.I.C. for E. coli alone, in the absence of any plasmid is 1-2 µg/ml and as expected 
the introduction of the empty pSUPROM vector (which specifies kanamycin resistance) 
in these cells does not change this M.I.C. When the Rieske-Bla variant is expressed in 
the tat+ strain and tested, the M.I.C. increases to 16 µg/ml. This is due to the translocation 
of the Bla into the periplasm via both the Sec and the Tat pathways. In comparison when 
this variant is expressed in the tat- strain the M.I.C. is 8 µg/ml which is a measure of the 
level of Bla translocated by the Sec machinery. This would appear to be a reliable and 
quantifiable assay that could support investigation into the Sec recognition of Rieske 
TMD3. Therefore, this will be the standard assay for further work using Rieske-Bla.  
 
Figure 3.10 M.I.C.EvaluatorTM test strips show Sec and Tat translocation of the Rieske-Bla fusion. 
Representative images of M.I.C.EvaluatorTM strip tests of strains MC4100 (tat+) and DADE (tat-) alone (cells 
only), harbouring the pSUPROM plasmid (Empty vector) or pSUPROM encoding Rieske-Bla. Stationary 
phase cultures were diluted to OD600 of 0.1 and a lawn of bacteria was spread onto LB agar plates, 
M.I.C.EvaluatorTM strips were placed on the lawn and the plates were incubated at 37°C for 18 h. The M.I.C. 
(µg/ml) for ampicillin is read at the intersection of the test strip by the clearing of bacteria. The average M.I.C 
for these variants is located at the bottom of the test strip. 
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3.2.3.2.2 Testing Rieske-Bla twin-arginine variants for Sec translocation 
The first Rieske-Bla variants tested using the M.I.C.EvaluatorTM assay were the 
twin-arginine variants that were generated above and previously tested in liquid media, 
allowing comparison of the two testing methods. As with the previous results using the 
M.I.C.EvaluatorTM assay, Figure 3.11 shows that when the tat- strain produces some of 
the twin-arginine variants there is detectable translocation through the Sec machinery. 
Figure 3.11A shows the results from the M.I.C.EvaluatorTM test strip analysis of the tat- 
strain producing Rieske-Bla, RRKK-Rieske-Bla, RRAD-Rieske-Bla, RRAA-Rieske-Bla, 
RRKQ-Rieske-Bla and ΔRR-Rieske-Bla and Figure 3.11B is the analysis of triplicate 
results showing the mean M.I.C. and standard deviation (s.d.) for the tat- strain producing 
each Rieske-Bla variant.  
Strain DADE (tat-) producing ΔRR-Rieske-Bla has a similar M.I.C. to DADE producing 
Rieske-Bla, indicating that the twin-arginines are not essential for Sec translocation of 
TMD3. The RRAA-Rieske-Bla fusion variant specified a slightly decreased M.I.C. 
whereas both RRKK-Rieske-Bla and RRKQ-Rieske-Bla yielded significantly decreased 
M.I.C.s, however, they still showed some translocation through the Sec machinery. This 
is in contrast to RRAD-Rieske-Bla, which as previously shown (Figure 3.8) prevents 
translocation through the Sec machinery with an M.I.C. the same as cells only (Figure 
3.10, 1 µg/ml) due to the negative charge replacement of the twin-arginine. These results 
corroborate previously shown data for Rieske-Bla variants and demonstrate the reliability 
of this test. 
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Figure 3.11 Sec-dependent translocation of Rieske-Bla twin-arginine variants. 
(A) Representative M.I.C.EvaluatorTM strip test of strain DADE (tat-) harbouring the pSUPROM vector 
encoding Rieske-Bla or twin-arginine variants RRKK-Rieske-Bla, RRAD-Rieske-Bla, RRAA-Rieske-Bla, 
RRKQ-Rieske-Bla and ΔRR-Rieske-Bla. Stationary phase cultures were diluted to OD600 of 0.1 and a lawn 
of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The dotted white line across the pictures indicates the M.I.C. of Rieske-Bla 
(8 µg/ml).  
(B) The mean of the M.I.C.EvaluatorTM assay data with the s.d. (error bars) calculated and plotted on a 
graph. The number of biological replicates is indicated under the graph. Significance is calculated by the 
Mann-Whitney Rank Sum Test and if p<0.04 then the bars are red, representing a significant decrease in 
M.I.C. compared to Rieske-Bla, purple shows no significance calculated. 
 
  
 
Chapter 3: Development of reporter fusion assays 
110 
 
 
3.3 Discussion 
S. coelicolor Rieske is a dual-targeted cytoplasmic membrane protein that is inserted 
into the membrane using both Sec and Tat translocation pathways. While this 
dual-targeting of Rieske has been investigated in its native S. coelicolor (Hopkins et al., 
2014) and within E. coli (Keller et al., 2012), the specific requirements of this insertion 
process are not known.  
Exploring insertion of the membrane portion of Rieske required the use of reliable fusion 
reporter proteins. These are tools that are used to probe transport pathways and 
determine transmembrane protein topologies. A good phenotypic screening assay was 
required to assess the output by the reporter fusion protein. Keller et al. (2012) used two 
fusion reporters, MBP and AmiA, to assess insertion of Rieske by Sec and Tat. Although 
these reporters were of sufficient utility to assess the insertion of Rieske into the 
cytoplasmic membrane, MBP is not a reliable enough reporter to allow further 
investigation into the dual targeting mechanism. AmiA is a reliable reporter but the 
phenotypic screening assay needed to be refined to assess small differences in growth 
supported by the Rieske-AmiA variants. 
A consistent and reliable assay was developed using the fusion reporter AmiA which 
enabled discrimination between relatively small differences in Tat translocation caused 
by mutations in Rieske. For Tat substrates, the twin-arginines of the signal peptide are 
essential for recognition by the Tat machinery. Substitution of these arginines for 
twin-lysine has been found to abolish Tat translocation for many substrates (Bachmann 
et al., 2006, Buchanan et al., 2001, Widdick et al., 2008, Stanley et al., 2000). However, 
when produced from the vector pSUPROM, a twin-lysine substitution of Rieske-AmiA 
variant was still able to translocate AmiA to the periplasm through the Tat pathway. 
Interestingly, this is in contrast to previous work of Keller et al. (2012), and further 
analysis revealed that the expression level of the fusion protein has a major impact on 
the translocation to the periplasm.  
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The second reporter developed in this study was Bla. Bla is a well-known reporter for 
topology studies and has been shown to be compatible with both Sec and Tat pathways 
for transport into the periplasm (Stanley et al., 2002, McCann et al., 2007). In this case, 
Bla is a robust Sec reporter when expressed in the tat- strain and a reliable assay has 
been developed based on ampicillin-impregnated test strips that is able to quantify small 
differences in Sec translocation specified by Rieske-Bla variants. 
In conclusion, in this Chapter, two reliable Rieske fusion reporter proteins have been 
developed and robust assay systems to assess the insertion and translocation of 
Rieske-AmiA and Rieske-Bla variants by the Tat and Sec machineries have been 
established. These assays will be used in future Chapters to investigate the co-operation 
of Sec and Tat translocation machineries in the insertion of S. coelicolor Rieske into the 
E. coli cytoplasmic membrane. 
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coelicolor Rieske-Bla 
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4.1 Introduction 
4.1.1 Topological determinants 
As discussed in Chapter 1, the insertion propensity of a TMD into the cytoplasmic 
membrane by the Sec machinery depends on a number of determinants within the helix; 
overall hydrophobicity, length and location of charged and polar residues (Hessa et al., 
2005, Hessa et al., 2007). Other factors are also involved, including the nature of 
residues present in internal and external loop regions, and the thermodynamics of 
protein-lipid interactions (Hessa et al., 2005). Figure 4.1 illustrates the most important of 
these topological determinants; hydrophobicity, charge difference across the membrane 
and the positive inside rule.  
 
 
Figure 4.1 The main topological determinants for the Sec machinery to correctly insert a TMD. 
1) Hydrophobicity is the driving force for TMD insertion into the membrane 2) The charge difference within 
a TMD is based on the location of charged residues within the helix 3) The positive inside rule specifies that 
positive charges are more likely to be located in the cytoplasmic loop regions. 
 
4.1.2 Hydrophobicity 
Overall hydrophobicity of a TMD is the driving force for insertion into the cytoplasmic 
membrane from the Sec machinery; a stretch of hydrophobic residues cause the opening 
of the lateral gate to allow the release of the helix into the membrane (von Heijne, 1997). 
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Typically the hydrophobicity of a TMD is additive, the more hydrophobic residues within 
the helix the greater the insertion propensity (White & von Heijne, 2008).  
Biological hydrophobicity scales have been produced that measure the apparent free 
energy of insertion of a TMD by the Sec61 complex into the ER membrane using an in 
vitro system (Hessa et al., 2005) and this has been extended experimentally to establish 
a position-specific biological hydrophobicity scale (Hessa et al., 2007). The methodology 
for these experiments makes use of an engineered version of the E. coli IM protein 
Leader peptidase, Lep, which consists of two TMD which insert into the membrane with 
both N- and C-terminus in the lumen, followed by a large luminal P2 domain. A 
hydrophobic segment (H-segment) to be tested is engineered into the normally luminal 
P2 domain of Lep that is flanked at both sides by acceptor sites for N-linked glycosylation. 
This engineered Lep protein is expressed in ER-derived dog pancreas rough 
microsomes, the degree of integration of the H-segment is the difference between a 
singly or doubly glycosylated protein, which is quantified by SDS-PAGE and Western 
blotting. This is then converted into the apparent free energy of insertion of the 
H-segment (ΔGapp).  
Each individual amino acid was placed in the centre of a 19 residue H-segment and the 
free energy of insertion was calculated to generate a ‘biological’ scale (Hessa et al., 
2005). The position specificity of every amino acid was also investigated by 
systematically scanning each residue across an H-segment to calculate the effect of 
each residue on the overall insertion into the membrane (Hessa et al., 2007). Both of 
these scales generated a full quantitative explanation of TMD recognition by the Sec61 
translocon for insertion into the ER membrane.  
These scales have subsequently been investigated for the SecYEG-mediated insertion 
of TMDs into the bacterial IM (Ojemalm et al., 2013). The methodology used here differs 
as in this case two hydrophobic segments were inserted into P2 of Lep; the engineered 
H-segment, as previously described, and a reporter TMD (R-segment) identical to TMD2 
of the E. coli IM protein lactose permease (LacY). This R-segment is cleaved by the 
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intramembrane rhomboid protease, GlpG, if inserted into the membrane with an Nout-Cin 
orientation. Therefore, when an H-segment is efficiently inserted into the membrane 
there is no cleavage as the R-segment is inserted in Nin-Cout orientation producing a full-
length form or LepLacY. On the other hand, if the H-segment is unable to insert into the 
membrane, the R-segment is incorrectly inserted, leading to cleavage by GlpG and 
yielding a truncated form of LepLacY. The comparison between these forms can determine 
the degree of insertion of the H-segment. Using similar experimental engineering of 
residues within the H-segment as Hessa et al. (2005; 2007), the ΔGapp was calculated 
for each individual amino acid and how its position in the TMD affects the insertion of the 
H-segment into the bacterial IM. It was found that the positional relevance of residues in 
the TMD overall correlates well with previous values for the mammalian ER (Hessa et 
al., 2007, Hessa et al., 2005). However, the hydrophobicity threshold was significantly 
lower than that measured for TMD insertion by Sec61 into the mammalian ER membrane 
and a little higher than the value for a YidC-mediated TMD insertion into the E. coli IM 
(Xie et al., 2007).  
A hydrophobicity threshold needs to be overcome before insertion of a hydrophobic 
stretch is possible. Marginally hydrophobic TMDs are unable to reach this threshold 
without assistance from neighbouring TMDs and charged residues flanking the TMD. 
Both the influence of other TMDs and positive charges can contribute to lowering the 
hydrophobicity threshold for this type of TMD (Ojemalm et al., 2012, Lundin et al., 2008). 
 
4.1.3 Positive inside rule 
Charges have been found to be critical in topology decisions by the Sec machinery. This 
is particularly notable within cytoplasmic loop regions where arginine and lysine residues 
are found to be four times more prevalent compared to periplasmic loops (Heijne, 1986). 
This is known as the positive inside rule. Positive charges are more likely to be found in 
the cytoplasmic loop regions due to the energetic cost for the Sec machinery to 
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translocate them across the membrane into the periplasm against the proton gradient. 
This positive inside rule appears to be applied universally to IM proteins that are found 
in the ER, plasma membrane, inner mitochondrial membrane, chloroplast thylakoid 
membrane and the bacterial IM (Gavel et al., 1991, von Heijne & Gavel, 1988). 
The positive inside rule has been fully explored in a small multidrug transporter, EmrE, 
which has inherent properties allowing it to adopt two different orientations in the 
membrane (Rapp et al., 2007). Its lack of positive charges leads to a small charge bias 
between internal and external loops. Therefore, it is possible to fix the topology of this 
protein by the addition of a positive charge in one of these loops (Rapp et al., 2006) and 
a single positive charge located in the very C-terminus can cause a topology inversion 
(Seppala et al., 2010). Manipulation of the location of positive charges within the loop 
regions can also invert the topology of another protein, Lep, containing two TMDs 
(Nilsson & von Heijne, 1990, von Heijne, 1989). Positive charges have also been found 
to affect the insertion of the neighbouring TMD (Lerch-Bader et al., 2008, Hessa et al., 
2007) indicating that topological determinants can have an additive effect on the Sec 
machinery for correct insertion of TMDs. 
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4.2 Aims 
It was seen in Chapter 3 that there was unexpectedly some interaction of the Sec 
machinery with TMD3 of Rieske, which was revealed when Bla was used as the fusion 
reporter. The aim of this Chapter was to further assess the interaction of the Sec 
machinery with Rieske, to dissect whether there are features within the TMD region of 
Rieske that modulate interactions with the Sec machinery, and in particular to promote 
the release of TMD3. To do this a full programme of mutagenesis was undertaken with 
the Rieske-Bla fusion and variants generated were tested for translocation by 
determining the M.I.C. of ampicillin. Variants of Rieske-Bla that differed significantly from 
the ‘wild-type’ in terms of the level of ampicillin resistance they conferred were further 
analysed biochemically to support the results of the phenotypic observations. 
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4.3 Results 
4.3.1 Investigating the cytoplasmic loop between TMD2 and TMD3 
Keller et al. (2012) undertook a series of TMD-swapping experiments, where TMD1 and 
TMD2 of Rieske were replaced by the first two TMDs of a typical SRP-targeted 
Sec-dependent membrane protein, MtlA (Beck et al., 2000). Furthermore, Keller et al. 
(2012) also increased the length and hydrophobicity of the Rieske transmembrane region 
by fusing these same two TMDs of MtlA N-terminal to Rieske’s TMD1 and TMD2, to give 
a five TMD protein. In both of these cases, the insertion of the last TMD of Rieske 
remained Tat dependent, thereby indicating that there is nothing unusual or special about 
TMD1 and TMD2 of Rieske that facilitates the dual recognition by Sec and Tat. Therefore 
it was concluded that the cytoplasmic loop region between TMD2 and TMD3 must be 
critical to facilitate the co-operation of the Sec and Tat machineries, acting as a stop 
transfer signal for the Sec machinery and allowing recognition of a tethered twin-arginine 
signal sequence by the Tat machinery.  
There is clear sequence conservation present in this loop region between different 
actinobacterial Rieske proteins, as shown in Figure 4.2. The linker length, between the 
end of TMD2 and the twin-arginine of the Tat motif, is always 43 amino acids long. 
Moreover, the loop contains a cluster of 4 negative amino acids, a highly conserved RH 
motif and a predicted α-helix region. The Tat motif is located N-terminal to TMD3 and as 
was seen in Chapter 3, it is essential for recognition by the Tat machinery. As these 
features appear to be conserved across the different Rieske proteins, they were deemed 
important for the release of the polypeptide from the Sec machinery and/or the 
recognition of the tethered signal sequence by the Tat machinery. In this Chapter the 
translocation of Rieske-Bla by the Sec machinery was investigated.
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Figure 4.2 Alignment of Actinobacterial Rieske proteins loop region between TMD 2 and TMD 3 
Protein sequence alignment of the Rieske FeS proteins for different Actinobacteria (as indicated on the left – order, suborder and species). Proteins were aligned using Clustal WS and 
Jalview (Waterhouse et al., 2009). Conserved regions are indicated under the alignment; negative amino acids (pink), RH motif (red) potential conserved α-helix (orange) and the Tat 
motif (brown). Transmembrane domains (TMD) were predicted using TMHMM Server v. 2.0 (http://www.cbs.dtu.dk/services/TMHMM/). 
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4.3.1.1 Mutations generated in the cytoplasmic loop region have little effect on 
the insertion of TMD3 by the Sec machinery 
The first step in understanding whether the conserved residues in the cytoplasmic loop 
region are important for modulating interaction with the Sec pathway was to undertake a 
systematic site-directed mutagenesis programme where each of the conserved residues 
in the loop region encoded by the pSUPROM Rieske-Bla construct were individually 
mutated. The cytoplasmic loop region is shown above Figure 4.4 and conserved residues 
that were mutated in this Chapter are highlighted in colour. These variants were 
produced in DADE (tat- strain) to allow Sec-dependence to be scored, and tested for the 
M.I.C. of ampicillin using M.I.C.EvaluatorTM test strips, as undertaken previously in 
Chapter 3 and a representative example is seen in Figure 4.3, the raw data can be found 
in the Appendix. Experiments were performed in triplicate and the mean of these data 
was assessed for significance compared to Rieske-Bla using Mann-Whitney Rank Sum 
Test. Figure 4.4 and Table 4.1 show the results of these site-directed mutagenesis 
experiments, alongside the M.I.C. determined for the twin-arginine variants that were 
previously described in Chapter 3. 
 
4.3.1.1.1 Conserved amino acid substitutions have little effect on Sec 
translocation 
The first set of residues that were mutated in this study was the RH motif (R133 and 
H134, coloured green in the sequence above Figure 4.4) as apart from the invariant 
twin-arginine motif this is the most conserved pair of residues present in the loop region. 
Two substitutions of these residues were made: R133H H134R (RH-HR) and R133K 
H134K (RR-KK). As shown in Figure 4.3 these substitutions did not significantly change 
the M.I.C. for ampicillin compared to ‘wild-type’ Rieske-Bla. It can therefore be concluded 
that these mutations do not change Sec translocation of TMD3. 
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Figure 4.3 RH motif mutations has no effect on Sec translocation. 
Representative M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding 
Rieske-Bla or RH motif variants RHHR-Rieske-Bla and RHKK-Rieske-Bla. Stationary phase cultures were 
diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were 
placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at 
the intersection of the test strip and the clearing of bacteria. The dotted white line across the pictures 
indicates the M.I.C. of Rieske-Bla (8 µg/ml). The mean M.I.C. value and the number of biological replicates 
for these variants is given below the images. 
 
 
 
 
 
 
 
 
Figure 4.4 Sec dependent translocation of Rieske-Bla fusion variants. 
M.I.C.EvaluatorTM strip test of strain DADE (tat-) harbouring the pSUPROM vector encoding the Rieske-Bla 
fusion variants indicated on the graph. Stationary phase cultures were diluted to OD600 of 0.1 and a lawn of 
bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The mean of the M.I.C.EvaluatorTM assay data with the s.d. (error bars) 
calculated (as seen in Table 4.1) and plotted on the graph. The number of biological replicates for each 
variant can be found in Table 4.1. Significance compared to Rieske-Bla is calculated by the Mann-Whitney 
Rank Sum Test and if p<0.04 then the bars are green (significant increase in M.I.C.) or red (significant 
decrease in M.I.C.). Above the graph is the conserved loop region for S. coelicolor Rieske where the 
conserved residues that were mutated are indicated in colour. 
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Table 4.1 Sec dependent translocation of Rieske-Bla fusion variants 
M.I.C.EvaluatorTM strip test of strain DADE (tat-) harbouring the pSUPROM vector encoding the Rieske-Bla 
fusion variants indicated in the table. Stationary phase cultures were diluted to OD600 of 0.1 and a lawn of 
bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The mean of the M.I.C.EvaluatorTM assay data with the s.d. and number of 
biological replicates, n (in brackets) is shown in the table. Significance compared to Rieske-Bla is calculated 
by the Mann-Whitney Rank Sum Test and if p<0.04 then the numbers are shown in green (significant 
increase in M.I.C.) or red (significant decrease in M.I.C.). 
 Variant Average M.I.C. (s.d.)  Variant 
Average 
M.I.C. (s.d.) 
 Rieske-Bla 7.6 (0.9,n=5) 
Truncat
ions 
∆118-122 10.0 (2.3,n=4) 
TAT motif 
RRKK 3.8 (0.5,n=4) ∆123-127 5.3 (2.3,n=4) 
RRAD 1.3 (0.3,n=3) ∆128-132 12.0 (0.0,n=4) 
RRAA 5.5 (1.0,n=3) ∆133-137 6.7 (2.3,n=3) 
RRKQ 3.3 (0.6,n=3) ∆138-142 7.0 (2.0,n=4) 
∆RR 9.3 (2.3,n=3) ∆143-147 6.7 (2.3,n=3) 
RH motif RHHR 7.3 (1.2,n=3) ∆148-152 10.0 (3.3,n=6) RHKK 7.0 (2.0,n=3) ∆153-157 9.6 (3.6,n=5) 
Negatively 
charged 
M124L 6.0 (2.0,n=3) ∆118-127 6.0 (0.0,n=3) 
M124A 6.0 (2.0,n=3 ∆128-137 9.5 (3.0,n=4) 
S125L 6.7 (2.3,n=3) ∆138-147 8.0 (0.0,n=3) 
S125A 8.0 (0.0,n=5) ∆148-157 9.3 (2.3,n=3) 
D126L 7.3 (1.2,n=3) ∆118-132 9.0 (3.8,n=4) 
D126A 7.3 (1.2,n=3) ∆123-137 8.0 (0.0,n=3) 
E127L 6.0 (2.0,n=3) ∆128-142 10.0 (2.3,n=4) 
E127A 8.0 (2.8,n=5) ∆133-147 9.3 (2.3,n=3) 
Predicted 
α-helix 
A138P 6.0 (2.3,n=4) ∆138-152 5.0 (1.4,n=2) 
A144P 6.7 (1.2,n=3) ∆143-157 4.8 (1.5,n=3) 
A148P 8.0 (2.8,n=4) ∆118-137 7.3 (1.2,n=3) 
A154P 8.0 (0.0,n=3) ∆138-157 5.5 (1.9,n=4) 
Removal of 
negative 
charges 
∆126-128 8.0 (0.0,n=3) ∆118-142 12.0 (0.0,n=3) 
∆126-127 7.5 (1.0,n=4) ∆123-147 7.6 (0.9,n=5) 
∆127-128 8.0 (2.8,n=4) ∆128-152 8.0 (0.0,n=3) 
∆131-132 7.3 (1.2,n=3) ∆133-157 6.0 (0.0,n=4) 
∆137 ∆141 4.0 (0.0,n=3) ∆118-147 10.0 (2.8,n=5) 
∆131-132 ∆141 6.0 (2.0,n=3) ∆123-152 13.6 (2.2,n=5) 
Δ149 Δ156 8.0 (0.0,n=3) ∆128-157 7.3 (1.2,n=3) 
∆126-128 ∆137 ∆141 8.0 (0.0,n=2) ∆118-152 12.0 (0.0,n=3) 
∆126-128 ∆131-132 8.0 (2.4,n=5) ∆123-157 3 (0.0,n=3) 
∆126-128 ∆131-132 ∆137 ∆141 10.4 (2.2,n=5) ∆118-157 2.5 (0.6,n=4) 
∆126-128 ∆131-132 ∆137 ∆141 
Δ149 Δ156 10.0 (2.8,n=3) 
Ins D129 E130 E131 6.7 (1.2,n=3) 
D131A E132A 6.0 (2.3,n=6) 
E137A E141A 6.7 (2.3,n=5) 
D126A E127A E128A 7.2 (1.1,n=4) 
D131K E132K 7.3 (1.2,n=3) 
E137K E141K 6.5 (1.9,n=4) 
D126K E127K E128K 9.0 (2.0,n=4) 
D126K E127K E128K E137K 
E141K 8.0 (0.0,n=3) 
D126K E127K E128K D131K 
E132K E137K E141K 10.0 (2.2,n=5) 
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Next, the negatively charged portions of the loop region were investigated. Charged 
residues are known to be important for correct insertion and orientation of membrane 
proteins when translocated by the Sec machinery. This is particularly true for positive 
charges as explained by the positive inside rule; prevalence for lysine and arginine 
residues in the cytoplasmic loop regions (Heijne, 1986). This is not a counter balance of 
positive and negative charges as it is not the overall charge that has an effect, but the 
charge bias of lysine and arginine between loops in the cytoplasm and the periplasm. In 
fact, statistical studies have found that the frequency of negative charges is similar in 
translocated and untranslocated loop regions (Heijne, 1986, von Heijne & Gavel, 1988), 
indicating that they are less important for modulating activity of the Sec machinery. 
Nevertheless, it has been discovered that sufficiently large number of negative charges 
can have an effect on topology (Nilsson & von Heijne, 1990, Andersson et al., 1992) and 
have been known to reduce the rate of translocation through the Sec machinery (Laws 
& Dalbey, 1989). 
Therefore, it was hypothesised that manipulation of the conserved motif including some 
charged residues in the loop region may have an effect on the translocation of the 
polypeptide by the Sec machinery. Initially, residues in the M124, S125, D126 and E127 
section (coloured in green in the sequence above Figure 4.4) were each individually 
mutated to alanine and to leucine. Figure 4.4 shows that none of these variants 
generated had any significant effect on Sec translocation of TMD3 as the M.I.C.s 
conferred by these constructs were, within experimental error, the same as that of ‘wild-
type’ Rieske-Bla (M.I.C. of 8 µg/ml).  
Closer inspection of the loop region revealed a number of negative charges dispersed 
throughout the sequence (boxed in orange in the sequence above Figure 4.4). Thus, a 
systematic approach was taken where each negatively charged residue was individually, 
or in multiples, deleted from the loop, or substituted to positively charged lysine residues. 
To this end, the following mutations were made Δ126-127, Δ127-128, Δ126-128, Δ131-
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132, Δ137/Δ141, Δ149/Δ156, Δ131-132/Δ141, Δ126-128/Δ131-132, Δ126-128/Δ131-
132/Δ137/Δ141, Δ126-128/Δ131-132/Δ137/Δ141/Δ149/Δ156, insertion of 
D129/E130/E131, D131A/E132A, E137A/E141A, D126A/E127A/E128A, D131K/E132K, 
D126K/E127K/E128K and D126K/E127K/E128K/E137K/E141K, 
D126K/E127K/E128K/D131K/E132K/E137K/E141K. Analysis of each of these variants 
showed that, with one exception, none of them resulted in a significant difference of the 
M.I.C. and consequently it can be inferred that there is no change to the Sec translocation 
of these fusion variants of Rieske-Bla. The sole exception was observed for the 
Δ137/Δ141-Rieske-Bla, which showed a significant decrease in M.I.C. to 4 µg/ml.  
To determine whether the Δ137/Δ141-Rieske-Bla fusion protein was stably produced, 
this variant was expressed in the tat- strain, membranes were prepared and the level of 
fusion protein assessed by Western blotting with an anti-Rieske antiserum. Figure 4.5 
shows that there is potentially a slight decrease in protein produced that might account 
for the lower M.I.C. Moreover, if these same residues are deleted along with additional 
negatively charged residues (Δ126-128/Δ137/Δ141-Rieske-Bla) then the M.I.C. is no 
longer significantly different to Rieske-Bla. Taken together this indicates that these two 
negative charges at positions 137 and 141 are not critical for interaction with the Sec 
machinery and therefore the Δ137/Δ141-Rieske-Bla were not investigated further.  
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Figure 4.5 Stability of protein produced of variant Δ137/Δ141-Rieske-Bla. 
Crude membrane extracts of DADE (tat-) harbouring the pSUPROM vector alone (Empty vector) or the 
pSUPROM vector encoding Rieske-Bla or loop truncation variant Δ137Δ141-Rieske-Bla was separated on 
SDS-PAGE (12% acrylamide), electroblotted and immunoreactive bands were detected with anti-Rieske 
antibody. As a loading control the levels of the OM protein BamA were detected using an anti-BamA 
antiserum. 
 
Finally, a potential role for the predicted α-helical region was probed. It should be noted 
that although there is not high sequence conservation across this region between Rieske 
proteins, the predicted helical structure in this region of the loop is conserved. To assess 
whether this potential helical region was essential for interaction with the Sec pathway, 
all of the alanines (A138, A144, A148 & A154, coloured pink in the sequence above 
Figure 4.4) were individually mutated to proline, an amino acid that is well known as a 
helix breaker (Nilsson & von Heijne, 1998, Nilsson et al., 1998). As shown in Figure 4.4, 
none of these individual substitutions had any significant effect on the M.I.C. of ampicillin 
conferred by the fusion protein, indicating that interaction with the Sec pathway was not 
noticeably altered by these substitutions.  
 
Chapter 4: Sec translocation 
 
127 
 
 
4.3.1.1.2 Truncations of residues in the cytoplasmic loop mostly have little effect 
on Sec translocation 
Since the point mutagenesis failed to identify important determinants for Sec recognition 
of TMD3, more drastic mutations were constructed. To this end, truncations of the loop 
region were generated. Initially, sliding truncations of 5 amino acids at a time were 
constructed along the loop region; Δ118-122, Δ123-127, Δ128-132, Δ133-137, 
Δ138-142, Δ143-147, Δ148-152 and Δ153-157. As seen in Figure 4.4 and Table 4.1 
most of these resulted in no significant change in M.I.C. compared to ‘wild-type’ 
Rieske-Bla, with the exception of the Δ128-132 truncation.  
The Δ128-132 truncation resulted in a significant increase in M.I.C. compared to 
‘wild-type’ Rieske-Bla (12 µg/ml) and is deleted for the following 5 residues; E128, V129, 
A130, D131 and E132. It is possible that the deletion of three negative charges could 
affect Sec translocation, although it has already been shown that removing all the 
negative charges from the loop has no significant effect on the M.I.C. of the variant 
(Δ126-128/Δ131-132/Δ137/Δ141/Δ149/Δ156-Rieske-Bla, 10 µg/ml) and neither did the 
removal of these specific negative charges (Δ126-128/Δ131-132-Rieske-Bla, with an 
M.I.C. of 8 µg/ml). 
The next truncations to be generated were 10 residue deletions (Δ118-127, Δ128-137, 
Δ138-147 and Δ148-157). None of these variants showed any significant increase or 
decrease in M.I.C. (Figure 4.4), despite extending the deletion of the Δ128-132 region of 
Rieske-Bla that was previously shown to result in a significant increase in M.I.C. This 
indicates that this region is not critical for Sec recognition or release. 
Subsequently, the sliding truncations were increased to 15 residues; Δ118-132, 
Δ123-137, Δ128-142, Δ133-147, Δ138-152 and Δ143-157. These variants also had no 
detectable effect on the Sec translocation of Rieske-Bla, with no significant differences 
observed in M.I.C conferred by these variants. Next, 20 residues were removed from the 
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loop region with two mutations, Δ118-137 and Δ138-157, again without any significant 
difference in M.I.C. compared to ‘wild-type’ Rieske-Bla.  
When 25 residues were removed from the loop to generate truncations Δ118-142, 
Δ123-147, Δ128-152 and Δ133-157 there was no effect on M.I.C. conferred by the 
Rieske-Bla variants except for the Δ118-142 variant that yielded a small but significant 
increase in M.I.C. (12 µg/ml). Likewise, the removal of 30 residues from the cytoplasmic 
loop region (Δ118-147, Δ123-152 and Δ128-157) also identified a single variant, Δ123-
152-Rieske-Bla, that supported a significantly increased M.I.C. of 13.6 µg/ml. The 
truncation of 35 residues from the cytoplasmic loop region, to give Δ123-157- and Δ118-
152-Rieske-Bla showed that the Δ118-152-Rieske-Bla also supported an increase in 
M.I.C. to 12 µg/ml. This is in comparison to its counterpart Δ123-157-Rieske-Bla which 
supported a significantly decreased M.I.C. of 2 µg/ml. 
Firstly, focusing on the variants that resulted in a statistically significant increase in M.I.C. 
(coloured green in the graph in Figure 4.4 and Table 4.1) it was reasoned that these 
variants may either be expressed at a higher level or have enhanced stability leading to 
more protein being present, or alternatively the truncations could remove feature(s) in 
the loop that partially blocks Sec translocation which would likewise result in a higher 
M.I.C. Although these variants showed increased M.I.C. overlap in their truncated 
regions, there is no obvious feature of the loop that they all delete which is not also 
truncated in other variants with ‘wild-type’ Rieske-Bla M.I.C. values. In the case of Δ123-
152-Rieske-Bla and Δ118-152-Rieske-Bla it is possible that the increase in M.I.C. is a 
result of removing a large number of residues from the loop, although it should be noted 
that this effect is not seen with any of the other variants with 30 or 35 residues removed. 
The most drastic truncation made was a deletion of 40 residues (Δ118-157) leaving only 
3 residues in the loop. As with the earlier deletion of 35 residues there was a substantial 
decrease in Sec translocation indicated by a significant change in M.I.C., Δ123-152-
Rieske-Bla conferred an M.I.C. of 2 µg/ml and Δ118-157-Rieske-Bla an M.I.C. of 3 µg/ml. 
 
Chapter 4: Sec translocation 
 
129 
 
 
These M.I.C. results are very similar to that seen with empty vector alone and would 
therefore be consistent with no Sec translocation of TMD3. 
 
4.3.1.2 Rieske-Bla loop truncations affect Sec translocation 
Next, an in-depth investigation into the truncation variants that specified a significant 
decrease in the M.I.C for ampicillin compared to ‘wild-type’ Rieske-Bla (Δ123-157-
Rieske-Bla and Δ118-157-Rieske-Bla) was undertaken to try and understand why these 
variants conferred very little ampicillin resistance, particularly when the Δ118-152-
Rieske-Bla resulted in an increased M.I.C. To this end, further variants were generated, 
where the truncation Δ118-152-Rieske-Bla was extended one residue at a time to give 
Δ118-153-, Δ118-154-, Δ118-155- and Δ118-156-Rieske-Bla. 
Figure 4.6A is a representation of M.I.C.EvaluatorTM test strip results obtained for the tat- 
strain producing these truncation variants while Figure 4.6B is a graph of the mean M.I.C. 
with the s.d. as error bars. The Δ118-153-Rieske-Bla (depicted in green) showed a 
significant increase in M.I.C., whereas Δ118-154-Rieske-Bla showed no significant 
change of M.I.C. compared to Rieske-Bla (8 µg/ml; shown in purple). By comparison, 
Δ118-155-Rieske-Bla had a significantly reduced M.I.C. along with the variants Δ118-
156-Rieske-Bla and previously seen Δ118-157-Rieske-Bla (in red).  
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Figure 4.6 Significant M.I.C. differences mediated by closely related Rieske-Bla truncation variants.  
A) The remainder of the conserved loop region for S. coelicolor Rieske for these truncation variants. 
B) Representative M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding 
Rieske-Bla or loop truncation variants Δ123-157-Rieske-Bla, Δ118-152-Rieske-Bla, Δ118-153-Rieske-Bla, 
Δ118-154-Rieske-Bla, Δ118-155-Rieske-Bla, Δ118-156-Rieske-Bla and Δ118-157-Rieske-Bla. Stationary 
phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, 
M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. 
(µg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The dotted white 
line across the pictures indicates the M.I.C. of Rieske-Bla (8 µg/ml). 
C) The mean of the M.I.C.EvaluatorTM assay data with the s.d. (error bars) was calculated and plotted on a 
graph. The number of biological replicates is indicated under the graph. Significance compared to Rieske-Bla 
is calculated by the Mann-Whitney Rank Sum Test and if p<0.04 then the bars are green (significant increase 
in M.I.C.) or red (significant decrease in M.I.C.), purple shows no significance calculated.  
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To confirm that the M.I.C. difference for the tat- strain producing the truncated fusion 
variants is due to an effect of the amino acid deletions and not a lack of protein production 
or protein stability, membranes from the tat- strain harbouring these variants were 
analysed by Western blotting with an anti-Rieske antiserum. Representative results are 
shown in Figure 4.7A, which gives an example of a Western blot of the truncated fusion 
proteins. It is apparent from the blot that a band shift is seen for the truncation variants 
due to shortening of the protein. For a comprehensive analysis, samples, collected in 
triplicate and analysed by Western blot, were quantified by densitometry analysis where 
Rieske-associated signals were normalised to the BamA-associated signals (which 
served as the loading control). The results were subsequently expressed as percentage 
of the normalised signal obtained for ‘wild-type’ Rieske-Bla, as seen in Figure 4.7B. The 
results indicate that all of the fusion proteins are stable and located in the membrane 
with a substantial amount of protein produced when analysed against Rieske-Bla. 
Therefore, it can be concluded that the severely reduced M.I.C.is due to effects of the 
truncations on interaction of TMD3 with the Sec pathway rather than on protein 
production or stability. 
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Figure 4.7 Protein is still stably produced from all truncation variants. 
A) Crude membrane extracts of DADE (tat-) harbouring the pSUPROM vector alone (Empty vector) or the 
pSUPROM vector encoding Rieske-Bla or loop truncation variants Δ123-157-Rieske-Bla, Δ118-152-Rieske-
Bla, Δ118-153-Rieske-Bla, Δ118-154-Rieske-Bla, Δ118-155-Rieske-Bla, Δ118-156-Rieske-Bla and 
Δ118-157-Rieske-Bla were separated on SDS-PAGE (12% acrylamide), electroblotted and immunoreactive 
bands were detected with anti-Rieske peptide antibody. As a loading control the levels of the OM protein 
BamA were detected using an anti-BamA antiserum. Western blots used can be found in Figure 8.1. 
B) Western blots were quantified by densitometry analysis and Rieske-associated signals were normalised 
with BamA-associated signals. The results were expressed as percentage of the normalised signal obtained 
for Rieske-Bla and the standard error of the mean (s.e.m) is indicated (error bars).  
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4.3.1.3 Addition of a positive charge restores Sec translocation to loop 
truncations 
As seen above, a significant decrease in M.I.C. was found for the Δ118-155-Rieske-Bla 
construct, but intriguingly not for a one residue shorter truncation (Δ118-154-Rieske-Bla) 
that specified an M.I.C. similar to ‘wild-type’ Rieske-Bla. The additional residue that is 
deleted between these variants is K155. Previous data did not indicate that this residue 
per se was important for Sec translocation as other truncation variants containing a 
deletion of this residue had no significant effect on Sec translocation (for example, 
Δ153-157-Rieske-Bla with a mean M.I.C. of 9.6 µg/ml, Figure 4.4 and Table 4.1). 
However, an important Sec topology determinant is the positive inside rule; positively 
charged residues are four times more prevalent in the cytoplasmic loops of membrane 
proteins (Heijne, 1986). These residues probably remain in the cytoplasm due to the high 
energetic cost of translocating them across the membrane (Nilsson & von Heijne, 1990). 
Positive charges can influence the orientation of the TMD within membrane proteins and 
if charges within the loop regions are manipulated, the topology of some proteins, like 
EmrE, can be changed (Rapp et al., 2006). Positive charges flanking TMDs can affect 
the insertion of TMDs, with similar effects from both arginine and lysine residues 
(Andersson et al., 1992, Hessa et al., 2007). This is particularly imperative when placed 
downstream of the helix where the charges can contribute to insertion (Lerch-Bader et 
al., 2008). 
The Δ118-155-Rieske-Bla construct no longer has any positive charges in the truncated 
cytoplasmic loop region, whereas Δ118-154-Rieske-Bla still contains one positive charge 
(K155). Assuming Rieske-Bla follows the Sec topology determinant, the positive inside 
rule, then removal of all the charges (particularly the positive charges) would be expected 
to have an effect on the insertion of its TMDs by the Sec machinery (Figure 4.8B). If this 
is the case then returning a positive charge to the truncated cytoplasmic loop region 
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within these variants should restore Sec translocation due to the return of a topological 
signal.  
To this end, V158 was substituted with a lysine (V158K) and this mutation was introduced 
into ‘wild-type’ Rieske-Bla and the Δ118-153-, Δ118-154-, Δ118-155-, Δ118-156- and 
Δ118-157-Rieske-Bla truncation variants. As seen in Figure 4.8 the reintroduction of a 
positive charge into the ‘wild-type’ the Δ118-153- and the Δ118-154- Rieske-Bla, did not 
significantly alter the M.I.C. that they conferred. However, when it was introduced into 
the Δ118-155-, Δ118-156- and Δ118-157-Rieske-Bla constructs this ‘rescued’ the Sec 
translocation of TMD3 and restored the M.I.C. conferred by these variants to the same 
as ‘wild-type’ Rieske-Bla. Thus it can be concluded that the reduced M.I.C. from the 
original truncated variants was not due to the substantial decrease in size of the 
cytoplasmic loop but to the removal of a topological signal connected to the positive 
inside rule.  
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Figure 4.8 The addition of a positive charge to some of the loop truncations restores translocation 
of TMD3 through the Sec machinery. 
A) Representative M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding 
Rieske-Bla or loop truncation variants with the mutation V158K, Δ118-153-V158K-Rieske-Bla, Δ118-154-
V158K-Rieske-Bla, Δ118-155-V158K-Rieske-Bla, Δ118-156-V158K-Rieske-Bla and Δ118-157-V158K-
Rieske-Bla. Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB 
agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. 
The M.I.C. (µg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The 
dotted white line across the pictures indicates the M.I.C. of Rieske-Bla (8 µg/ml). The number of biological 
replicates are indicated under the images.  
B) Predicted topologies of Rieske-Bla with (left) and without (right) positively charged residues in the 
cytoplasmic loop region (blue). 
C) The mean of the M.I.C.EvaluatorTM assay data, with or without the mutation V158K, was plotted on a 
graph with the s.d. (error bars). Significance compared to Rieske-Bla is calculated by the Mann-Whitney 
Rank Sum Test and if p<0.04 then the bars are green (significant increase in M.I.C.) or red (significant 
decrease in M.I.C.), purple shows no significance calculated.   
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4.3.2 Topological determinants of Sec translocation 
4.3.2.1 Positive charge distribution around TMD3 affects Sec translocation 
During the systematic site-directed mutagenesis of the cytoplasmic loop region, a 
serendipitous mutation was introduced, R185C. This mutation was present within the 
construct Δ126-128-Rieske-Bla, and when this variant was tested for Sec-dependent 
translocation it was discovered that it had a strikingly high M.I.C. of 32 µg/ml. After 
re-sequencing the construct the additional mutation was found, consequently, both of 
these mutations were separately generated and re-tested for the M.I.C. of ampicillin to 
determine which one was the cause of the increase in Sec translocation. It was found 
that Δ126-128-Rieske-Bla produced a mean M.I.C. of 8 µg/ml, as indicated in Table 4.1, 
this is the same M.I.C. as ‘wild-type’ Rieske-Bla. On the other hand, R185C-Rieske-Bla 
generated a mean M.I.C. of 38 µg/ml (Figure 4.9), which is markedly high compared to 
Rieske-Bla (8 µg/ml) indicating that it is a potential Sec release over-ride variant.  
The R185C mutation is located after the C-terminus of TMD3, and directly before the 
fusion junction with the reporter Bla. Although cysteines are generally tolerated at most 
positions in membrane proteins, it is not a substitution that is usually introduced during 
site-directed mutagenesis studies as it introduces an often-unwanted functionality. 
Therefore, R185 was also substituted by an alanine to observe whether the over-ride of 
Sec resulted from substitution of the arginine or by introduction of the cysteine. As seen 
in Figure 4.9 this R185A substitution further increased the M.I.C. to a mean of 64 µg/ml, 
indicating that it is the removal of the positively charged arginine residue that specifically 
causes increased efficiency of Sec-dependent export.  
As discussed in Section 4.1.3, charged residues are important within membrane proteins 
to dictate the topology of the TMDs and are particularly prevalent in cytoplasmic loop 
regions, as described by the positive inside rule (Heijne, 1986). A change to the charges 
in loop regions, by adding or removing positively charged residues, can potentially 
reverse the topology of TMDs and sometimes the protein itself (Rapp et al., 2006, Nilsson 
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& von Heijne, 1990). Charged residues are also important in the charge bias across a 
TMD and manipulation of this can also affect the orientation of a helix by increasing or 
decreasing the threshold hydrophobicity required for insertion (Ojemalm et al., 2012). 
‘Frustrated’ topologies occur when a sufficiently hydrophobic segment is prevented from 
inserting into the membrane by a neighbouring TMD with a strong orientational 
preference (Gafvelin & Vonheijne, 1994). This can also occur when a C-terminal positive 
charge prevents insertion of Nout-Cin TMD as the charge prevents the TMD from inserting 
‘incorrectly’ by the positive inside rule. This frustrated TMD can be forced to insert if the 
hydrophobicity of the helix is increased (Ojemalm et al., 2012). 
The effect of R185 indicates that the Sec machinery samples the polypeptide before 
insertion which can permit these different topologies. This positive charge (R185) is 
located C-terminal to the helix and therefore, is at the periplasmic side of the membrane, 
where charges cause an energetic cost for translocation across the membrane against 
the transmembrane proton gradient (Yamagishi et al., 2014). The loss of the positive 
charge changes the charge bias of TMD3, thereby, causing the Sec machinery to insert 
this variant more efficiently, yielding a higher M.I.C. for ampicillin. 
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Figure 4.9 The removal of a positive charge C-terminal to TMD3 increases translocation through the 
Sec machinery. 
A) Representative M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding 
Rieske-Bla or variants R185C-Rieske-Bla or R185A-Rieske-Bla. Stationary phase cultures were diluted to 
OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on 
the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the 
intersection of the test strip and the clearing of bacteria. The dotted white line across the pictures indicates 
the M.I.C. of Rieske-Bla (8 µg/ml). 
(B) The mean of the M.I.C.EvaluatorTM assay data with the s.d. (error bars) calculated and plotted on a 
graph. The number of biological replicates are indicated under the graph. Significance compared to 
Rieske-Bla is calculated by the Mann-Whitney Rank Sum Test, if p<0.04 then the bars are green (significant 
increase in M.I.C.). 
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4.3.2.2 Increasing the hydrophobicity of TMD3 increases Sec translocation 
Another topological signal involved in the insertion and orientation of helices in the 
cytoplasmic membrane is the overall hydrophobicity of the TMD. Hydrophobicity is the 
driving force for insertion of a helix into the membrane, strongly hydrophobic segments 
entering the Sec translocon cause the lateral gate to open, which allows the helix to 
contact the lipid bilayer and escape into the membrane to generate a TMD (von Heijne, 
1997, Hessa et al., 2005, White & von Heijne, 2008). Quantification of TMD insertion into 
the mammalian ER (Hessa et al., 2005, Hessa et al., 2007), the yeast ER (Hessa et al., 
2009), the mitochondrial IM (Botelho et al., 2011), a YidC-dependent protein in the E. coli 
IM (Xie et al., 2007) and a TMD into the E. coli IM by SecYEG (Ojemalm et al., 2013) 
have all been reported. These studies have allowed the generation of several 
position-specific biological hydrophobicity scales which measure the contribution of each 
amino acid on the free energy of insertion of a Nout-Cin TMD into the mammalian ER 
(Hessa et al., 2007) and the bacterial IM (Ojemalm et al., 2013). The reverse orientation 
(Nin-Cout) has also been investigated in the ER and the position specific effects of the 
individual amino acid residues are similar. However, the threshold hydrophobicity for a 
Nin-Cout TMD to be inserted is lower, this threshold is the level of hydrophobicity which is 
needed to open the lateral gate in the Sec translocon, thereby allowing Nin-Cout TMD to 
be less hydrophobic (Lundin et al., 2008).  
A highly hydrophobic helix has a strong orientational preference which can influence the 
topology of the nearby TMDs (Ojemalm et al., 2012). Increasing the hydrophobicity of a 
TMD can change the orientation of a helix, previous findings have shown that an 
N-terminal signal-anchor sequence when increased in hydrophobicity will favour a 
Nin-Cout orientation (Goder & Spiess, 2003). The last TMD in a polytopic protein is on 
average more hydrophobic than central TMDs, comparable to the first TMD which is 
required to be strongly hydrophobic for targeting to the insertion machinery (Virkki et al., 
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2014). This is supposedly due to the lack of neighbouring TMDs to exert an orientational 
preference. 
To test how critical hydrophobicity is for Sec insertion of TMD3 of Rieske-Bla, an Nin-Cout 
TMD, mutations were generated to increase the hydrophobicity of TMD3 
(P177L/S179L/G180L-Rieske-Bla, S179L/G180L-Rieske-Bla, S179L-Rieske-Bla and 
G180L-Rieske-Bla), these were then expressed in the tat- strain and tested for the M.I.C. 
of ampicillin conferred. Figure 4.10 demonstrates that increasing the hydrophobicity of 
TMD3 increases Sec translocation compared to Rieske-Bla, with up to a 25 fold larger 
M.I.C. This substantial increase in M.I.C. when only a few hydrophobic residues are 
added suggests that TMD3 is not particularly hydrophobic. The contribution to 
hydrophobicity in a TMD is usually additive so the more hydrophobic residues the greater 
the insertion propensity of the TMD (White & von Heijne, 2008).  
The ΔG for TMD insertion into the ER membrane by Sec61can be calculated using a ΔG 
prediction server, http://dgpred.cbr.su.se/, based on the hydrophobicity scale from Hessa 
et al. (2007). This server can both calculate the ΔGapp for membrane insertion of a 
potential TMD and scan a protein sequence for putative TMDs, giving calculated ΔGapp 
for any TMDs found. In principle, if the ΔG value for a given potential helix is negative 
then it indicates that the sequence is recognised as a TMD by Sec61 and so would be 
integrated into the ER membrane. In comparison, if the value is positive it does not 
necessarily imply that the sequence is not a TMD, but it does flag that it is not a strongly 
hydrophobic helix and may not be efficiently inserted by itself suggesting that stabilising 
interactions from surrounding TMDs and residues are required. This would make it a 
marginally hydrophobic helix. 
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Figure 4.10 Increasing hydrophobicity of TMD3 increases translocation through the Sec machinery. 
A) Representative M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding 
Rieske-Bla or variants P177L/S179L/G180L-Rieske-Bla or S179L/G180L-Rieske-Bla.or G180L-Rieske-Bla. 
Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, 
M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. 
(µg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The dotted white 
line across the pictures indicates the M.I.C. of Rieske-Bla (8 µg/ml). 
 (B) The mean of the M.I.C.EvaluatorTM assay data with the s.d. (error bars) calculated and plotted on a 
graph. The number of biological replicates are indicated under the graph. Significance compared to 
Rieske-Bla is calculated by the Mann-Whitney Rank Sum Test if p<0.04 then the bars are green (significant 
increase in M.I.C.). 
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Using this server the ΔGapp for each TMD in S. coelicolor Rieske was calculated, and the 
results are given in Table 4.2. As these values are calculated for insertion into the ER 
membrane and Ojemalm et al. (2013) calculated that the threshold for the bacterial 
SecYEG complex is lower than the ER Sec61 complex, it is unlikely that TMD2, with the 
ΔG of 0.006, is a marginally hydrophobic helix. However, TMD3 does have a high 
positive value compared to TMD1 and TMD2, and this indicates that it might be a 
marginally hydrophobic helix. The ΔGapp of TMD3 of the S179L-Rieske-Bla variant is 
lower than that of ‘wild-type’ Rieske, which is in agreement with the M.I.C. results 
indicating that this variant is more readily inserted into the membrane. 
 
Table 4.2 Predicted ΔG values for TMDs of Rieske. 
 Sequence Predicted ΔG 
TMD1 VALLFTLSMLATIAFIAAFVAI -2.177 
TMD2 ISALNFALGMTLGVALFAIGAGAV 0.006 
TMD3 IRNTMLGALTLVPLSGVVLLR 1.215 
S179L-TMD3 IRNTMLGALTLVPLLGVVLLR 0.377 
 
It is known that the last TMD of a polytopic membrane protein is usually strongly 
hydrophobic (Virkki et al., 2014). As this is not the case for S. coelicolor Rieske, E. coli 
Sec-dependent IM proteins that have been experimentally shown to have three TMDs 
and Nin-Cout topology were analysed for the ΔGapp of their last TMD, shown in Table 4.3. 
These proteins were used because they have previously been analysed by Nilsson et al. 
(2000) who were investigating the reliability of topology prediction methods. The topology 
of these proteins has been agreed to be Nin-Cout by at least four out of five topology 
prediction methods, which increases the reliability of the orientation suggested. As seen 
in Table 4.3, the final TMD for all these proteins has a negative or close to zero ΔG value. 
This indicates that, unlike Rieske, TMD3 is fairly hydrophobic for all of these 
Sec-dependent proteins.  
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Table 4.3 Predicted ΔG values for E. coli IM proteins with three TMDs 
Ecogene ID Primary gene name Predicted ΔG for TMD3 
EG10332 frdC -2.671 
EG10934 sdhD -3.173 
EG10939 secE -1.167 
EG11695 yidG -0.74 
EG11696 yidH -3.983 
EG12395 ybgE -1.234 
EG12477 yjeO -0.936 
EG12575 yjiN 0.047 
EG12747 yhaH -3.097 
EG12748 yhaI -3.187 
EG13028 ygiZ -2.953 
EG10178 cyoA -2.775 
EG10333 frdC -1.43 
EG10933 sdhC -0.174 
EG12382 fxsA -1.359 
EG12707 ygbE -2.601 
EG13987 yniB -1.804 
 
TMD3 of Rieske is shown to be a marginally hydrophobic TMD (ΔG value of 1.215, Table 
4.2), which means it is not sufficiently hydrophobic to insert into the membrane on its 
own, requiring other TMDs or the influence of loop residues to increase the insertion 
potential. This low hydrophobicity could be significant in the release of the Rieske 
polypeptide by the Sec machinery, however, it cannot be the only feature for release as 
the Sec machinery is capable of inserting this helix to some degree.  
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4.3.3 Confirming the predicted topology of truncation Rieske-Bla fusion 
variants 
Previously it was observed that the loss of topogenic signals prevents the insertion of 
TMD3 by the Sec machinery, highlighting the importance of the positive inside rule. 
Substituting positive charges can have the ability to change the orientation of helices 
inserted by Sec, switching loop regions from one side of the membrane to the other 
depending on where the charges are placed (Rapp et al., 2006, von Heijne, 1989). The 
experiments described above show that truncation variant Δ118-155-Rieske-Bla is not 
inserted correctly as Bla is not located in the periplasm to confer resistance to ampicillin, 
but that the variant is located in the membrane so at least one of the TMD must be 
inserted. However, the overall topology of this construct is not clear. For example, is the 
loss of the topological signal K155 enough to re-orientate the helices and the loop 
regions, potentially generating a topologically frustrated TMD2 (Gafvelin & Vonheijne, 
1994, Ojemalm et al., 2012)? Or is TMD3 just left uninserted at the cytoplasm side of the 
membrane? Genetic experiments alone are not sufficient to answer these questions, and 
therefore, a sulphydryl labelling approach was undertaken to directly address which side 
of the membrane residues in the TMD2 and TMD3 loop regions are located for 
Rieske-Bla variants. 
 
4.3.3.1 Experimental system for Sulphydryl labelling topology determination 
experiments 
The accessibility of the cytoplasmic loop region was probed using cysteine labelling, 
according to the methodology described in Koch et al. (2012). The sulphydryl reactive 
agent used was methoxypolyethylene glycol maleimide (malPEG) which is a 5 kDa 
molecule that specifically reacts with an accessible sulfhydryl group to form an 
irreversible 3-thiosuccinimidyl ether linkage (Figure 4.11A). As a 
membrane-impermeable molecule it cannot cross the cytoplasmic membrane, therefore, 
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only reacts with cysteines exposed in the periplasm. Labelled cysteines are verified by 
Western blot and a covalent reaction with malPEG is detected by a 5 kDa band shift after 
immunoblotting. 
 
 
Figure 4.11 Reaction of malPEG and schematic to show approach to test for accessible cysteine 
residues. 
A) The methoxypolyethylene glycol maleimide (malPEG) molecule reacts with an accessible sulfhydryl group 
to form an irreversible 3-thiosuccinimidyl ether linkage. 
B) Schematic of sulphydryl labelling of crude membrane fractions. 1) Cells producing single cysteine 
substituted variants of Rieske-Bla were disrupted by ultracentrifugation isolating the crude membrane 
fraction. 2) The crude membrane fraction contains mixed orientation of membrane vesicles allowing both the 
periplasm and cytoplasm membrane protein domains to be exposed to the surrounding buffer. 3) Aliquots 
of the membrane fractions were either unlabelled or treated with malPEG. 4) Samples were separated by 
SDS-PAGE, electroblotted and immunoreactive bands were detected with an anti-Bla antibody. Labelling of 
malPEG was indicated by an electrophoretic mobility-shift compared to the band in the unlabelled sample. 
Labelled bands show the accessibility of cysteine residues to malPEG.  
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4.3.3.2 Selection of control residues for cysteine substitution to probe Rieske-Bla 
topology 
‘Wild-type’ Rieske-Bla contains one cysteine residue which is buried within Bla and is 
therefore inaccessible to the surrounding buffer and labelling by malPEG. Cysteine 
substitutions were chosen within the loop regions of Rieske-Bla to detect labelling in the 
periplasm and the cytoplasm, as suitable controls for the experiment. V82 is in the 
periplasmic loop region between TMD1 and TMD2, consequently, this variant should be 
labelled when expressed in whole cells and treated with malPEG, Figure 4.12A. V158 is 
in the very C-terminal part of cytoplasmic loop region between TMD2 and TMD3 (seen 
in Figure 4.12A), therefore, in V158C-Rieske-Bla this cysteine should not be labelled by 
malPEG when expressed in whole cells. This residue is located outside of the truncations 
made in the cytoplasmic loop region and, therefore, it can be mutated in all the truncation 
variants to be tested. 
It is critical that the cysteine substitutions generated are membrane-extrinsic and 
therefore potentially accessible for labelling. To test this, the protocol described in Figure 
4.11B was followed. Crude membrane fractions of strains MC4100 (tat+) or DADE (tat-) 
producing either of these cysteine-substituted constructs, the ‘wild-type’ (i.e. Cys-less) 
Rieske-Bla or harbouring the empty plasmid vector were prepared by sonication and the 
membrane fraction isolated by ultracentrifugation. This produces membrane vesicles 
with mixed orientation exposing both periplasmic and cytoplasmic membrane protein 
domains to the surrounding buffer. The crude membrane fractions were split into two 
aliquots; one was left untreated (the negative control), whilst the other was treated with 
malPEG which would react with the accessible cysteine generating an additional mass 
to the truncation variant. After quenching the reaction with dithiothreitol (DTT), samples 
were separated by SDS-PAGE and analysed by Western blotting. As shown in Figure 
4.12B following treatment with malPEG both of the cysteine variants were labelled, 
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indicated by a band shift. This confirms that both cysteines are accessible to the 
surrounding buffer.  
 
 
Figure 4.12 Analysis of cysteine accessibility by malPEG labelling in membrane fractions. 
A) A schematic of where the control cysteine mutations are located on Rieske-Bla. 
B) Labelling reactions were performed on membrane fractions of MC4100 (tat+) or DADE (tat-) strain 
harbouring an empty vector (pSUPROM) or the pSUPROM vector encoding Rieske-Bla or cysteine variants 
V82C-Rieske-Bla and V158C-Rieske-Bla. Samples were separated on SDS-PAGE, electroblotted and 
immunoreactive bands were detected with an anti-Bla antibody. 
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4.3.3.2.1 Determining the topology of ‘wild-type’ Rieske-Bla in whole cells 
Next it was necessary to probe whether the introduced cysteines were located at the 
cytoplasmic or periplasmic side of the membrane, using sulphydryl labelling of whole 
cells. In this approach, one sample of whole cells is left untreated as a negative control 
whereas the other is incubated with malPEG to test the periplasmic accessibility of 
cysteine residues. Note that EDTA was present in both the positive and negative control 
samples as it is essential to render the cell envelope permeable to malPEG by chelating 
cations that normally stabilise the LPS component of the OM (Ferris & Beveridge, 1986, 
van Alphen et al., 1978). This overall strategy is summarised in Figure 4.13A.  
As these experiments are undertaken in whole cells, a cytoplasmic control is required to 
confirm that the cytoplasmic membrane was not disrupted during the procedure. The 
integrity control chosen was the HA-tagged SoxY protein (Figure 4.13B), that was 
derived from the single-cysteine-containing Paracoccus pantotrophus SoxYZ complex 
(Koch et al., 2012). The signal sequence of SoxY has been replaced with a HA-tag, 
trapping the complex in the cytoplasm. Therefore, if the cells are leaky during the 
experiment, HA-SoxY will be accessible to malPEG and a size shift will be observed for 
HA-SoxY in labelled samples. 
Whole cell samples of strains MC4100 (tat+) or DADE (tat-) producing either of these 
cysteine-substituted constructs, the ‘wild-type’ (i.e. Cys-less) Rieske-Bla or harbouring 
the empty plasmid vector were treated with malPEG and the samples analysed (Figure 
4.14). The results showed that the V82C-Rieske-Bla variant is labelled with malPEG in 
the tat+ and tat- cells, indicating that this cysteine is located in the periplasm, whereas 
V158C remained unlabelled in both strains confirming a cytoplasmic location. These 
results support the expected topology of TMD1 and TMD2 of Rieske and confirm the 
findings of Keller et al. (2012) that there is no role for the Tat pathway in the membrane 
assembly of this portion of the protein. 
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Figure 4.13 Schematic of sulphydryl labelling of whole cells with malPEG. 
A) Sulphydryl labelling of periplasmic and cytoplasmic cysteines with malPEG 1) Aliquots of the cells 
producing single cysteine substituted variants of Rieske-Bla were treated in two ways. 2) The first aliquot 
was unlabelled, the second was labelled with malPEG. 3) The reaction was stopped and cells were disrupted 
by ultracentrifugation isolating the labelled or unlabelled crude membrane fraction. 4) Samples were 
separated by SDS-PAGE, electroblotted and immunoreactive bands were detected with an anti-Bla 
antibody. Labelling of malPEG was indicated by an electrophoretic mobility-shift compared to the band in 
the unlabelled sample. Labelled bands show the accessibility of cysteine residues to malPEG. B) The crystal 
structure of the SoxYZ complex of Paracoccus pantotrophus (Sauve et al., 2007). The cytoplasmic control 
of cell integrity is SoxY which contains a cysteine residue at position 110. The mature SoxY protein has 
previously had a hemagglutinin tag fused to the N-terminus allowing detection by anti-HA immunoblotting 
(Koch et al., 2012). 
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Figure 4.14 Analysis of cysteine accessibility by malPEG labelling in whole cells. 
Labelling reactions were performed on whole cells of MC4100 (tat+) or DADE (tat-) strains harbouring an 
Empty vector (pSUPROM) or the pSUPROM vector encoding Rieske-Bla or cysteine variants V82C-Rieske-
Bla and V158C-Rieske-Bla. Membrane fractions were isolated by ultracentrifugation and samples were 
separated on SDS-PAGE, electroblotted and immunoreactive bands of Rieske-Bla were detected with an 
anti-Bla antibody (top panels) and SoxY with an anti-HA antibody (bottom panels).  
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4.3.3.2.2 Large truncations of the TMD2-TMD3 loop block accessibility of V158C 
To probe the arrangement of potentially topologically frustrated Rieske-Bla variants 
induced by loss of positive charges in the TMD2-TMD3 loop region, the V158C 
substitution was introduced into Δ118-153-, Δ118-155-, Δ118-156-, and Δ118-157-
Rieske-Bla. Initially sulphydryl labelling experiments were conducted on crude 
membrane fractions of strains MC4100 (tat+) or DADE (tat-) producing each of these 
variants, the ‘wild-type’ Rieske-Bla or harbouring the empty plasmid vector to assess 
accessibility of the introduced cysteine residue. As Figure 4.15 shows, when membrane 
fractions containing each of the cysteine variants were treated with malPEG there was 
no labelling, as no band shift was detected. This indicates that the cysteines in these 
variants are not accessible to the surrounding buffer, possibly because they are partially 
pulled into the membrane by the very short loop region. Unfortunately, this finding 
precluded any further labelling analysis in whole cells. Without a positive control for the 
maleimide then these results could also be due to failed experimental conditions. 
 
Figure 4.15 Western blot analysis of Rieske-Bla variants labelled with malPEG in membrane 
fractions. 
Labelling reactions were performed on membrane fractions of DADE (tat-) strain harbouring an empty vector 
(pSUPROM) or the pSUPROM vector encoding Rieske-Bla or cysteine variants. Samples were separated 
on SDS-PAGE, electroblotted and immunoreactive bands were detected with an anti-Bla antibody.  
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4.3.4 Positive charges are located C-terminal of TMD3 in actinobacterial 
Rieske proteins 
As described previously, the positive inside rule is an important determinant for the 
correct insertion of TMDs by the Sec machinery. Positive charges have also been known 
to affect the topology of a protein even when acting over large distances. In the protein 
EmrE, a positive charge located in the C-terminus can invert the topology of the protein 
(Seppala et al., 2010). Positive charges have also been found to anchor a marginally 
hydrophobic TMD even when placed 60 residues C-terminal of the helix (Fujita et al., 
2010). The importance of positive charges is also seen by topologically frustrated TMDs, 
where a positive charge forces the exclusion of a TMD, over-riding the hydrophobicity 
that drives insertion (Ojemalm et al., 2012). 
The results obtained so far in the first two results Chapters have shown that surprisingly 
there is some recognition of S. coelicolor Rieske TMD3 by the Sec pathway when it is 
fused to Bla and that increasing the hydrophobicity of TMD3 or removal of a positive 
charge shortly after the C-terminal end of TMD3 resulted in better insertion of TMD3 by 
the Sec machinery. With this knowledge in mind, a closer examination of actinobacterial 
Rieske proteins, particularly downstream of TMD3, was made, and an alignment of 
selected actinobacterial Rieske proteins covering TMD3 and immediately downstream is 
shown in Figure 4.16.  
Interestingly, it is clear that for each Rieske protein examined there are a number of 
non-conserved positive charges located within the C-terminal vicinity of TMD3. It should 
be noted that these strings of positive charges are not found in other Rieske proteins that 
only contain a single TMD (Figure 3.1). Moreover, in the S. coelicolor Rieske-Bla 
construct used in this work these charges were removed as the Bla reporter is fused 
directly after R185 of Rieske. As the position and nature of the positive charges are not 
conserved among the actinobacterial Rieske proteins it is unlikely that they are essential 
for the structure/function of the Rieske protein. Instead it raised the possibility that they 
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are present to serve as a topological signal preventing the insertion of the helix by the 
Sec machinery.  
 
Figure 4.16 Alignment of TMD3 and downsteam regions of Actinobacterial Rieske proteins. 
Protein sequence alignments of the TMD3 of the Rieske FeS proteins for different Actinobacteria. Proteins 
were aligned using Clustal WS and Jalview (Waterhouse et al., 2009). The Tat motif is highlighted in red, 
positive charges are indicated in green and the predicted C-terminal end of TMD3 is also indicated. 
To test this directly, a new construct was produced, termed 205-extended-Rieske-Bla, 
which included the first 205 residues of S. coelicolor Rieske (i.e. including 20 residues 
after TMD3 and all four positive charges, K194, R196, K202 and K204 shown in green 
in Figure 4.16). When this construct was expressed in DADE (tat-) strain and tested for 
the M.I.C. of ampicillin, very unusual results were obtained. As shown in Figure 4.17A, 
the construct did not give reliable M.I.C. test results, instead sometimes there was a 
slight clearing of the bacteria down to an M.I.C. level of 1-2 µg/ml, with breakthrough 
colonies growing within the zone of clearing, suggesting that two populations of cells 
were present in the test. On other occasions, the cells grew up to the edge of the strip 
indicating they were resistant to the highest concentration of ampicillin present. These 
findings suggest that the cells producing this construct were stressed or unstable in some 
way. 
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Figure 4.17 Extending the sequence of S. coelicolor Rieske-Bla leads to unexpected results. 
A) Representative M.I.C.EvaluatorTM strip test of MC4100 (tat+) and DADE (tat-) harbouring the pSUPROM 
vector (Empty vector) or the pSUPROM vector encoding Rieske-Bla or extension variants 198-extended-
Rieske-Bla or three repeats of 205-extended-Rieske-Bla. Stationary phase cultures were diluted to OD600 0.1 
and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn 
and the plate was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the intersection of 
the test strip and the clearing of bacteria. The dotted white line across the pictures indicates the M.I.C. of 
Rieske-Bla (tat- strain 8 µg/ml and tat+ strain 16 µg/ml). 
B) Crude membrane extracts of DADE (tat-) harbouring the pSUPROM vector encoding Rieske-Bla or 
extended variants 198-Rieske-Bla and 205-Rieske-Bla, were separated on SDS-PAGE (12% acrylamide), 
electroblotted and immunoreactive bands were detected with an anti-Bla antibody. As a loading control the 
levels of the OM protein BamA were detected using anti-BamA antiserum.  
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Given the unusual behaviour of cells harbouring the 205-extended-Rieske-Bla construct, 
a further construct was generated, 198-extended-Rieske-Bla, which contains an 
additional 13 residues compared to Rieske-Bla, including positive charges K194 and 
R196. Cells producing this construct did not show the unusual sectoring behaviour that 
was seen with the 205-extended-Rieske-Bla, but unexpectedly, it did confer an extremely 
high M.I.C. of > 256 µg/ml (Figure 4.17A). This level is very much higher than that 
conferred by positive charge removal or increased hydrophobicity of Rieske-Bla seen 
earlier in this Chapter and is completely contrary to what would be predicted.  
The absence of the Tat machinery in the DADE strain produces a pleiotropic cell 
envelope phenotype which leads to a leaky cell envelope (Stanley et al., 2001, Ize et al., 
2003). One possibility that was considered was that the extended Rieske-Bla protein 
could further interfere with the cell envelope somehow rendering cells resistant to 
ampicillin. To this end, these variants were also tested in MC4100 (the cognate tat+ 
strain), however, Figure 4.17A shows that the M.I.C. values from these variants was also 
extremely high, with an M.I.C. of > 256 µg/ml. This indicates that the leaky cell envelope 
phenotype conferred by the loss of the Tat system is not the reason for this unexpected 
result. 
To confirm that these atypical results are not due to overproduction of the Bla fusion 
proteins, or generation of truncated Bla-containing products, membranes from the tat- 
strain harbouring the extended-Rieske-Bla variants were analysed by Western blotting 
with an anti-Bla antiserum, the results are shown in Figure 4.17B. The levels of 
Rieske-Bla detected by the anti-Bla antiserum were not significantly different from 
‘wild-type’ Rieske-Bla, and although there was a degradation band seen for 198-
extended-Rieske-Bla, this is not seen in 205-extended-Rieske-Bla indicating that it is 
probably not the cause of the dramatic increase in M.I.C observed. 
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As the results obtained with the extended Rieske-Bla constructs were puzzling and 
difficult to explain, it was decided to test whether it was a unique feature of the 
S. coelicolor Rieske or whether a different actinobacterial Rieske protein would behave 
similarly. To this end, the M. tuberculosis Rieske sequence was codon optimised for 
expression in E. coli and the globular FeS domain was genetically removed and replaced 
with the mature region of Bla to generate M. tuberculosis Rieske-Bla. This ‘wild-type’ 
construct was expressed in strain DADE and tested for the M.I.C. of ampicillin it 
conferred. As seen in Figure 4.18, the M.I.C. was comparable to that conferred by 
S. coelicolor Rieske-Bla. To ensure that the M. tuberculosis Rieske-Bla was comparable 
in other aspects, a twin-arginine variant was generated with a mutation of R161A and 
R162D (RR-AD). The negative charge replacement of the twin-arginine in 
M. tuberculosis Rieske-Bla yielded a significantly decreased M.I.C. of 4 µg/ml, and is 
similar to previously shown data for S. coelicolor RRAD-Rieske-Bla (2 µg/ml; Figure 
3.12).  
The next construct generated, 243-extended-Rieske-Bla, includes the four positive 
charges located C-terminal of TMD3 (K228, K232, K241 and K242 seen in green in 
Figure 4.16). When this construct was expressed in the DADE (tat-) strain and tested for 
the M.I.C. of ampicillin, it was found that the M.I.C. was decreased to 2 µg/ml. This 
indicates that, as expected, the positive charges beyond TMD3 act as a topological 
signal by preventing the Sec machinery from translocating Bla across the membrane. 
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Figure 4.18 Extending the sequence of M. tuberculosis Rieske-Bla prevents translocation through 
the Sec machinery. 
Representative M.I.C.EvaluatorTM strip test DADE (tat-) harbouring the pSUPROM vector encoding M. 
tuberculosis Rieske-Bla, the M. tuberculosis Tat motif variant RRAD-Rieske-Bla and the extension variant 
M. tuberculosis 243-extended-Rieske-Bla. Stationary phase cultures were diluted to OD600 0.1 and a lawn 
of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (µg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The dotted white line across the pictures indicates the M.I.C. of M. tuberculosis 
Rieske-Bla (8 µg/ml).  
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4.4 Discussion 
4.4.1 The cytoplasmic loop region is not important for the release of the 
Rieske polypeptide by the Sec machinery 
The cytoplasmic loop region between TMD2 and TMD3 was predicted by Keller et al. 
(2012) to contain all the information required for the Sec machinery to release the 
Actinobacterial Rieske polypeptide. To test this prediction, mutations of conserved 
residues in this loop region were generated in the construct Rieske-Bla. It was found that 
even large truncations of the loop had no significant effect on Sec translocation of 
Rieske-Bla, allowing the conclusion that this cytoplasmic loop region does not contain 
any specific features that cause the Sec machinery to release the translocating 
polypeptide. It remains a possibility that the sequence of the cytoplasmic loop region is 
critically important for the recognition of TMD3 by the Tat machinery. The interaction of 
the Tat machinery with the cytoplasmic loop region will be investigated in Chapter 5. 
 
4.4.2 The insertion of Rieske-Bla by the Sec machinery adheres to the 
topology determinant; the positive inside rule 
The investigation of the cytoplasmic loop region revealed the dependence of the Rieske 
protein on the topological determinants necessary for correct insertion and orientation of 
proteins when translocated by the Sec machinery. The ability of a protein to be correctly 
inserted into the cytoplasmic membrane by the Sec machinery depends on a number of 
determinants within the TMDs; overall hydrophobicity, length and location of charged 
and polar residues (Hessa et al., 2005, Hessa et al., 2007). These are known as intrinsic 
determinants, there are also extrinsic determinants usually contained in the loop regions 
between TMDs, such as positive charges.  
Charges are critical in orienting the TMDs of the protein. The positive inside rule 
proposes that positive charges are enriched in the cytoplasmic loops (Heijne, 1986) and 
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substitution of positive charges within the loop regions can change the topology of some 
proteins (Nilsson & von Heijne, 1990, Rapp et al., 2006). In this Chapter it was seen that 
the substitution R185A, that removes a positive charge located at the C-terminal end of 
TMD3, dramatically increases integration of this helix by the Sec pathway. It has been 
previously reported that manipulation of the charge bias across a TMD can cause a 
change in the insertion of the TMD, even leading to ‘frustrated’ helices which are not 
inserted into the membrane (Ojemalm et al., 2012). This charge could also enable a 
larger energetic cost for inserting this TMD (Yamagishi et al., 2014). The removal of this 
positive charge at R185 has the effect of changing the charge bias and lowering the cost 
of insertion of this TMD, causing an increase in the M.I.C. specified by this variant (Figure 
4.9).  
The effect of the positive inside rule is also observed in the cytoplasmic loop region, 
Figure 4.6, where the removal of all of the positive charges in this loop (Δ118-155-
Rieske-Bla) prevents the translocation of Bla across the membrane. Consequently, when 
a positive charge is returned into this region (Δ118-155-V158K-Rieske-Bla) the 
translocation of Bla into the periplasm is restored, Figure 4.8. This result indicates the 
dependence of Rieske-Bla on the positive inside rule as an important topological 
determinant required by the Sec machinery for the correct insertion and topology of 
helices in a Sec-dependent protein. 
Manipulation of charges can cause incompatible insertion of TMDs, if they cannot 
sequentially follow the orientation of the previous helix due to the change in charge 
balance it can lead to topologically frustrated TMDs. These helices are then located 
outside of the membrane as their insertion is prevented by mislocalised positive charges 
(Ojemalm et al., 2012). It is possible for the loss of positive charges in the cytoplasmic 
loop region of Rieske to generate a topologically frustrated TMD2, this would be difficult 
to determine as Bla would still be located in the cytoplasm and therefore, no M.I.C. for 
ampicillin would be seen. For this reason, labelling experiments were undertaken to 
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probe the subcellular location of the loop region between TMD2 and TMD3. However, a 
cysteine residue introduced into the truncated loop was not accessible to the malPEG 
labelling reagent, (Figure 4.15), probably due to the very short loop causing the cysteine 
to be positioned too close to the membrane. Thus the actual topology of these truncated 
variants remains to be experimentally determined.  
 
4.4.3 TMD3 is a marginally hydrophobic helix 
Hydrophobicity is the most important intrinsic determinant for insertion of a TMD by the 
Sec pathway. A helix is required to reach a threshold of hydrophobicity before the Sec 
machinery is able to release these residues into the membrane through the lateral gate. 
As discussed in Section 4.3.2.2, TMD3 of Actinobacterial Rieske proteins have low 
hydrophobicity, with a ΔGapp of 1.215 estimated for S. coelicolor Rieske TMD3, and so it 
is assumed that these are marginally hydrophobic helices. 20-30% of TMDs are 
marginally hydrophobic helices; they are not sufficiently hydrophobic to insert into the 
membrane by themselves (von Heijne, 2006). This is frequently due to a lack of 
hydrophobic residues but can also describe kinked, broken or short helices which are 
difficult for the Sec machinery to embed in the membrane. The insertion of these helices 
into the membrane is dependent on the adjoining TMDs and the residues outside of the 
helix (Hedin et al., 2010, Lerch-Bader et al., 2008). A neighbouring TMD with a strong 
orientational preference can either increase or decrease the insertion efficiency for the 
marginally hydrophobic helix (Ojemalm et al., 2012). Adjacent helices are known to 
interact via polar and electrostatic interfaces (Buck et al., 2007, Zhang et al., 2007). It is 
presumably these interactions with TMD2 and the residues located in the cytoplasmic 
loop that allow the insertion of TMD3 of Rieske-Bla by the Sec machinery. Thus the 
substitution of a leucine residue into TMD3 significantly increases the hydrophobicity of 
the helix (ΔGapp of 0.377) allowing it to overcome the hydrophobicity threshold, which 
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allows a better efficiency of insertion into the membrane, observed by a higher M.I.C. for 
ampicillin. 
It would be expected that substituting a couple of leucine residues would be additive to 
further increase the hydrophobicity of TMD3 and thus the M.I.C. conferred by the variant. 
This was not the case, as even when three leucine residues were substituted 
(P177L/S179L/G180L-Rieske-Bla) the M.I.C., although significantly increased from 
Rieske-Bla (8 µg/ml) was lower than the substitution of a single leucine residue (S179L-
Rieske-Bla), Figure 4.10. It has been found that it is not only the number of hydrophobic 
residues that is important for the hydrophobicity but their location in the helix. Leucine 
residues located throughout the helix can be additive to the overall hydrophobicity, but 
clusters of leucines can diminish the propensity for insertion (Demirci et al., 2013). This 
could explain why the M.I.C. for P177L/S179L/G180L-Rieske-Bla is lower than S179L-
Rieske-Bla. 
This data infers that the low hydrophobicity of TMD3 is a one of the factors that drives 
Sec release of the polypeptide during insertion. As TMD3 is the final helix it lacks the 
downstream TMD which would facilitate its insertion, and as seen in Table 4.3, the final 
TMD of a typical Sec-dependent protein is usually reasonably hydrophobic to ensure it 
is correctly inserted by the Sec machinery (Virkki et al., 2014). Insertion efficiency of 
marginally hydrophobic helices can also be specifically adjusted by the manipulation of 
charged residues flanking the helix (Ojemalm et al., 2012). In the case of Actinobacterial 
Rieske proteins a series of positive charges downstream of TMD3 appear to work in 
tandem with the low hydrophobicity of this helix to ensure that Sec does not insert this 
stretch of protein as a TMD, ultimately allowing it instead to be inserted by the Tat 
pathway. 
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4.4.4 Implications of this Sec-release mechanism for substrate 
recognition by the Tat pathway 
Positive charges in membrane proteins are known to have long distance effects. A single 
positive charge located 60 residues C-terminal of a marginally hydrophobic helix can 
anchor it to the membrane with an Nout-Cin topology (Fujita et al., 2010). This infers that 
the Sec machinery scans residues C-terminal of the translocating helix and responds to 
any signals that are present.  
Ojemalm et al. (2012) discovered that if a TMD has a strong orientational preference due 
to positively charged flanking residues then the insertion of the downstream TMD can be 
affected. This TMD is possibly already inserted into the membrane or located in the 
lateral gate region of the Sec translocon when the strong orientational preference of the 
neighbouring TMD is determined by the Sec machinery. This causes the already inserted 
TMD to be forced across the membrane, with the final topology adopting a re-entrant 
loop, as seen in Figure 4.19A. Re-entrant regions are defined as a sequence that starts 
and ends on the same side of the membrane. They must penetrate the membrane to a 
depth between 1.5 and 25 Å and the more shallow insertions are required to have a ‘clear 
turn’ within the sequence (Viklund et al., 2006). Analysis of these re-entrant regions 
within proteins has found that they are less hydrophobic than efficiently inserted TMDs 
(Yan & Luo, 2010). 
It is, therefore, likely that the positive charges present C-terminal to TMD3 in Rieske 
(Figure 4.16) prevent its insertion as the charges will try to force an orientational 
preference on the helix. The Sec machinery should have already interacted with TMD3 
possibly locating it in the lateral gate region when the positive charges are recognised, 
making it is very likely that TMD3 will form a re-entrant loop as the Sec machinery rejects 
the insertion, seen by the low M.I.C. in Figure 4.18. This is shown schematically in Figure 
4.19B. As there is no further TMDs the Sec machinery presumably releases the Rieske 
protein at this point.  
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Figure 4.19 Schematics for the insertion of proteins by the Sec machinery. 
A) Strong orientation preference of TMD can cause a re-entrant loop. The positive charge located C-terminal of the yellow TMD causes a strong orientational preference of Nin-Cout which 
forces the already inserted Nin-Cout neighbouring (red) TMD to reorient across the membrane forming a re-entrant loop on the cytoplasmic side of the membrane. Schematic based on 
Figure 6C (Ojemalm et al., 2012). 
B) Schematic of the insertion of the Rieske protein by the Sec machinery. TMD3 (red) is starting to be inserted by the Sec machinery with an Nin-Cout topology when the positive charges 
in the C-terminal are recognised and prevent the translocation across the membrane. This caused the TMD to be inserted across the membrane as a re-entrant loop and the Sec 
machinery releases the Rieske peptide. 
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Subsequently, the Tat machinery would recognise the twin-arginine motif and facilitate 
the insertion of TMD3. Clearly, this model would suggest that, in this case, the Tat 
machinery recognises a signal sequence that is partially located in the membrane, rather 
than free in the cytoplasm as has been generally assumed for most soluble Tat 
substrates. Interestingly, it might be that such a model can be applied more broadly to 
operation of the Tat pathway. It has long been known that Tat signal peptides often 
contain one or more positively charged residues in their c-regions which are known to 
act as a Sec-avoidance motif. Removal of these charges results in signal sequences that 
can now mediate transport by the Sec machinery (Bogsch et al., 1997, Blaudeck et al., 
2003). In addition, signal peptides that direct proteins to the Tat machinery are known to 
be less hydrophobic than Sec signal peptides and if the hydrophobicity of a Tat signal 
peptide is increased it can mediate efficient transport by the Sec pathway (Cristobal et 
al., 1999). Both of these features have been similarly noted above to promote release of 
Rieske TMD3 by the Sec machinery. However, despite possessing these 
‘Sec-avoidance’ features, over half of the native E. coli Tat signal peptides are capable 
of transporting reporter proteins through the Sec pathway (Tullman-Ercek et al., 2007). 
This raises the possibility that rather than being an exception, Sec interaction with Tat 
signal peptides is much more frequent, and that following abortive attempts at 
Sec-translocation, membrane-associated twin-arginine signal peptides are common 
substrates of the Tat pathway. 
Several groups have proposed that signal peptide recognition by the Tat pathway always 
occurs in the lipid phase. For example, it has been shown that thylakoidal Tat substrates 
interact with the membrane before a subsequent interaction with Tat machinery (Musser 
& Theg, 2000, Asai et al., 1999, Cline & Mori, 2001), and some Tat preproteins bind to 
the E. coli membrane in a tat mutant strain (Ray et al., 2003). Using an in vitro model 
system, Tat precursors were found to have a tight interaction with lipid membranes, 
stabilised by both hydrophobicity and electrostatic interactions (Shanmugham et al., 
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2006). Finally, direct interactions between the signal peptide and lipids has been found 
to easily interconvert to translocon binding which suggests that lipid-bound precursor 
proteins are functionally important in the Tat translocation pathway (Bageshwar et al., 
2009). However, in these cases it is not known whether the interaction with the 
membrane is partial or full penetration, or just an adsorption to the membrane surface. 
Together the findings in this Chapter support the hypothesis that at least a fraction of Tat 
preproteins interact with the membrane as an early step in Tat translocation. It is possible 
that this binding is influenced by the Sec machinery trying to insert the signal peptide into 
the membrane before recognising the relatively low hydrophobicity and positively 
charged ‘Sec-avoidance’ motif and thus leaving the signal sequence as a re-entrant loop. 
This lipid-bound protein is then able to laterally diffuse along the membrane surface until 
it can bind to the Tat translocase for subsequent insertion into the membrane. 
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5.1 Introduction 
5.1.1 Tat translocation and substrate recognition 
The signal peptide is essential for targeting substrates to the Tat machinery and is 
usually located at the N-terminus of the protein (Berks, 1996). It comprises of a tripartite 
structure, seen in Figure 5.1, with a basic n-region, a hydrophobic middle h-region and 
a polar c-region. The n-region is of variable length and includes the essential consensus 
Tat motif, SRRxFLK. The twin-arginines in this sequence are crucial for recognition by 
the Tat machinery and are nearly always invariant (Berks, 1996). The h-region is slightly 
less hydrophobic than Sec signal peptides. The c-region contains a signal peptidase 
recognition site, usually AxA. In addition this region often contains a number of basic 
residues that together with the low hydrophobicity of the h-region acts as a Sec 
avoidance signal (Bogsch et al., 1997, Blaudeck et al., 2003, Cristobal et al., 1999). 
 
 
Figure 5.1 The tripartite structure of the Tat signal peptide. 
The N-terminal Tat signal peptide has a tripartite structure; a basic n-region (green), a hydrophobic h-region 
(yellow) and a polar c-region (blue). The essential Tat motif is found within the n-region, whereas the signal 
peptidase cleavage site is located within the c-region. 
 
Tat signal peptides are longer than Sec signal peptides which is largely due to an 
extended n-region which varies in length from a few residues up to 23 residues long, for 
example HyaA and DmsA (Tullman-Ercek et al., 2007). This extended region is predicted 
to be α-helical and the primary sequence is generally conserved between related 
proteins from different bacterial species implying a functional importance.  
There are a number of known signal peptide binding proteins that are believed to be 
important as proofreading chaperones or involved in quality control. For example, DmsD 
is required for cofacter insertion into apo-DmsA and TorD has been found to bind the 
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signal peptide of TorA, both of these interactions potentially prevent contact of the signal 
peptide with the Tat machinery (Sargent et al., 2002, Oresnik et al., 2001, Jack et al., 
2004). The n-region of the signal peptide is important in signal peptide-chaperone binding 
as the removal of this n-region abolishes TorD binding to the TorA signal peptide (Jack 
et al., 2004). 
Initially the signal peptide is recognised by and interacts with the TatBC complex (Cline 
& Mori, 2001). This selective binding is mediated by the twin-arginine motif of the signal 
peptide that contacts a surface patch on the cytoplasmic face of TatC, which comprises 
the N-terminal tail and loop region between TMD2 and TMD3 (Rollauer et al., 2012). This 
has been experimentally confirmed by crosslinking (Zoufaly et al., 2012) and mutational 
studies (Kreutzenbeck et al., 2007, Strauch & Georgiou, 2007, Rollauer et al., 2012) and 
enables the twin-arginines to interact with conserved glutamic acid residues of TatC 
(Berks et al., 2014). It has also been found that the n-region can adopt a helical 
conformation which can associate with the intra-membrane face of TatC, the Lys of the 
signal peptide being proposed to interact with a conserved glutamate/glutamine located 
within the TatC cavity (Ramasamy et al., 2013). If the n-region of the signal peptide is in 
an extended conformation, it is possible for it to interact with both the cytoplasmic side 
of TatC and the TatC cavity this also allows the important Phenylalanine of the signal 
peptide to stack with a conserved Phenylalanine of TatC (F94 in E. coli TatC) (Berks et 
al., 2014).  
Gerard et al. (2007) found two binding modes for signal peptide interacting with the 
thylakoid Tat machinery, peripheral-binding and deep-insertion. The peripheral-binding 
mode involved weak electrostatic interactions between the signal peptide and the TatBC 
complex allowing the signal peptide to still be accessible for proteolysis from the stroma. 
In comparison, when the signal peptide is in deep-insertion mode there is no proteolysis 
as the interactions are greatly strengthened with the signal peptide buried in the TatBC 
complex. The conversion from peripheral-binding to deep-insertion mode is driven by the 
PMF (Gerard & Cline, 2007). 
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This PMF-dependent conversion of binding has not been shown for the E. coli Tat 
machinery, however, weak-binding where the substrate can be exchanged and 
strong-binding where the substrate can be co-purified with the TatBC complex have been 
found for the same Tat substrate (Bageshwar et al., 2009, Tarry et al., 2009). The signal 
peptide has been found accommodated deep inside a TatC cavity in a hairpin loop 
conformation while the passenger domain is still located in the cytoplasm (Blummel et 
al., 2015) Together this generates a model where the signal peptide is deeply bound 
within the Tat machinery and extends further into the cavity as the passenger domain 
crosses the membrane ultimately reaching the periplasm. Modelling has also suggested 
that the signal peptide can extend so it can both bind in the cytoplasm to TatC and 
expose its c-region signal peptidase site in the periplasm. This is supported by 
experimental observations which shows that TatC can act autonomously and guide the 
signal peptide across the membrane (Frobel et al., 2012). The fate of the signal peptide 
after cleavage is unclear but it is probably released laterally into the membrane as with 
the uncleaved signal anchors of bacterial Rieske proteins. 
 
5.1.2 The Rieske protein is Tat-dependent 
Most well characterised Rieske proteins comprise of an N-terminal signal anchor 
followed by a globular FeS cofactor-containing domain. In bacteria and plants the 
N-terminal TMD comprises an uncleaved Tat signal sequence and it has been shown 
that the Tat pathway is essential for the integration of the Rieske protein into the 
membrane of bacteria and plant thylakoids (De Buck et al., 2007, Molik et al., 2001). 
Actinobacterial Rieske proteins contain 3TMDs with the final TMD encompassing a Tat 
signal sequence. The Tat machinery has been found to insert the final TMD of 
S. coelicolor Rieske in the heterologous host E. coli as well as in the native organism 
(Keller et al., 2012, Hopkins et al., 2014). 
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5.2 Aims 
It was seen in Chapter 3, and previously shown by Keller et al. (2012) that the 
translocation of TMD3 of S. ceolicolor Rieske is Tat-dependent when AmiA is used as 
the fusion reporter. The aim of this chapter was to further assess the interactions of the 
Tat machinery with Rieske and dissect whether there are features within the cytoplasmic 
loop region which modulate the interactions with the Tat machinery, in particular the 
recognition of the Tat motif. To do this, a full programme of mutagenesis was undertaken 
with the Rieske-AmiA fusion, similar to that described in the previous chapter, and 
variants generated were tested for Tat-translocation by determining the level of growth 
on SDS-containing media. Variants of Rieske-AmiA that differed significantly from the 
‘wild-type’ in terms of the amount of growth they supported on SDS-containing media 
were further analysed biochemically to support the results of the phenotypic 
observations. 
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5.3 Results 
5.3.1 Investigating the cytoplasmic loop between TMD2 and TMD3 
As discussed in Chapter 4, at the outset, the cytoplasmic loop region between TMD2 
and TMD3 was predicted to contain all of the information necessary to co-ordinate the 
Sec and Tat machineries to facilitate the insertion of S. coelicolor Rieske (Keller et al., 
2012). In Chapter 4, however, it was seen that there are no clear features in this loop 
region that are important for the Sec machinery to release the Rieske polypeptide after 
the insertion of TMD1 and TMD2. However, it remains possible that the length and 
sequence features of this region are important for the recognition of the tethered signal 
sequence by the Tat machinery. 
As indicated in Figure 4.2 there is some sequence conservation within the cytoplasmic 
loop region between Actinobacterial Rieske proteins. For example, the linker length is 
always 43 residues long residing between the C-terminus of TMD2 and finishing directly 
before the invariant twin-arginine of the Tat motif. There is a cluster of four negatively 
charged residues, a highly conserved RH motif and a predicted α-helical region. These 
features all appear to be conserved across the different Rieske proteins and, therefore, 
are expected to be important, perhaps with a potential role in presenting the signal 
sequence in the appropriate context to be recognised by Tat. In this Chapter the 
translocation of Rieske-AmiA by the Tat machinery was investigated. 
 
5.3.1.1 Mutations generated in the cytoplasmic loop region had little effect on the 
insertion of TMD3 by the Tat machinery 
The initial step in investigating whether the conserved residues in the cytoplasmic loop 
region were crucial for moderating interaction with the Tat pathway was to undertake a 
systematic site-directed mutagenesis approach where each of the conserved residues 
were individually mutated in the loop region encoded by the pSUPROM Rieske-AmiA 
construct. The cytoplasmic loop region is shown above Figure 5.2 and conserved 
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residues that were mutated in this Chapter are highlighted in colour. These variants were 
produced in MCDSSAC (tat+) and MCDSSACΔtat (tat-) strains to allow Tat-dependence 
to be scored, and tested for growth on SDS-containing media, as undertaken previously 
in Chapter 3, and a representative example is seen in Figure 5.2. The tat+ and tat- strains 
expressing variants of the Rieske-AmiA fusion were grown until they reached stationary 
phase in liquid media, diluted to give approximately 10, 100, 1,000 or 10,000 cells per 
5 μl aliquot and spotted onto standard LB media (as a control) and media containing 1% 
SDS. If the variant is Tat-compatible, and the Tat machinery is present (MCDSSAC 
strain) then there should be growth on SDS-containing media, and by comparison when 
there is no Tat machinery (MCDSSACΔtat strain) then there should be no growth. Table 
5.1 shows the results seen for cytoplasmic loop variants when tested in the MCDSSAC 
(tat+) strain, alongside the SDS growth for the twin-arginine variants that were previously 
described in Chapter 3 and the raw data can be found in the Appendix. Growth of variants 
on SDS-containing media is scored by a Y and no growth by an N. 
 
5.3.1.2 Conserved amino acid substitutions had little effect on Tat translocation 
The initial residues that were mutated in the Rieske-AmiA construct was the well 
conserved RH motif (R133 and H134, coloured green in the sequence above Figure 5.2). 
Aside from the twin-arginines of the Tat motif, these are the most conserved residues in 
the loop region. Two different substitutions were generated; R133H/H134R (RH-HR) and 
R133K/H134K (RH-KK). As shown in Figure 5.2 these substitutions did not change the 
growth on SDS-containing media compared to ‘wild-type’ Rieske-AmiA when expressed 
in the tat+ strain, there was still growth when 10 cells per 5 µl was spotted. It can, 
therefore, be concluded that this motif is not essential for the Tat machinery to recognise 
the Rieske protein. 
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Figure 5.2 RHHR- and RHKK-Rieske-AmiA variants are Tat-dependent. 
Representative spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector (pSUPROM), and the pSUPROM vector encoding Rieske-AmiA 
and RH motif fusion variants (RHHR-Rieske-AmiA and RHKK-Rieske-AmiA). Strains were grown overnight in liquid media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 
5 µl aliquots which were spotted onto LB solid agar (left) and LB solid agar containing 1% (w/v) SDS (right). LB agar plates were incubated at 37°C for 16 h. 
Above is the conserved loop region for S. coelicolor Rieske where the conserved residues that were mutated are indicated in colour. 
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Table 5.1 Tat dependence of Rieske-AmiA fusion variants. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector 
(pSUPROM), or the pSUPROM vector encoding, Rieske-AmiA or the cytoplasmic loop variants. Strains were 
grown overnight in liquid media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 5 μl aliquots 
which were spotted onto LB containing 1% SDS. The tat+ strain results were scored Y for growth and N (red) 
for no growth. Raw data can be found in the Appendix (Figure 8.3, Figure 8.4 and Figure 8.5). 
 Variant Growth on SDS  Variant Growth on SDS 
WT Rieske-Bla Y 
Truncations 
∆118-122 Y 
TAT motif 
RRKK Y ∆123-127 Y 
RRAD N ∆128-132 Y 
RRAA N ∆133-137 Y 
RRKQ N ∆138-142 Y 
∆RR N ∆143-147 Y 
RH motif 
RHHR Y ∆148-152 Y 
RHKK Y ∆153-157 Y 
Negatively 
charged 
M124L Y ∆158-162 N 
M124A Y ∆118-127 Y 
S125L Y ∆128-137 Y 
S125A Y ∆138-147 Y 
D126L Y ∆148-157 Y 
D126A Y ∆118-132 Y 
E127L Y ∆123-137 Y 
E127A Y ∆128-142 Y 
Predicted 
α-helix 
A138P Y ∆133-147 Y 
A144P Y ∆138-152 Y 
A148P Y ∆143-157 Y 
A154P Y ∆118-137 Y 
  ∆138-157 Y 
∆118-142 Y 
∆123-147 Y 
∆128-152 Y 
∆133-157 Y 
∆118-147 Y 
∆123-152 Y 
∆128-157 Y 
∆118-152 Y 
∆123-157 N 
∆118-157 N 
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The subsequent region to mutate was the conserved negatively charged region. This 
contains four residues; M124, S125, D126 and E127 which are coloured in blue in the 
sequence above Figure 5.2. These were individually mutated to alanine and to leucine 
and tested for Tat dependence on SDS-containing media. When variants were 
expressed in the tat+ strain there was no growth difference observed compared to 
‘wild-type’ Rieske-AmiA, as indicated in Table 5.1. 
The final conserved region is the predicted α-helix section. To assess if this structure is 
essential for Tat machinery recognition, the alanine residues in the loop (A138, A144, 
A148 and A154, coloured pink in the sequence above Figure 5.2) were mutated to 
prolines. As discussed previously, these mutations should disrupt any α-helix structure 
as proline is known to be a helix breaker (Nilsson & von Heijne, 1998, Nilsson et al., 
1998). Table 5.1 shows that there is no change in growth on SDS-containing media for 
these variants when expressed in the tat+ strain, indicating that there was no change in 
the interactions with the Tat machinery.  
 
5.3.1.3 Truncations of residues in the cytoplasmic loop had little effect on Tat 
translocation 
As the site-directed mutagenesis of the cytoplasmic loop region had no detectable effect 
on the translocation of Rieske-AmiA by the Tat machinery, more extreme mutations, i.e. 
truncations of the loop region were generated. At the outset, sliding truncations of 5 aa 
at a time were constructed along the loop region to give Δ118-122-, Δ123-127-, 
Δ128-132-, Δ133-137-, Δ138-142-, Δ143-147-, Δ148-152-, Δ153-157- and Δ158-162-
Rieske-AmiA. As seen in Table 5.1, and presented in the Appendix of this thesis, most 
of these variants supported no significant change in growth on SDS-containing media 
compared to ‘wild-type’ Rieske-AmiA when variants were expressed in the tat+ strain. 
The exception is Δ158-162-Rieske-AmiA which did not support any growth on SDS-
containing media. This result is exactly as predicted since these deleted residues (V158, 
I159, G160, R161 and R162) include the essential twin-arginine of the Tat motif. If these 
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residues are removed then it is not possible for the Tat machinery to recognise the 
tethered sequence and so there is no translocation of TMD3 or AmiA into the periplasm 
and no growth on SDS-containing media.  
The subsequent truncations to be generated were deletions of 10 residues (Δ118-127-, 
Δ128-137-, Δ138-147- and Δ148-157-Rieske-AmiA). None of these truncated variants 
when expressed in the tat+ strain and tested for growth on SDS-containing media 
exhibited a growth difference relative to ‘wild-type’ Rieske-AmiA. Therefore, the 
truncation was increased to 15 residues to give Δ118-132-, Δ123-137-, Δ128-142-, 
Δ133-147-, Δ138-152- and Δ143-157-Rieske-AmiA. Again, the expression of these 
variants in the tat+ strain followed by testing on SDS-containing media also yielded 
‘wild-type’ growth. Next, 20 and 25 residue truncations were tested by generating 
constructs Δ118-137-, Δ138-157-, Δ118-142-, Δ123-147-, Δ128-152- and Δ133-157-
Rieske-AmiA. These also gave ‘wild-type’ Rieske-AmiA levels of growth when tested on 
SDS-containing media. Subsequently, 30 residues were removed from the cytoplasmic 
loop region (Δ118-147-, Δ123-152- and Δ128-157-Rieske-AmiA) and these variants also 
demonstrated Tat-dependent growth on SDS-containing media.  
The first significant result was obtained when 35 residue truncations were constructed, 
generating Δ123-157- and Δ118-152-Rieske-AmiA. Although Δ118-152-Rieske-AmiA 
supported ‘wild-type’ growth, the Δ123-157-Rieske-AmiA did not allow any grow on 
SDS-containing media (Figure 5.3, Table 5.1). Therefore, a further deletion was 
constructed to remove 40 residues from the loop region, Δ118-157-Rieske-AmiA – this 
leaves only 3 residues remaining in the loop region (V158, I159 and G160 located 
immediately before the twin-arginines). Again, this variant also supported no growth on 
SDS-containing media (Figure 5.3, Table 5.1).  
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Figure 5.3 RieskeAmiA variants that give reduced or no Tat translocation. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector (pSUPROM), and the pSUPROM vector encoding Rieske-AmiA and truncation 
fusion variants (∆123-157-Rieske-AmiA, ∆118-152-Rieske-AmiA, ∆118-153-Rieske-AmiA, ∆118-154-Rieske-AmiA, ∆118-155-Rieske-AmiA, ∆118-156-Rieske-AmiA and ∆118-157-
Rieske-AmiA). Strains were grown overnight in liquid media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 5 µl aliquots which were spotted onto LB solid agar and LB 
solid agar containing 1% (w/v) SDS. LB agar plates were incubated at 37°C for 16 h. 
Above is the remainder of the conserved loop region for S. coelicolor Rieske for these truncation variants. 
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5.3.1.4 Significant Rieske-AmiA fusion truncation variants are not recognised by 
the Tat system 
 It was seen above that the truncated variants Δ123-157-Rieske-AmiA and Δ118-157-
Rieske-AmiA supported no growth on SDS, consistent with a complete inability of the 
Tat system to recognise these variants. To explore this further, additional variants were 
generated, where the truncation of Δ118-152 was sequentially increased one residue at 
a time to Δ118-157, generating the new constructs Δ118-153-, Δ118-154-, Δ118-155- 
and Δ118-156-Rieske-AmiA.  
As seen in Figure 5.3, Δ118-152-Rieske-AmiA shows ‘wild-type’ growth, whereas the 
additional deletion of one residue (Δ118-153-Rieske-AmiA) resulted a slight decrease in 
growth, when expressed in MCDSSAC (tat+) strain and tested on SDS-containing media. 
Thus some very faint growth was seen when 100 cells were spotted but no growth when 
10 cells were spotted, seen in Figure 5.3. The Δ118-154-Rieske-AmiA resulted in a 
further decrease in growth as MCDSSAC harbouring this variant struggled to grow when 
10 000 cells were spotted on SDS-containing media. The truncation variants Δ118-155-
Rieske-AmiA and Δ118-156-Rieske-AmiA supported no growth of MCDSSAC on 
SDS-containing media, alongside the previously mentioned Δ123-157-Rieske-AmiA and 
Δ118-157-Rieske-AmiA (Figure 5.3). 
The lack of growth on SDS-containing media for cells harbouring these variants indicates 
that there is no translocation by the Tat machinery. However, this might not be due to a 
direct effect of the mutation on recognition by the Tat system, for example as it could 
arise due to a lack of protein stability. To determine whether stability of the fusion protein 
was affected by the truncations, membranes from the tat+ (MCDSSAC) strain harbouring 
the variants were analysed by Western blotting with an anti-Rieske antiserum. 
Representative results are observed in Figure 5.4A, which gives an example of a 
Western blot of the truncated fusion variants. It is apparent from the blot that a size shift 
is seen for the truncation variants due to shortening of the protein.  
 
Chapter 5: Tat translocation 
179 
 
 
For a quantitative analysis, samples, collected in triplicate and analysed by Western blot, 
were quantified by densitometry analysis where Rieske-associated signals were 
normalised to the BamA-associated signals (which served as the loading control). The 
results were subsequently expressed as percentage of the normalised signal obtained 
for ‘wild-type’ Rieske-AmiA, as seen in Figure 5.4B. The results indicate that although 
when some variants are expressed in a tat+ strain and tested for growth on 
SDS-containing media there is little Tat-dependent translocation, all fusion proteins are 
stable and located in the membrane with a considerable amount of protein produced 
when compared to ‘wild type’ Rieske-AmiA. It can be concluded that the lack of growth 
seen with some of these variants is due to the truncation of the loop region directly 
affecting the recognition or translocation of TMD3 and AmiA by the Tat machinery. 
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Figure 5.4 Rieske-AmiA protein is still produced from all truncation variants tested 
A) Crude membrane extracts of MCDSSAC (tat+) harbouring the pSUPROM vector alone (Empty vector) or 
the pSUPROM vector encoding Rieske-AmiA or loop truncation variants Δ123-157-Rieske-AmiA, Δ118-152-
Rieske-AmiA, Δ118-153-Rieske-AmiA, Δ118-154-Rieske-AmiA, Δ118-155-Rieske-AmiA, Δ118-156-Rieske-
AmiA and Δ118-157-Rieske-AmiA were separated on SDS-PAGE (12% acrylamide), electroblotted and 
immunoreactive bands were detected with anti-Rieske peptide antibody. As a loading control, the levels of 
the OM protein BamA were detected using an anti-BamA antiserum. Western blots used can be found in 
Figure 8.2. 
B) Western blots were quantified by densitometry analysis and Rieske-associated signals were normalised 
with BamA-associated signals. The results were expressed as percentage of the normalised signal obtained 
for Rieske-AmiA and the s.e.m is indicated (error bars). 
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It was seen above that cells producing Δ118-154-Rieske-AmiA (a truncation of 37 
residues) struggled to grow on SDS-containing media whereas the same strain 
producing Δ118-153-Rieske-AmiA only showed a slight decrease in growth. In 
comparison, the removal of 38 residues from the cytoplasmic loop (Δ118-155-Rieske-
AmiA) abolished translocation through the Tat machinery. These results indicate that 
reducing the cytoplasmic loop region to a length of 6 residues (Δ118-154) or less causes 
a significant decrease in Tat translocation.  
A hypothesis for this loss of Tat translocation is that the cytoplasmic loop region is not 
long enough to allow exposure of the Tat motif to the translocation machinery. The 
essential recognition sequence for the Tat machinery is based on a consensus 
sequence; SRRxFLK. This demonstrates that at least one residue, usually a serine, is 
required before the twin-arginines. In E. coli Tat substrates two or more residues are 
usually present in the N-terminus of the signal peptide prior to the ‘serine’ position of the 
Tat motif (Tullman-Ercek et al., 2007). However, the Rieske protein is tethered to the 
membrane through the TMD1 and TMD2 insertion by the Sec machinery. This would 
potentially make it more difficult for the Tat machinery to recognise the Tat motif as the 
N-terminus of the signal sequence is not free and will probably lie very close to the 
membrane surface, or even within the phospholipid head groups.  
 
5.3.2 Tryptophan at residue 119 is part of TMD2, decreasing the length of 
the cytoplasmic loop 
It was seen from the results presented in Figure 5.3 that seven amino acid residues is 
the minimum length of the cytoplasmic loop region required for efficient Tat translocation 
of TMD3. However, it was also seen that the variant Δ123-157-Rieske-AmiA did not 
support growth on SDS-containing media despite seemingly having eight residues 
present in the loop region. This Δ123-157-Rieske-AmiA variant has a 35 residue 
truncation, as intriguingly does its counterpart variant, Δ118-152-Rieske-AmiA, which in 
contrast did support growth on SDS. To investigate why these two variants differed, the 
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Δ123-157-Rieske-AmiA variant was lengthened by addition of one residue at a time, to 
give Δ124-157- and Δ125-157-Rieske-AmiA followed by expression in the tat+ 
(MCDSSAC) and tat- (MCDSSACΔtat) strains and tested for growth on SDS-containing 
media.  
As Figure 5.5 showed, a Rieske-AmiA truncation lacking residues 124-157 (34 aa 
truncation) behaved similarly to the Δ123-157-Rieske-AmiA variant and could not 
support growth on SDS-containing media when expressed in the tat+ strain, whereas a 
Rieske-AmiA truncation lacking residues 125-157 had ‘wild-type’ levels of Tat 
translocation of AmiA into the periplasm as seen by the growth on SDS-containing 
media. Thus examination of this truncation series would indicate that the minimum loop 
length required for Tat translocation is ten residues. 
To try and reconcile these two contrasting conclusions (i.e. that the minimum loop length 
for Tat recognition is seven residues when the truncations started from amino acid 118, 
versus ten residues when truncations started further along the loop) the loop sequence 
remaining in these variants was examined more closely. It was noted that all of the 
truncations starting from 118 were lacking a tryptophan residue which is located 
N-terminal of the cytoplasmic loop (W119), this residue was present in the truncations 
starting at residues further along the loop region. Tryptophan has an amphipathic nature 
and so has a preference for the water-membrane interface. Analysis of membrane 
protein structures has indicated that aromatic residues, like tryptophan and tyrosine, are 
frequently located in the interface between the TMDs and the membrane (Hessa et al., 
2005). Tryptophan has been found to interact with the polar lipid head groups which 
attracts it to the membrane, with support from the hydrophobic effect which drives 
tryptophan out of the water phase (Yau et al., 1998, de Jesus & Allen, 2013). Together, 
this enables tryptophan to serve as a membrane anchor, adding structural constraint to 
the movement of TMDs and enhancing stability with interfacial interactions (Granseth et 
al., 2005, Yau et al., 1998). If tryptophan is located within the loop region then it orientates 
with its side chain towards the membrane enabling it to be buried within the hydrophobic 
 
Chapter 5: Tat translocation 
183 
 
 
bilayer, this facilitates the pulling of the loop into the membrane allowing tryptophan to 
extend the helix by a residue (Granseth et al., 2005, Braun & von Heijne, 1999). 
Taking this knowledge into account, it is likely that W119 and consequently H118 are 
both located at the interface of TMD2 with the membrane, and should probably be 
considered to be part of TMD2 rather than residing in the loop region. By making this 
adjustment, the truncations 123-157, 124-157 and 125-157 should be considered to have 
loop lengths of six, seven and eight residues, respectively, rather than eight, nine and 
ten as was assumed previously. To support this proposition, a further set of truncation 
variants was generated which included residues from both ends of the loop region. 
HWAKES-Rieske-AmiA contains the H118, W119 and A120 from the N-terminal region 
of the cytoplasmic loop and the K155, E156 and S157 from the C-terminal, this 
encompasses a deletion of residues Δ121-154. This variant produces a loop length of 9 
residues including H118 and W119 which can, therefore, be considered as a 7 residue 
loop. The other mutations were generated in a similar fashion and decrease this loop 
region to 6 residues (HWKES, Δ120-154) and 5 residues (HWES, Δ120-155). As seen 
in Figure 5.5, all these variants struggle to grow on SDS-containing media. 
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Figure 5.5 The truncated Rieske-AmiA W119-containing variants are not recognised by the Tat system. 
Spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring an empty vector (pSUPROM), and the pSUPROM vector encoding Rieske-AmiA and truncation 
fusion variants (∆124-157-Rieske-AmiA, ∆125-157-Rieske-AmiA, HWAKES-Rieske-AmiA, HWKES-Rieske-AmiA and HWES-Rieske-AmiA). Strains were grown overnight in liquid media, 
diluted to give serial dilutions of 10, 102, 103 and 104 cells per 5 µl aliquots which were spotted onto LB solid agar and LB solid agar containing 1% (w/v) SDS. LB agar plates were 
incubated at 37°C for 16 h. 
Above is the remainder of the conserved loop region for S. coelicolor Rieske for these truncation variants. 
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To ensure that these variants were stably produced, membranes from the tat+ strain 
(MCDSSAC) harbouring these constructs were analysed by Western blotting with an 
anti-Rieske antiserum. The results are observed in Figure 5.6 which shows that all the 
variants produce protein that is stable and located in the membrane. Therefore, the lack 
of growth on SDS-containing media from some of these variants is due to the truncation 
of the loop region affecting the recognition of the Tat motif by the Tat machinery. 
 
 
Figure 5.6 The truncated Rieske-AmiA W119-containing variants are stably produced. 
Crude membrane extracts of MCDSSAC (tat+) harbouring the pSUPROM vector alone (Empty vector) or the 
pSUPROM vector encoding Rieske-AmiA or loop truncation variants Δ124-157-Rieske-AmiA, Δ123-157-
Rieske-AmiA, HWAKES-Rieske-AmiA, HWKES-Rieske-AmiA and HWES-Rieske-AmiA were separated on 
SDS-PAGE (12% acrylamide), electroblotted and immunoreactive bands were detected with anti-Rieske 
peptide antibody. As a loading control the levels of the OM protein BamA were detected using an anti-BamA 
antiserum. 
 
Thus it can be concluded that a minimum length of 7-8 amino acid residues is necessary 
between the end of TMD2 and the twin-arginine motif to allow the Tat system to 
recognise TMD3 as a Tat signal sequence, and that conserved sequence features in the 
loop region, with the exception of the twin-arginine motif, are not directly required for 
interaction of the substrate with the Tat pathway.  
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5.4 Discussion 
5.4.1 Most of the cytoplasmic loop region is not important for the 
recognition of the Rieske polypeptide by the Tat machinery 
Keller et al. (2012) predicted that the cytoplasmic loop region between TMD1 and TMD2 
contained all the information required for both the Sec machinery to release the Rieske 
polypeptide and the Tat machinery to recognise the tethered protein as a Tat substrate. 
Chapter 4 demonstrated that there are no features within this region required by the Sec 
machinery to release the partially inserted Rieske protein, although it probably does 
contain topological signals that are necessary for the correct Sec-dependent insertion of 
TMD2. To test whether any features in the loop region are important for Tat recognition, 
mutations of the conserved residues in this loop region were generated in the construct 
Rieske-AmiA. It was found that large truncations of the loop region had no significant 
effect on the translocation of Rieske-AmiA (Table 5.1). Therefore, aside from the Tat 
motif, there are no specific features in the cytoplasmic loop that aid the recognition of 
Rieske.  
The question that must arise as a result of these findings is why is there such length and 
sequence conservation in the Actinobacterial Rieske TMD2-TMD3 loop regions? Having 
ruled out a role in protein translocation, it seems likely that the conserved features of this 
cytoplasmic loop are important for other interactions. In this thesis, the Rieske protein 
was truncated to remove its cofactor-containing domain, and was analysed outside of 
the context of its native host. This simplified the study of its assembly into the membrane, 
by removing any interacting partner proteins (which are shown in cartoon form in Figure 
5.7), chaperones and any interactions with the iron-sulphur cluster machinery. In the 
native organism, the assembly of Rieske is much more complex, and indeed the Tat 
machinery must not recognise Rieske immediately after its release by the Sec pathway 
because the iron-sufur cluster cofactor must be inserted, and the protein must be allowed 
to fold, before it can be translocated across the membrane (Figure 5.8 panel C). 
Currently nothing is known about how this is achieved for Rieske, however, for other 
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cofactor-containing Tat substrate proteins, system-specific, proof-reading chaperones 
bind to Tat signal sequences of their partner proteins to prevent transport before cofactor 
insertion has occurred (Jack et al., 2004, Maillard et al., 2007, Hatzixanthis et al., 2005, 
Schubert et al., 2007). It is not known whether a similar proof-reading chaperone exists 
for Actinobacterial Rieske proteins, however, these system-specific chaperones are 
usually encoded in operons with the Tat substrate protein they interact with, and there is 
no candidate ORF close to or within the S. coelicolor cytochrome bc1 coding region. 
Nonetheless, co-ordinating cofactor-insertion into Rieske prior to translocation could be 
one important role mediated by the conserved loop region. 
 
Figure 5.7 Schematic representation of the S. coelicolor cytochrome bc1 complex catalytic 
components. 
A representation of the three subunits of the cytochrome bc1 complex from S. coelicolor. The cofactors are 
indicated; FeS for iron-sulfur cluster, yellow diamond for a b-type heme and white diamond for a c-type 
heme. 
A second important role that the loop could serve might be in mediating interactions with 
partner proteins in the cytochrome bc1 complex. Prokaryotic bc1 complexes contain three 
essential catalytic subunits; cytochrome b, cytochrome c1 and Rieske, seen in Figure 
5.7. Cytochrome b, in most bacteria, contains 8 TMD, whereas in Actinobacteria this is 
predicted to be 9 TMD. This protein utilises the SRP/Sec pathway for insertion into the 
cytoplasmic membrane (Figure 5.8, panel A). Two heme b molecules are inserted into 
the apoprotein following its membrane assembly, the mechanism for this insertion is 
unknown. Cytochrome c1, in Actinobacteria, is a membrane-anchored di-heme (Niebisch 
& Bott, 2003) instead of containing a single heme which interacts with a soluble 
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cytochrome c shuttle (Xia et al., 1997). Its insertion into the membrane is Sec-dependent, 
presumably mediated by SecA (Figure 5.8, panel B). Once inserted the covalent 
attachment of heme c by the system I cytochrome c biogenesis machinery occurs at the 
extracytoplasmic side of the membrane (Thony-Meyer & Kunzler, 1997). This is an 
essential step for the folding of the cytochrome and hence generation of the complex. 
Cytochromes b and c1 have been found to form a protease resistant primary complex 
before the final addition of the Rieske protein (Davidson et al., 1992). Rieske is usually 
a single TMD protein with a C-terminal globular FeS cofactor-containing domain, 
however, in Actinobacteria this protein has an additional 2 N-terminal TMDs (Xia et al., 
1997, Kurisu et al., 2003, Keller et al., 2012). The interaction of Rieske with its partner 
proteins is dependent on the insertion of its cofactor (Figure 5.8). Hopkins et al. (2014) 
found that, in S. coelicolor, even when a key component of the Tat system is absent 
(ΔtatC) and the Rieske protein is mislocalised, a stable complex with cytochrome bc1 
components forms. Therefore, it can be proposed that the interactions with the 
cytochrome b and cytochrome c1 components might in part be mediated by the 
cytoplasmic loop region. 
Cytochrome bc1 complexes are obligate dimers, with the bacterial Rieske protein 
contributing significantly to dimer stability by domain swapping; its, usually single, TMD 
obliquely spans the membrane in one monomer while its extrinsic FeS containing domain 
is located in the other monomer (Kurisu et al., 2003). However, Actinobacterial Rieske 
proteins contain additional TMDs which could also contribute to the stability of the 
complex, with the features of the cytoplasmic loop region potentially involved in 
interactions to facilitate this stability. This is especially important as other components of 
the Actinobacterial cytochrome bc1 complex also show unusual features when compared 
to the well-characterised complexes from bovine heart mitochondria and Paracoccus 
dentrificans (Baker et al., 1998, Lenaz & Genova, 2012), for example, the protein 
encoded by qcrB (cytochrome b, Figure 5.7) likewise has an additional TMD compared 
to the mitochondrial homologue (Xia et al., 1997). 
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5.4.2 The minimum cytoplasmic loop length for recognition of TMD3 by the 
Tat pathway is 7 residues  
Although there are no specific features in the Rieske protein cytoplasmic loop region 
(aside from the twin-arginine motif) that are required for recognition of TMD3 by the Tat 
pathway, it was discovered that there is a specific minimum length requirement for the 
loop to allow recognition and translocation by the Tat machinery. As seen in Figure 5.3, 
efficient translocation through the Tat machinery for these variants of Rieske-AmiA 
requires at least 7 residues immediately before the twin-arginines of the Tat motif.  
As discussed in Chapter 4, it is probable that TMD3 remains in the membrane as a 
re-entrant loop due to the Sec machinery attempting to insert it into the membrane before 
the recognition of Sec-avoidance positive charges (a schematic is shown in Figure 
4.19B). If Rieske has a very short cytoplasmic loop region, the formation of a re-entrant 
loop along with the tethering to the membrane by the already inserted TMDs would make 
it problematic for the Tat machinery to recognise the Tat motif which could be embedded 
in the cytoplasmic membrane. This would explain the requirement for a minimum number 
of residues within the loop that enable the Tat motif to be accessible for recognition by 
the Tat machinery while tethered to the membrane.  
These results suggest that the Tat machinery is capable of recognising the Tat motif 
when it is at least partially embedded in the membrane, further supporting the hypothesis 
that at least a fraction of Tat precursors interact with the membrane as an early stage in 
Tat translocation. 
 
 
 
 
Figure 5.8 Schematic of S. coelicolor cytochrome bc1 complex biogenesis. 
1) Translocation of individual components into the cytoplasmic membrane by the Sec machinery, mediated 
by SRP or SecA binding to the signal peptide (SP). 2) Insertion of cofactors; b-type heme (yellow diamond), 
c-type heme (white diamond) and iron-sulfur cluster (FeS) 3) Interactions between cytochrome b and c1 and 
the final insertion step of Rieske by the Tat machinery 4) Model of assembled cytochrome bc1 complex.
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The Rieske proteins of S. coelicolor, and from the work in this thesis M. tuberculosis, are 
the only known proteins to be inserted into the cytoplasmic membrane by the concerted 
action of both the Sec and the Tat machineries (Keller et al., 2012, Hopkins et al., 2014). 
The work in this thesis has shown that there are no specific features of the cytoplasmic 
loop region preceding the twin-arginine motif which facilitate its release from the Sec 
machinery or its recognition by the Tat machinery. Instead it was found that it is the 
topology determinants for insertion by the Sec machinery that are important in the 
release of the polypeptide. The combination of the low hydrophobicity of the final TMD 
and the positive charges located C-terminal to this TMD, enables the Sec machinery to 
release the partially inserted Rieske protein leaving it membrane anchored. This then 
allows the cofactor machinery to insert the FeS cluster prior to the Tat machinery 
recognising the Tat motif and completing the integration process. 
The cooperation of Sec and Tat in the insertion of membrane proteins is a complex 
process which necessitates interplay between two tightly regulated machineries. As 
previously discussed, the Rieske protein studied here displays extra TMDs compared to 
most Rieske proteins yet fulfils a similar cellular role. The presence of extra TMDs likely 
increases the stability of the protein once inserted as well as the overall stability of the 
cytochrome bc1 complex as interactions with the partner proteins are mediated via the 
TMDs (Hopkins et al., 2014, Niebisch & Bott, 2001, Sone et al., 2001).  
An immediate question that arises from this research is how beneficial is it to the cell to 
synthesise such complex membrane proteins? The answer to this is not clear. However, 
it should be noted that there are many examples of multisubunit cofactor-containing 
proteins with membrane anchors that are synthesised as separate polypeptides rather 
than a single dual-targeted protein, two possible examples are the E. coli isoenzymes 
hydrogenase 1 and 2, and the Salmonella enterica tetrathionate reductase, TtrABC 
(James et al., 2013). 
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6.1 Identification of additional dual-targeted membrane proteins 
The study by Keller et al. (2012) along with work described in this thesis leads to some 
interesting further questions, such as how widespread across the domains of life is this 
dual-insertion mode? Is it conserved or is it only found in Actinobacteria? Are there 
further dual targeted proteins? And if so, is the mechanism of assembly of such proteins 
conserved? 
To identify potential dual-targeted candidates, a stringent set of criteria need to be met. 
Firstly, the membrane protein would be required to have a Tat motif N-terminal to the 
final TMD and contain a C-terminal domain that binds a cofactor of the type associated 
with ‘standard’ Tat substrates. In addition, an even number of TMDs must be located 
prior to the Tat motif for the final TMD to be located at the cytoplasmic side of the 
membrane to allow interaction with the Tat machinery. To identify potential candidates 
meeting these criteria, a bioinformatics search was undertaken in collaboration with Dr 
Govind Chandra (John Innes Centre, Norwich; data not shown) where all publicly 
available bacterial and archaeal protein sequences were interrogated using TatFind 
(version 1.4 (Rose et al., 2002)) in conjunction with TMHMM (Server v. 2.0, CBS) to 
select potential dual-targeted candidates. The list was then further sorted manually to 
identify any potential cofactor-containing domains. 
The original search yielded 1712 non-redundant archaeal (58) or bacterial (1654) 
proteins which displayed an overall odd number of TMDs with a potential Tat motif 
located just before the last TMD. The results were classified according to the presence 
of predicted functional domains using EggNOG (Server v. 4.5 (Huerta-Cepas et al., 
2016)) and manually analysed for cofactor-containing domains using Pfam 29.0 (Finn et 
al., 2016). Most candidates were predicted not to contain any cofactor and did not show 
strong conservation of the twin-arginine motif across closely related species, making 
them unlikely to be true dual-targeted proteins. However, from this analysis, two further 
candidates were identified. 
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The first candidate is a predicted polyferredoxin protein which appears to harbour several 
4Fe-4S binding domains, including one at the trans side of the membrane and the 
predicted topology is shown in Figure 6.1B. Homologues of this protein have been found 
in several different species, five of which are listed in Figure 6.1A and their sequences 
are aligned in Figure 6.2.  
 
 
Figure 6.1 Selection of predicted polyferredoxin dual-targeted candidates. 
A) A table of five of the predicted dual-targeted polyferredoxin proteins with their taxonomy. B) Cartoon 
representation of the topology of predicted 5TMD polyferredoxin dual-targeted candidates. The twin-arginine 
motif is indicated by RR and iron-sulfur binding domains by FeS. 
 
Ferredoxin proteins are involved in numerous biological functions, generally linked to 
energy conversion/metabolism (Johnson et al., 2005). FeS cluster-containing proteins 
are frequently found within complexes of the respiratory chain and the export of the FeS 
domain is generally Tat-dependent (Berks, 1996). 4Fe-4S polyferredoxins are often 
referred to as bacterial-type ferredoxins. They are involved in a number of different 
biological functions varying from electron transfer, substrate binding and activation, Fe 
or cluster storage and regulation of gene expression or enzyme activity. Proteins with 
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multiple FeS clusters are likely due to the evolution of bacterial-type ferredoxins by 
intrasequence gene duplication, transposition or fusion events.  
There are no clear functions assigned to any of these predicted dual-targeted candidates 
and deducing the function from neighbouring genes in the operons that encode these 
proteins is not trivial as mostly the available genome sequences are only partial and 
partner proteins are not known. However the presence of FeS clusters at the cytoplasmic 
and periplasmic sides of the membrane suggest that the protein could carry out electron 
transfer reactions from one side of the membrane to the other.  
It is possible that the insertion of the C-terminal FeS cluster into these proteins before 
export into the cytoplasm is part of an internal quality control mechanism. The 
twin-arginines are unlikely to be accessible by the Tat system before the cluster is 
inserted, allowing the cofactor insertion to control the recognition of this region and the 
final translocation of the protein. This is an important step in the mechanism of insertion 
of dual-targeted proteins and would prevent translocation before the protein is fully 
matured. 
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Figure 6.2 A sequence alignment of predicted polyferredoxin dual-targeted candidates. 
The sequence alignment was performed with Jalview using TcoffeeWS (default settings) of the predicted 
polyferredoxin candidates listed in Figure 6.1A. The Tat motif is underlined with the twin-arginines in red and 
the residues involved in Iron–sulphur ligation predicted using MotifFinder are boxed (orange for 4Fe-4S 
before the Tat motif and green for 4Fe-4S in the periplasmic C-terminal extremity). Conserved residues are 
colour-coded according to Jalview, using a conservation threshold of 30. The position of the TMDs was 
predicted with TMHMM and TMPred and is indicated with black line for the template sequence of PFD 
(Q1NSB0).  
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The second dual-targeted candidate protein contains a C-terminal molybdopterin binding 
domain (MoCo). Prokaryotic molybdenum-associated proteins are also Tat-dependent 
with a complicated insertion process occurring in the cytoplasm before export (Iobbi-
Nivol & Leimkuhler, 2013, Berks, 1996). Homologues of the predicted MoCo-containing 
protein from S. coelicolor (SCO3746) were found in 86 different species of bacteria and 
archaea, some of which are shown in Figure 6.3A; 76 of these are in Actinobacteria. 
These proteins are predicted to have 5TMDs prior to the C-terminal-MoCo domain. They 
also display a predicted cytochrome b561 binding domain at their N-terminal region, as 
shown in Figure 6.3B. Despite being reported as absent from prokaryotes and fungi 
(Verelst & Asard, 2003), a family of cytochrome b561 annotated proteins in prokaryotes 
(Murakami et al., 1986) and more recently fungal homologues (Tsubaki et al., 2005) have 
been described. Whereas the function in ascorbate recycling/iron absorption of 
cytochrome b561 in eukaryotes has been extensively studied (Lu et al., 2014), roles for 
these proteins in bacteria remain elusive. Figure 6.4 shows an alignment of the proteins 
in Figure 6.3A, indicating the cofactor binding domains and the Tat motif. 
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Figure 6.3 A selection of predicted molybdopterin dual-targeted proteins. 
A) A table of some of the predicted candidate proteins and their taxonomy. Position and i-Evalue of domains 
is indicated. PF00174: Oxidoreductase molybdopterin binding domain (Pfam ID: Oxidored_molyb) and 
PF01292: Prokaryotic cytochrome b561 (Pfam ID: Ni_hydr_CYTB). B) Cartoon representation of the topology 
of predicted 5TMD molybdopterin dual-targeted proteins. The twin-arginine motif is indicated by RR and the 
molybdopterin-binding domain by MoCo. 
 
As with the predicted polyferredoxin candidates, these proteins also do not have any 
assigned function. However, a number of molybdoenzymes are also sulphite-oxidizing 
enzymes (SOE) with a function as sulphite oxidases or sulphite dehydrogenases. 
Bacterial SOEs, containing a MoCo domain are exported by the Tat system into the 
periplasm (Brokx et al., 2005) where they have been shown to catalyse sulphite 
oxidation. There are a subgroup of bacterial heme-containing SOEs where the 
Tat-dependent MoCo subunit interacts with a membrane-intrinsic heme-containing 
subunit which is Sec-dependent (Kappler, 2011). The domains of these two subunits, 
YedY and YedZ, mimics the predicted MoCo dual-targeted proteins which indicates a 
possible function as a sulphite dehydrogenase, as in these proteins the electrons are 
transferred from the cytochrome to the MoCo domain. The identification of such proteins 
also raises the possibility that heme-MoCo dual-targeted proteins arose during the 
course of evolution from separate polypeptides. Alternatively, the ancestoral protein may 
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have been a dual-targeted fusion of the heme and MoCo domains that subsequently 
separated in some organisms. 
 
 
Figure 6.4 Sequence alignment of predicted MoCo dual-targeted proteins. 
The sequence alignment was performed with Jalview using TcoffeeWS (default settings) using the proteins 
indicated in Figure 6.3A. The Tat motif is underlined with the twin-arginine in red and the residues involved 
in the molybdopterin binding domain predicted using MotifFinder are boxed (Green). The predicted 
cytochrome b561binding domain is underlined in orange. Conserved residues are colour-coded according to 
Jalview, using a conservation threshold of 30. The position of the TMDs was predicted with TMHMM and 
TMPred and is indicated with black line for the template sequence of Sco3746 (Q9L0V8). 
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The bioinformatics search also highlighted around a hundred QcrA (Rieske) proteins with 
3TMDs, suggesting that Rieske is the most common dual-targeted protein. Surprisingly 
a 5TMD Rieske protein (KSE_30950) was also found in the Actinobacterial Kitasatospora 
setae strain. This organism is known to produce setamycin (bafilomycin B1) which has 
antimicrobial activity, and it is morphologically similar to the genus Streptomyces 
(Ichikawa et al., 2010). KSE_30950 is a putative Rieske protein predicted to contain 
5TMDs with a Tat motif directly before the final TMD which is followed by an FeS cluster 
domain. It is interesting to speculate why there are two further TMDs within this organism, 
perhaps due to a duplication of the TMDs. 
Actinobacteria had a higher number of predicted dual-targeted candidates than any other 
phylum. As Streptomyces have also been predicted to have a large number of Tat 
substrates (Schaerlaekens et al., 2004, Widdick et al., 2008, Joshi et al., 2010), this 
indicates that the Tat pathway might have a more important role in these bacteria. 
  
 
Chapter 6: Discussion 
201 
 
 
6.2 Is the mechanism of dual-targeting of S. coelicolor Rieske 
conserved? 
The mechanism of dual-targeting established in this work uses the topology 
requirements for Sec substrates and it was concluded that the combination of 
hydrophobicity and positive charges cause the Sec machinery to release the 
translocating polypeptide allowing the rest of the insertion to occur by the Tat pathway. 
Analysis of the most likely predicted dual-targeted substrates (Sco3746, PFD and 5TMD 
Rieske) found that these proteins, as with S. coelicolor Rieske, have lower 
hydrophobicity of the final TMD, calculated by a positive ΔG value (Table 6.1) and have 
one or more positive charges located directly after the final TMD. Although dual-targeting 
will have to be confirmed experimentally it is very likely that these three candidates are 
inserted into the cytoplasmic membrane by the co-operation of the Sec and Tat 
machineries.  
 
Table 6.1 Predicted ΔG values for TMDs of predicted dual-targeted proteins. 
Strain Protein Number of TMDs Sequence 
Predicted 
ΔG 
S. coelicolor  Rieske 3 IRNTMLGALTLVPLSGVVLLR 1.215 
Kitasatospora setae  Rieske 5 LDGGIAAVALGGAGLLSGSLTA 1.1312 
S. coelicolor  Sco3746 5 RGALWFVGGGSLLMFATNAGRSF 2.166 
deltaproteobacterium 
MLMS-1  
PFD 5 RLLGAAAAGLVVGPLLRVSN 1.419 
 
The presence of additional TMDs in these proven and potential dual-targeted proteins is 
likely due to evolution. Gene duplication is known as an important mechanism for 
adapting to charges in environment (Coenye et al., 2005) and it is possible that TMDs 
were gained in this process alongside the mechanism which evolved to cope with the 
assembly of these proteins. It also possible that they have become evolutionary 
redundant and this mechanism is only retained by the organisms where the larger more 
hydrophobic proteins are essential. This is probably due to diverse locations, dormant 
life cycles and survival in extreme stress conditions. 
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The evolution of this dual-targeted system can only be speculated on until more 
experimentally confirmed substrates have been identified and a clear evolutionary 
pathway investigated. The bioinformatics search has found a large number of potential 
candidates, however, as there are proteins that have been reported to bind cofactors 
with an unusual motif that differs to the standard conserved motifs (Rao et al., 2011), 
these proteins would not have been included in the final output. Further work on 
uncharacterised proteins and novel binding motifs may lead to the identification of a 
larger number of substrates that require this dual insertion mode in the future. 
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8.1 Oligonucleotides used in this study  
Table 8.1 Oligonucleotides used in this study for generation of constructs. 
All oligonucleotides unless designated are forward (white) reverse (grey). 
Primer Sequence Restriction 
sites 
Use 
BamHI Bla GCGCGGATCCATGCACCCAGAAACGCTGG BamHI For construction of vector containing 
Bla 
BamHI AmiA GCGCGGATCCATGAGCACTTTTAAACCACTAAAA BamHI For construction of vector containing 
AmiA 
SU18.1 CGTATGTTGTGTGGAATTGTGAGC 
 
 For sequencing of vector pSU18 & 
pSUPROM 
SU18.2 GGGTAACGCCAGGGTTTTCCC 
 
 For sequencing of vector pSU18 & 
pSUPROM 
Uni-Rep1-Hind GCGCAAGCTTTGTCGGTTGGCGCAAAACACGCTG  For sequencing of Tat promoter 
Inside Bla reverse GCTGCAGGCATCGTGGTGTCACGCTCGTC  For sequencing within Bla 
Inside AmiA reverse TCAAACAGCACTTGTTGCAATAGGTGATC  For sequencing within AmiA 
Mycobacterium 
tuberculosis Rieske 
GCGCGGATCCATGAGCCGCGCGGATGAT BamHI For construction of vector containing 
Mycobacterium tuberculosis extended 
Rieske 
Mycobacterium 
tuberculosis Rieske 
extension 243aa  
GCGCTCTAGACGCCTTCTTGCCTTCCGCGGTCGGCACCACCGGTTT
CCACGGGTTTTTAATCAGGCCGCCCGCAAA 
XbaI For construction of vector containing 
extended MTB Rieske 
Rieske forward GCGCGGATCCATGAGTAGCCAAGACATT BamHI For construction of vector containing 
extended Rieske  
Rieske extension 
205aa reverse 
GCGCTCTAGAGAGCTTGCCCTTGGACCA XbaI For construction of vector containing 
extended Rieske 
Rieske extension 
205aa 
GCGCTCTAGAGAGCTTGCCCTTGGACCACAGGGTGTGGCGGAGCT
TGGTCCCGGGCAGCGGACCGAGGTCGCGCAGCAGGACGACGCC 
XbaI For construction of vector containing 
extended Rieske 
Rieske extension 
204aa 
GCGCTCTAGACTTGCCCTTGGACCACAGGGTGTGGCGGAGCTTGG
TCCCGGGCAGCGGACCGAGGTCGCGCAGCAGGACGACGCC 
XbaI For construction of vector containing 
extended Rieske 
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Rieske extension 
206aa 
GCGCTCTAGAGATGAGCTTGCCCTTGGACCACAGGGTGTGGCGGA
GCTTGGTCCCGGGCAGCGGACCGAGGTCGCGCAGCAGGACGACG
CC 
XbaI For construction of vector containing 
extended Rieske 
Rieske extension 
198aa 
GCGCTCTAGAGGTGTGGCGGAGCTTGGTCCCGGGCAGCGGACCGA
GGTCGCGCAGCAGGACGACGCC 
XbaI For construction of vector containing 
extended Rieske 
Rieske RHHR GTCGCCGACGAGCATCGCCCGATCGAGGCG  For Rieske Quikchange  
 CGCCTCGATCGGGCGATGCTCGTCGGCGAC   
Rieske RHKK GTCGCCGACGAGAAAAAACCGATCGAGGCG  For Rieske Quikchange  
 CGCCTCGATCGGTTTTTTCTCGTCGGCGAC   
Rieske A138P CGTCACCCGATCGAGCCGTCCCCCGAGGTCCGT  For Rieske Quikchange  
 ACGGACCTCGGGGGACGGCTCGATCGGGTGACG   
Rieske A144P TCCCCCGAGGTCCGTCCCAAGGTCCACGCGGAC  For Rieske Quikchange  
 GTCCGCGTGGACCTTGGGACGGACCTCGGGGGA   
Rieske A148P CGTGCCAAGGTCCACCCGGACTTCAAGCAGGGT  For Rieske Quikchange  
 ACCCTGCTTGAAGTCCGGGTGGACCTTGGCACG   
Rieske A154P GACTTCAAGCAGGGTCCCAAGGAGTCCGTGATC  For Rieske Quikchange  
 CAGCACGGACTCCTTGGGACCCTGCTTGAAGTC   
Rieske M124A TGGGCCCGCACCCTGGCCTCCGACGAGGAGGTC  For Rieske Quikchange  
 GACCTCCTCGTCGGAGGCCAGGGTGCGGGCCCA   
Rieske S125A GCCCGCACCCTGATGGCCGACGAGGAGGTCGCC  For Rieske Quikchange  
 GGCGACCTCCTCGTCGGCCATCAGGGTGCGGGC   
Rieske D126A CGCACCCTGATGTCCGCCGAGGAGGTCGCCGAC  For Rieske Quikchange  
 GTCGGCGACCTCCTCGGCGGACATCAGGGTGCG   
Rieske E127A ACCCTGATGTCCGACGCCGAGGTCGCCGACGAG  For Rieske Quikchange  
 CTCGTCGGCGACCTCGGCGTCGGACATCAGGGT   
Rieske M124L TGGGCCCGCACCCTGTTGTCCGACGAGGAGGTC  For Rieske Quikchange  
 GACCTCCTCGTCGGACAACAGGGTGCGGGCCCA   
Rieske S125L GCCCGCACCCTGATGTTGGACGAGGAGGTCGCC  For Rieske Quikchange  
 GGCGACCTCCTCGTCCAACATCAGGGTGCGGGC   
Rieske D126L CGCACCCTGATGTCCTTGGAGGAGGTCGCCGAC  For Rieske Quikchange  
 GTCGGCGACCTCCTCCAAGGACATCAGGGTGCG   
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Rieske E127L ACCCTGATGTCCGACTTGGAGGTCGCCGACGAG  For Rieske Quikchange  
 CTCGTCGGCGACCTCCAAGTCGGACATCAGGGT   
Rieske RRKK GCCAAGGAGTCCGTGATCGGGAAGAAGAAGCTGATCCGCAACACG  For Rieske Quikchange  
 CGTGTTGCGGATCAGCTTCTTCTTCCCGATCACGGACTCCTTGGC   
Rieske RRKQ GCCAAGGAGTCCGTGATCGGGAAGCAGAAGCTGATCCGCAACACG  For Rieske Quikchange  
 CGTGTTGCGGATCAGCTTCTGCTTCCCGATCACGGACTCCTTGGC   
Rieske RRAA GCCAAGGAGTCCGTGATCGGGGCCGCCAAGCTGATCCGCAACACG  For Rieske Quikchange  
 CGTGTTGCGGATCAGCTTGGCGGCCCCGATCACGGACTCCTTGGC   
Rieske RRAD GCCAAGGAGTCCGTGATCGGGGCCGATAAGCTGATCCGCAACACG  For Rieske Quikchange  
 CGTGTTGCGGATCAGCTTATCGGCCCCGATCACGGACTCCTTGGC   
Rieske ∆RR TCCGTGATCGGGAAGCTGATCCGCAACACGATGCTG  For Rieske Quikchange  
 CGCCTAGTCGAAGGGCTAGTGCCTGAGGAACCGTGG   
Rieske ∆118-122 GCGGGCGCGGTCCTGATGTCCGACGAGGAGGTCGCC  For Rieske Modified Quikchange  
 GTCGGACATCAGGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆123-127 TGGGCCCGCACCGAGGTCGCCGACGAGCGTCACCCG  For Rieske Modified Quikchange  
 GTCGGCGACCTCGGTGCGGGCCCAGTGGACCGCGCC   
Rieske ∆128-132 ATGTCCGACGAGCGTCACCCGATCGAGGCGTCCCCC  For Rieske Modified Quikchange  
 GATCGGGTGACGCTCGTCGGACATCAGGGTGCGGGC   
Rieske ∆133-137 GTCGCCGACGAGGCGTCCCCCGAGGTCCGTGCCAAG  For Rieske Modified Quikchange  
 CTCGGGGGACGCGTCGGCGACCTCCTCGTCGGACAT   
Rieske ∆138-142 CACCCGATCGAGCGTGCCAAGGTCCACGCGGACTTC  For Rieske Modified Quikchange  
 GACCTTGGCACGCTCGATCGGGTGACGCTCGTCGGC   
Rieske ∆143-147 TCCCCCGAGGTCGCGGACTTCAAGCAGGGTGCCAAG  For Rieske Modified Quikchange  
 CTTGAAGTCCGCGACCTCGGGGGACGCCTCGATCGG   
Rieske ∆148-152 GCCAAGGTCCACGGTGCCAAGGAGTCCGTGATCGGG  For Rieske Modified Quikchange  
 CTCCTTGGCACCGTGGACCTTGGCACGGACCTCGGG   
Rieske ∆153-157 GACTTCAAGCAGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACCTGCTTGAAGTCCGCGTGGACCTT   
Rieske ∆157-162 GCCAAGGAGTCCAAGCTGATCCGCAACACGATGCTG  For Rieske Modified Quikchange  
 GCGGATCAGCTTGGACTCCTTGGCACCCTGCTTGAA   
Rieske ∆131-132 GAGGAGGTCGCCCGTCACCCGATCGAGGCGTCCCCC  For Rieske Modified Quikchange  
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 GATCGGGTGACGGGCGACCTCCTCGTCGGACATCAG   
Rieske ∆126-128 ACCCTGATGTCCGTCGCCGACGAGCGTCACCCGATC  For Rieske Modified Quikchange  
 CTCGTCGGCGACGGACATCAGGGTGCGGGCCCAGTG   
Rieske ∆137 ∆141 CACCCGATCGCGTCCCCCGTCCGTGCCAAGGTCCACGCG  For Rieske Modified Quikchange  
 GGCACGGACGGGGGACGCGATCGGGTGACGCTCGTCGGC   
Rieske ∆149 ∆156 AAGGTCCACGCGTTCAAGCAGGGTGCCAAGTCCGTGATCGGG  For Rieske Modified Quikchange 
 CCCGATCACGGACTTGGCACCCTGCTTGAACGCGTGGACCTT   
Rieske E137A E141A CGTCACCCGATCGCGGCGTCCCCCGCGGTCCGTGCCAAG  For Rieske Quikchange  
 CTTGGCACGGACCGCGGGGGACGCCGCGATCGGGTGACG   
Rieske D131A E132A GACGAGGAGGTCGCCGCGGCGCGTCACCCGATCGAG  For Rieske Quikchange  
 CTCGATCGGGTGACGCGCCGCGGCGACCTCCTCGTC   
Rieske D126A E127A 
E128A 
GCCCGCACCCTGATGTCCGCGGCGGCGGTCGCCGACGAGCGTCA
C 
 For Rieske Quikchange  
 GTGACGCTCGTCGGCGACCGCCGCCGCGGACATCAGGGTGCGGG
C 
  
Rieske ∆118-127 GCGGGCGCGGTCGAGGTCGCCGACGAGCGTCACCCGATC  For Rieske Modified Quikchange 
 GTCGGCGACCTCGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆128-137 ATGTCCGACGAGGCGTCCCCCGAGGTCCGTGCCAAG  For Rieske Modified Quikchange  
 CTCGGGGGACGCCTCGTCGGACATCAGGGTGCGGGC   
Rieske ∆138-147 CACCCGATCGAGGCGGACTTCAAGCAGGGTGCCAAG  For Rieske Modified Quikchange  
 CTTGAAGTCCGCCTCGATCGGGTGACGCTCGTCGGC   
Rieske ∆148-152 GCCAAGGTCCACGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACGTGGACCTTGGCACGGACCTCGGG   
Rieske Ins D129 E130 
E131 
TCCGACGAGGAGGACGAGGAGGTCGCCGACGAGCGTCACCCGATC  For Rieske Modified Quikchange  
 CTCGTCGGCGACCTCCTCGTCCTCCTCGTCGGACATCAGGGTGCG   
Rieske ∆126-8 ∆131-2 ATGTCCGTCGCCCGTCACCCGATCGAGGCGTCCCCC  For Rieske Modified Quikchange  
 GATCGGGTGACGGGCGACGGACATCAGGGTGCGGGC   
Rieske ∆126-7 ACCCTGATGTCCGAGGTCGCCGACGAGCGTCACCCG  For Rieske Modified Quikchange  
 GTCGGCGACCTCGGACATCAGGGTGCGGGCCCAGTG   
Rieske ∆127-8 CTGATGTCCGACGTCGCCGACGAGCGTCACCCGATC  For Rieske Modified Quikchange  
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 CTCGTCGGCGACGTCGGACATCAGGGTGCGGGCCCA   
Rieske-R185C-Bla TCCGGCGTCGTCCTGCTGTGCTCTAGACACCCAGAAACG  For Rieske Quikchange  
 CGTTTCTGGGTGTCTAGAGCACAGCAGGACGACGCCGGA   
Rieske ∆118-132 GCGGGCGCGGTCCGTCACCCGATCGAGGCGTCCCCC  For Rieske Modified Quikchange 
 GATCGGGTGACGGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆123-137 TGGGCCCGCACCGCGTCCCCCGAGGTCCGTGCCAAG  For Rieske Modified Quikchange  
 CTCGGGGGACGCGGTGCGGGCCCAGTGGACCGCGCC   
Rieske ∆128-142 ATGTCCGACGAGCGTGCCAAGGTCCACGCGGACTTC  For Rieske Modified Quikchange  
 GACCTTGGCACGCTCGTCGGACATCAGGGTGCGGGC   
Rieske ∆133-147 GTCGCCGACGAGGCGGACTTCAAGCAGGGTGCCAAG  For Rieske Modified Quikchange  
 CTTGAAGTCCGCCTCGTCGGCGACCTCCTCGTCGGA   
Rieske ∆138-152 CACCCGATCGAGGGTGCCAAGGAGTCCGTGATCGGG  For Rieske Modified Quikchange  
 CTCCTTGGCACCCTCGATCGGGTGACGCTCGTCGGC   
Rieske ∆143-157 TCCCCCGAGGTCGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACGACCTCGGGGGACGCCTCGATCGG   
Rieske ∆118-137 GCGGGCGCGGTCGCGTCCCCCGAGGTCCGTGCCAAG  For Rieske Modified Quikchange  
 CTCGGGGGACGCGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆138-157 CACCCGATCGAGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACCTCGATCGGGTGACGCTCGTCGGC   
Rieske ∆131-2 with 
template ∆126-8 ∆137 
∆141 
GCGCATGTCCGTCGCCCGTCACCCGATCGCGTCCCCCGTC  For Rieske Modified Quikchange  
 GCGCGATCGGGTGACGGGCGACGGACATCAGGGTGCGGGC   
Rieske D126K E127K 
E128K 
GCGCACCCTGATGTCCAAGAAGAAGGTCGCCGACGAGCGTCACCC
G 
 For Rieske Quikchange 
 GCGCCTCGTCGGCGACCTTCTTCTTGGACATCAGGGTGCGGGCCC
A 
  
Rieske D131K E132K GAGGAGGTCGCCAAGAAGCGTCACCCGATCGAGGCGTCC  For Rieske Quikchange  
 GATCGGGTGACGCTTCTTGGCGACCTCCTCGTCGGACAT   
Rieske E137K E141K CGTCACCCGATCAAGGCGTCCCCCAAGGTCCGTGCCAAGGTCCAC
GCG 
 For Rieske Quikchange  
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 CTTGGCACGGACCTTGGGGGACGCCTTGATCGGGTGACGCTCGTC
GGC 
  
Rieske ∆118-142 GCGGGCGCGGTCCGTGCCAAGGTCCACGCGGACTTC  For Rieske Modified Quikchange  
 GACCTTGGCACGGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆123-147 TGGGCCCGCACCGCGGACTTCAAGCAGGGTGCCAAG  For Rieske Modified Quikchange  
 CTTGAAGTCCGCGGTGCGGGCCCAGTGGACCGCGCC   
Rieske ∆128-152 ATGTCCGACGAGGGTGCCAAGGAGTCCGTGATCGGG  For Rieske Modified Quikchange  
 CTCCTTGGCACCCTCGTCGGACATCAGGGTGCGGGC   
Rieske ∆133-157 GTCGCCGACGAGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACCTCGTCGGCGACCTCCTCGTCGGA   
Rieske ∆118-147 GCGGGCGCGGTCGCGGACTTCAAGCAGGGTGCCAAG  For Rieske Modified Quikchange  
 CTTGAAGTCCGCGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆123-152 TGGGCCCGCACCGGTGCCAAGGAGTCCGTGATCGGG  For Rieske Modified Quikchange  
 CTCCTTGGCACCGGTGCGGGCCCAGTGGACCGCGCC   
Rieske ∆128-157 ATGTCCGACGAGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange 
 GCGCCCGATCACCTCGTCGGACATCAGGGTGCGGGC   
Rieske D131KE132K 
with template 
D126KE127K E128K 
E137KE141K 
AAGAAGGTCGCCAAGAAGCGTCACCCGATCAAGGCGTCC  For Rieske Quikchange  
 GATCGGGTGACGCTTCTTGGCGACCTTCTTCTTGGACAT   
Rieske ∆118-152 GCGGGCGCGGTCGGTGCCAAGGAGTCCGTGATCGGG  For Rieske Modified Quikchange  
 CTCCTTGGCACCGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆123-157 TGGGCCCGCACCGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACGGTGCGGGCCCAGTGGACCGCGCC   
Rieske ∆118-157 GCGGGCGCGGTCGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange  
 GCGCCCGATCACGACCGCGCCCGCGCCGATGGCGAA   
Rieske-R185A-Bla TCCGGCGTCGTCCTGCTGGCGTCTAGACACCCAGAAACG  For Rieske Quikchange  
 CGTTTCTGGGTGTCTAGACGCCAGCAGGACGACGCCGGA   
Rieske ∆118-153 GCGGGCGCGGTCGCCAAGGAGTCCGTGATCGGGCGC  For Rieske Modified Quikchange  
 GGACTCCTTGGCGACCGCGCCCGCGCCGATGGCGAA   
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Rieske ∆118-154 GCGGGCGCGGTCAAGGAGTCCGTGATCGGGCGCCGC  For Rieske Modified Quikchange  
 CACGGACTCCTTGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆118-155 GCGGGCGCGGTCGAGTCCGTGATCGGGCGCCGCAAG  For Rieske Modified Quikchange  
 GATCACGGACTCGACCGCGCCCGCGCCGATGGCGAA   
Rieske ∆118-156 GCGGGCGCGGTCTCCGTGATCGGGCGCCGCAAGCTG  For Rieske Modified Quikchange 
 CCCGATCACGGAGACCGCGCCCGCGCCGATGGCGAA   
Rieske S179LG180L ACCCTGGTGCCGCTCCTGCTGGTCGTCCTGCTGCGC  For Rieske Quikchange  
 GCGCAGCAGGACGACCAGCAGGAGCGGCACCAGGGT   
Rieske P177L S179L 
G180L 
GCGCTCACCCTGGTGCTGCTCCTGCTGGTCGTCCTGCTGCGC  For Rieske Quikchange  
 GCGCAGCAGGACGACCAGCAGGAGCAGCACCAGGGTGAGCGC   
Rieske V158C GGTGCCAAGGAGTCCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGGACTCCTTGGCACC   
Rieske ∆118-153 
V158C 
GTCGCCAAGGAGTCCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGGACTCCTTGGCGAC   
Rieske ∆118-154 
V158C 
GCGGTCAAGGAGTCCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGGACTCCTTGACCGC   
Rieske ∆118-155 
V158C 
GGCGCGGTCGAGTCCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGGACTCGACCGCGCC   
Rieske ∆118-156 
V158C 
GCGGGCGCGGTCTCCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGGAGACCGCGCCCGC   
Rieske ∆118-157 
V158C 
GGCGCGGGCGCGGTCTGCATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATGCAGACCGCGCCCGCGCC   
Rieske V158K GGTGCCAAGGAGTCCAAGATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATCTTGGACTCCTTGGCACC   
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Rieske ∆118-153 
V158K 
GTCGCCAAGGAGTCCAAGATCGGGCGCCGCAAG  For Rieske Quikchange 
 CTTGCGGCGCCCGATCTTGGACTCCTTGGCGAC   
Rieske ∆118-154 
V158K 
GCGGTCAAGGAGTCCAAGATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATCTTGGACTCCTTGACCGC   
Rieske ∆118-155 
V158K 
GGCGCGGTCGAGTCCAAGATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATCTTGGACTCGACCGCGCC   
Rieske ∆118-156 
V158K 
GCGGGCGCGGTCTCCAAGATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATCTTGGAGACCGCGCCCGC   
Rieske ∆118-157 
V158K 
GGCGCGGGCGCGGTCAAGATCGGGCGCCGCAAG  For Rieske Quikchange  
 CTTGCGGCGCCCGATCTTGACCGCGCCCGCGCC   
Rieske V82C TTCGTGGCGATCGACTGTGACAAGTCGGTCTAC  For Rieske Quikchange  
 GTAGACCGACTTGTCACAGTCGATCGCCACGAA   
Rieske S179L ACCCTGGTGCCGCTCCTGGGCGTCGTCCTGCTGCGC  For Rieske Quikchange 
 GCGCAGCAGGACGACGCCCAGGAGCGGCACCAGGGT   
Rieske G180L ACCCTGGTGCCGCTCTCCCTGGTCGTCCTGCTGCGC  For Rieske Quikchange  
 GCGCAGCAGGACGACCAGGGAGAGCGGCACCAGGGT   
Rieske Δ124-157 GCCCGCACCCTGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange 
 GCGCCCGATCACCAGGGTGCGGGCCCAGTGGACCGC   
Rieske Δ125-157 CGCACCCTGATGGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange 
 GCGCCCGATCACCATCAGGGTGCGGGCCCAGTGGAC   
Rieske Δ126-157 ACCCTGATGTCCGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange 
 GCGCCCGATCACGGACATCAGGGTGCGGGCCCAGTG   
Rieske Δ127-157 CTGATGTCCGACGTGATCGGGCGCCGCAAGCTGATC  For Rieske Modified Quikchange 
 GCGCCCGATCACGTCGGACATCAGGGTGCGGGCCCA   
Rieske Loop HWKES GCGGTCCACTGGAAGGAGTCCGTGATCGGGCGCCGC  For Rieske Modified Quikchange 
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 CACGGACTCCTTCCAGTGGACCGCGCCCGCGCCGAT   
Rieske Loop HWAKES GCGGTCCACTGGGCCAAGGAGTCCGTGATCGGGCGCCGC  For Rieske Modified Quikchange 
 CACGGACTCCTTGGCCCAGTGGACCGCGCCCGCGCCGAT   
Rieske Loop HWES GCGGTCCACTGGGAGTCCGTGATCGGGCGCCGC  For Rieske Modified Quikchange 
 CACGGACTCCCAGTGGACCGCGCCCGCGCCGAT   
Mycobacterium 
tuberculosis Rieske 
RRAD 
GGCAGCACCATTCGCGCCGACAAACTGATTGGCCTG  For MTB Rieske Quikchange 
 CAGGCCAATCAGTTTGTCGGCGCGAATGGTGCTGCC   
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8.2 Rieske-Bla quantification Western blots 
 
 
Figure 8.1 Protein is still stably produced from all truncation variants.  
In triplicate, biological replicates of crude membrane extracts of DADE (tat-) harbouring the pSUPROM vector 
alone (Empty vector) or the pSUPROM vector encoding Rieske-Bla or loop truncation variants (Δ123-157-
Rieske-Bla, Δ118-152-Rieske-Bla, Δ118-153-Rieske-Bla, Δ118-154-Rieske-Bla, Δ118-155-Rieske-Bla, 
Δ118-156-Rieske-Bla and Δ118-157-Rieske-Bla) were separated on SDS-PAGE (12% acrylamide), 
electroblotted and immunoreactive bands were detected with anti-Rieske peptide antibody (top panels). As 
a loading control the levels of the OM protein BamA were detected using an anti-BamA antiserum (bottom 
panels). 
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8.3 Rieske-AmiA quantification Western blots 
 
Figure 8.2 Protein is still stably produced from all truncation variants. 
In triplicate, biological replicates of crude membrane extracts of MCDSSAC (tat+) harbouring the pSUPROM 
vector alone (Empty vector) or the pSUPROM vector encoding Rieske-AmiA or loop truncation variants 
Δ118-152-Rieske- AmiA, Δ118-153-Rieske-AmiA, Δ118-154-Rieske-AmiA, Δ118-155-Rieske-AmiA, Δ118-
156-Rieske-AmiA and Δ118-157-Rieske-AmiA were separated on SDS-PAGE (12% acrylamide), 
electroblotted and immunoreactive bands were detected with anti-Rieske peptide antibody (top panels). As 
a loading control the levels of the OM protein BamA were detected using an anti-BamA antiserum (bottom 
panels). 
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8.4 Rieske-AmiA SDS tests 
 
Figure 8.3 SDS test analysis of predicted α-helix variants and negative charge region variants. 
Representative spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring the 
pSUPROM vector encoding Rieske-AmiA or predicited α–helix fusion variants (A138P-Rieske-AmiA, A144P-
Rieske-AmiA, A148P-Rieske-AmiA and A154P-Rieske-AmiA) or negative charge region fusion variants 
(M124A-Rieske-AmiA, M124L-Rieske-AmiA, S125A-Rieske-AmiA, S125A-Rieske-AmiA, D126A-Rieske-
AmiA, D126A-Rieske-AmiA E127A-Rieske-AmiA and E127L-Rieske-AmiA). Strains were grown overnight 
in liquid media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 5 µl aliquots which were spotted 
onto LB solid agar (A) and LB solid agar containing 1% (w/v) SDS (B). LB agar plates were incubated at 
37°C for 16 h.  
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Figure 8.4 SDS test analysis of truncation variants of 5, 10 and 15 residues. 
Representative spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring the 
pSUPROM vector encoding Rieske-AmiA or 5 aa deletion fusion variants (Δ118-122-Rieske-AmiA, Δ123-
127-Rieske-AmiA, Δ128-132-Rieske-AmiA, Δ133-137-Rieske-AmiA, Δ138-142-Rieske-AmiA, Δ143-147-
Rieske-AmiA, Δ148-152-Rieske-AmiA Δ153-157-Rieske-AmiA and Δ158-162-Rieske-AmiA) or 10 aa 
deletion fusion variants (Δ118-127-Rieske-AmiA, Δ128-137-Rieske-AmiA, Δ138-147-Rieske-AmiA, and 
Δ148-157-Rieske-AmiA) or 15 aa deletion fusion variants (Δ118-132-Rieske-AmiA, Δ123-137-Rieske-AmiA, 
Δ128-142-Rieske-AmiA, Δ133-147-Rieske-AmiA, Δ138-152-Rieske-AmiA, and Δ143-157-Rieske-AmiA). 
Strains were grown overnight in liquid media, diluted to give serial dilutions of 10, 102, 103 and 104 cells per 
5 µl aliquots which were spotted onto LB solid agar (A) and LB solid agar containing 1% (w/v) SDS (B). LB 
agar plates were incubated at 37°C for 16 h.  
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Figure 8.5 SDS test analysis of truncation variants of 20, 25 and 30 residues. 
Representative spot tests of strains MCDSSAC (tat+ strain) and MCDSSACΔtat (tat- strain) harbouring the 
pSUPROM vector encoding Rieske-AmiA or 20 aa deletion fusion variants (Δ118-137-Rieske-AmiA and 
Δ138-157-Rieske-AmiA) or 25 aa deletion fusion variants (Δ118-142-Rieske-AmiA, Δ123-147-Rieske-AmiA, 
and Δ128-152-Rieske-AmiA) or 30 aa deletion fusion variants (Δ118-147-Rieske-AmiA, Δ123-152-Rieske-
AmiA, and Δ128-157-Rieske-AmiA). Strains were grown overnight in liquid media, diluted to give serial 
dilutions of 10, 102, 103 and 104 cells per 5 µl aliquots which were spotted onto LB solid agar (A) and LB solid 
agar containing 1% (w/v) SDS (B). LB agar plates were incubated at 37°C for 16 h.  
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8.5 Rieske-Bla MIC tests 
 
Figure 8.6 M.I.C. analysis of Twin-arginine variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding Rieske-Bla and 
twin-arginine variants (RRKK-Rieske-Bla, RRAD-Rieske-Bla, RRAA-Rieske-Bla, RRKQ-Rieske-Bla and 
ΔRR-Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread 
onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C 
for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip and the clearing of 
bacteria. The table indicates the mean M.I.C. and in brackets the s.d. and number of biological replicates, 
n. 
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Figure 8.7 M.I.C. analysis of negatively charged region variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding negatively charged 
region variants (M124A-Rieske-Bla, S125A-Rieske-Bla, D126A-Rieske-Bla, E127A-Rieske-Bla M124L-
Rieske-Bla, S125L-Rieske-Bla, D126L-Rieske-Bla and E127L-Rieske-Bla). Stationary phase cultures were 
diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were 
placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at 
the intersection of the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. and in 
brackets the s.d. and number of biological replicates, n. 
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Figure 8.8 M.I.C. analysis of predicted α-helix and RH motif variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding predicted α-helix 
(A138P-Rieske-Bla, A144P-Rieske-Bla, A148P-Rieske-Bla, A154P-Rieske-Bla) or RH variants (RHHR-
Rieske-Bla, and RHKK-Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn of 
bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets the s.d. and number of 
biological replicates, n. 
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Figure 8.9 M.I.C. analysis of truncations of negatively charged variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding deletions of negatively 
charged variants (Δ126-128-Rieske-Bla, Δ126-127-Rieske-Bla, Δ127-128-Rieske-Bla, Δ131-132-Rieske-
Bla, Δ137Δ141-Rieske-Bla and Δ149Δ156-Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 
and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn 
and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of 
the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets the s.d. and 
number of biological replicates, n. 
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Figure 8.10 M.I.C. analysis of truncations of negatively charged variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding deletions of negatively 
charged variants (Δ128-128Δ137Δ141-Rieske-Bla, Δ126-128Δ131-132-Rieske-Bla, Δ131-132Δ137Δ141-
Rieske-Bla, Δ126-128Δ131-132Δ137Δ141-Rieske-Bla and Δ126-128Δ131-132Δ137Δ141Δ149Δ156-
Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB 
agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. 
The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The 
table indicates the mean M.I.C. and in brackets the s.d. and number of biological replicates, n. 
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Figure 8.11 M.I.C. analysis of negatively charged variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding negatively charged 
variants (InsD129E130E131-Rieske-Bla, D131AE132A-Rieske-Bla, E137AE141A-Rieske-Bla, and 
D126AE127AE128A-Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria 
was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate was 
incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip and 
the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets the s.d. and number of biological 
replicates, n. 
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Figure 8.12 M.I.C. analysis of negatively charged variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding negatively charged 
variants (D131KE132K-Rieske-Bla, E137KE141K-Rieske-Bla, D126KE127KE128K-Rieske-Bla, 
D126KE127KE128KE137KE141K-Rieske-Bla and D126KE127KE128KD131KE132KE137KE141K -
Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB 
agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. 
The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The 
table indicates the mean M.I.C. and in brackets the s.d. and number of biological replicates, n. 
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Figure 8.13 M.I.C. analysis of 5aa truncation variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding truncations of 5aa 
variants (Δ118-122-Rieske-Bla, Δ123-127-Rieske-Bla, Δ128-132-Rieske-Bla, Δ133-137-Rieske-Bla, Δ138-
142-Rieske-Bla, Δ143-147-Rieske-Bla, Δ148-152-Rieske-Bla and Δ153-157-Rieske-Bla). Stationary phase 
cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM 
strips were placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin 
is read at the intersection of the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. 
and in brackets the s.d. and number of biological replicates, n. 
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Figure 8.14 M.I.C. analysis of 10aa and 20aa truncation variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding truncations of 10aa 
(Δ118-127-Rieske-Bla, Δ123-137-Rieske-Bla, Δ138-147-Rieske-Bla, Δ148-157-Rieske-Bla) or 20aa 
variants (Δ118-137-Rieske-Bla and Δ138-157-Rieske-Bla). Stationary phase cultures were diluted to OD600 
0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn 
and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of 
the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets the s.d. and 
number of biological replicates, n. 
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Figure 8.15 M.I.C. analysis of 15aa truncation variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding truncations of 15aa 
variants (Δ118-132-Rieske-Bla, Δ123-137-Rieske-Bla, Δ128-142-Rieske-Bla, Δ133-147-Rieske-Bla, Δ138-
152-Rieske-Bla, and Δ143-157-Rieske-Bla). Stationary phase cultures were diluted to OD600 0.1 and a lawn 
of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn and the plate 
was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of the test strip 
and the clearing of bacteria. The tables indicates the mean M.I.C. and in brackets the s.d. and number of 
biological replicates, n. 
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Figure 8.16 M.I.C. analysis of 25aa truncation variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding truncations of 25aa 
variants (Δ118-142-Rieske-Bla, Δ123-147-Rieske-Bla, Δ128-152-Rieske-Bla, and Δ133-157-Rieske-Bla). 
Stationary phase cultures were diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, 
M.I.C.EvaluatorTM strips were placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. 
(μg/ml) for ampicillin is read at the intersection of the test strip and the clearing of bacteria. The table indicates 
the mean M.I.C. and in brackets the s.d. and number of biological replicates, n. 
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Figure 8.17 M.I.C. analysis of 30aa to 40aa truncation variants.  
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding truncations of 30aa 
(Δ118-147-Rieske-Bla, Δ123-152-Rieske-Bla, Δ128-157-Rieske-Bla) or 35aa (Δ118-152-Rieske-Bla and 
Δ123-157-Rieske-Bla) or significant truncation variants (Δ118-153-Rieske-Bla, Δ118-154-Rieske-Bla, Δ118-
155-Rieske-Bla, Δ118-156-Rieske-Bla and Δ118-157-Rieske-Bla). Stationary phase cultures were diluted to 
OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on 
the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the 
intersection of the test strip and the clearing of bacteria. The tables indicates the mean M.I.C. and in brackets 
the s.d. and number of biological replicates, n. 
 
Chapter 8: Appendix 
245 
 
 
 
Figure 8.18 M.I.C. analysis of truncation variants with V158K. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding significant truncation 
variants (V158K, Δ118-153 V158K-Rieske-Bla, Δ118-154V158K-Rieske-Bla, Δ118-155V158K-Rieske-Bla, 
Δ118-156V158K-Rieske-Bla and Δ118-157V158K-Rieske-Bla). Stationary phase cultures were diluted to 
OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on 
the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the 
intersection of the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets 
the s.d. and number of biological replicates, n. 
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Figure 8.19 M.I.C. analysis of hydrophobicity variants and R185 variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding hydrophobicity 
(S180L-Rieske-Bla, G179L-Rieske-Bla, G179LS180L-Rieske-Bla and P177LG179LS180L-Rieske-Bla) or 
R185 variants (R185C-Rieske-Bla, and R185A-Rieske-Bla,). Stationary phase cultures were diluted to OD600 
0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were placed on the lawn 
and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at the intersection of 
the test strip and the clearing of bacteria. The tables indicate the mean M.I.C. and in brackets the s.d. and 
number of biological replicates, n. 
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Figure 8.20 M.I.C. analysis of M. tuberculosis Rieske-Bla variants. 
M.I.C.EvaluatorTM strip test of DADE (tat-) harbouring the pSUPROM vector encoding M. tuberculosis 
variants (Rieske-Bla, RRAD-Rieske-Bla and 243-extended-Rieske-Bla,). Stationary phase cultures were 
diluted to OD600 0.1 and a lawn of bacteria was spread onto LB agar plates, M.I.C.EvaluatorTM strips were 
placed on the lawn and the plate was incubated at 37°C for 18 h. The M.I.C. (μg/ml) for ampicillin is read at 
the intersection of the test strip and the clearing of bacteria. The table indicates the mean M.I.C. and in 
brackets the s.d. and number of biological replicates, n. 
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